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Introduction  
Until the late 1960s blood collected in glass bottles was transfused to recipients as whole 
blood.  The introduction of closed sterile plastic blood bag systems of polyvinylchloride 
permitted separation of blood into several components and therewith ‘blood component 
therapy’. This therapy includes the use of only the needed blood component for the patients, 
allowing optimal utilization of donated whole blood.  By means of differential centrifugation 
whole blood can be separated through an integrated system of bags into components. The 
basic components of blood are red blood cells, platelets and plasma. Red cells are transfused 
to improve oxygen delivery from the lungs to the cells of the body, platelets are essential in 
hemostasis. Plasma is transfused to patients who need multiple clotting factors. However, the 
major part of plasma is not transfused as such but further fractionated into different plasma 
components (such as clotting factors, immunoglobulins and albumin). 
Transfusion of blood components involves many hazards. Among these, transmissions of 
viral and bacterial infections are the most known. Bacteria in donated blood have already been 
recognized as a risk for infectious disease when blood was collected and stored in glass 
bottles 
(1)
. The introduction of closed sterile bag systems has contributed to the reduction of 
this risk. Nevertheless compared to the great decline in the occurrence of transmission of viral 
diseases in the last decades, septicemia due to blood components contaminated with bacteria, 
particularly platelets persists. At present it is estimated that 1 in 3,000 platelet concentrates 
(PCs) may induce sepsis in the recipient, whereas the risk to transmit viral infections is 1 in 
200,000 (HBV) to approximately 1 in 2,000,000 (HIV, HCV) 
(2,3,4)
.  
In this introduction first the processing of whole blood into components will be described 
followed by a description of the methods currently applied to screen PCs for bacterial 
contamination.  
 
Processing of whole blood into components 
Collection of whole blood begins with inserting a needle into a vein of the arm of a healthy 
volunteer.  Prior to this the site of venepuncture is disinfected. The blood flows through the 
needle into a sterile collection bag containing an anticoagulant. The collection is ended by 
heat sealing the tubing and thereby closing off the blood bag. Drawn whole blood is used as 
source for blood component preparation. Upon subjection of this blood to centrifugation the 
platelets, leukocytes, and red cells fractionate according to their size and density. 
By low speed centrifugation a layer of platelet-rich plasma (PRP) containing leukocytes and a 
layer of red cells mixed with leukocytes and some platelets is formed. The PRP is transferred 
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to another bag and subjected to a second hard spin. The major part of platelet-poor plasma is 
then removed and the pellet of platelets is resuspended in about 60 mL of plasma. This PRP 
can be transfused as single units or can be pooled (4 to 6 units) prior to transfusion 
(5)
. The 
units can be filtered to reduce the number of leukocytes. Reduction of leukocytes is beneficial 
in preventing adverse reactions in recipients 
(6)
. 
The red cells can also be leukocyte-reduced by using a dedicated filter. The platelet-poor 
plasma is immediately frozen at or below -30
o
C . 
Another method of separating whole blood consists of high speed centrifugation 
(7,8,9)
. Three 
fractions are obtained: a cell free plasma, a buffy coat fraction containing 90% of the platelets, 
70% of the leukocytes and some red cells, and a red cell fraction comprising residual 
leukocytes and some platelets. These 3 fractions can be separated in different bags. Prior to 
transfusion the red cells fraction is diluted in an additive nutrient solution. Due to the high 
hematocrit, red cells are very viscous and do not flow easily through infusion lines. For this 
reason cell suspensions are diluted. Leukocyte-reduced red cells can be prepared by filtration. 
The plasma is immediately frozen at or below -30 
o
C. To obtain a therapeutic dose of platelets 
for transfusion to an adult, 4 to 6 units of ABO identical buffy coats are pooled together with 
a unit of plasma or platelet additive solution. Following a soft spin centrifugation the platelet-
rich supernatant is transferred through a leukocyte-reduction filter to a platelet storage bag. 
Blood components can also be prepared following the apheresis method: this method involves 
the use of a blood cell separator where blood circulation of the donor is connected to a 
centrifuge. With this system separation of blood takes place during the collection procedure. 
The intended component is transferred to a bag, whereas other blood components are returned 
to the donor.  
 
Storage of blood components 
Red cells are stored at +2 to +6 
o
C. Depending on the nutrients in the storage medium, plasma 
or additive solution, the storage time can be extended up to 42 days with preservation of 
quality. 
Plasma is freshly frozen to maintain labile clotting factors, and can be stored for up to 2 years 
at temperatures below -30 
o
C. 
PCs are stored at +20 to +24 
o
C with continuous gentle agitation for up to 5 days. Under 
optimal conditions, storage of PCs for up to 7 days without compromising the quality is 
possible. 
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In the early days of transfusion, platelets were stored at 4
o
C 
(1,3)
. Under these conditions their 
viability and haemostatic activities were affected. Alternatively, storage at room temperature 
for 3 days was proposed in the 1970s. With the development of gas permeable plastic bags to 
further preserve the quality of platelets at room temperature in 1981, the shelf life of PCs was 
extended from 3 to 5 days, and in 1984, it was further prolonged to 7 days. However storage 
under these conditions was facilitating for growth of bacteria. Due to the increase in the 
number of cases of platelet contamination with bacteria and instances of transfusion-
transmitted bacterial infections, the maximally allowed storage time of 7 days was reduced 
back to 5 days in 1986.  
Nowadays, a storage time for up to 7 days is permitted by the Food and Drug Administration 
(FDA) in the United States provided that a validated system for screening of PCs for bacterial 
contamination is implemented. In the Netherlands, bacterial screening of all PCs became 
mandatory since November 2001. The implementation of such a detection system allowed the 
prolongation of the storage time of PCs to 7 days 
(10)
. 
 
Over the years, the storage time of platelets at room temperature appeared to be correlated to 
the occurrence of bacterial contamination. This problem was a concern since the introduction 
of blood transfusion in medical practice. As early as 1951 Borden and Hall reported 2 
fatalities linked to the transfusion of whole blood contaminated with bacteria 
(1)
. Since then, 
numerous cases of platelets contamination and instances of transfusion-transmitted bacterial 
infections have been published. For example, during the period of 1998 to 2000, six cases of 
platelet transfusion-related fatalities were reported to FDA
(11)
. The UK surveillance system, 
SHOT (Serious Hazards of Transfusion) programme, reported 26 transfusion-transmitted 
infections, including 6 deaths between 1995 and 2002 
(12)
. From 1994 to 1998 the French 
Blood Agency Haemovigilance system has registered 18 deaths caused by transfusion of 
bacterially contaminated blood components 
(13,14)
.  Hence, to exclude this risk, blood centers 
are recommended to implement a system to assure the absence of bacterial contamination 
prior to transfusion of PCs. 
 
Screening for bacterial contamination of PCs 
Bacteria implicated in contamination 
Most organisms detected in contaminated PCs are a variety of Gram-negative and Gram-
positive bacteria. The organisms implicated in contamination comprised coagulase-negative 
Staphylococcus spp., B. cereus, Streptococcus spp., Peptostreptococcus spp., 
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Propionibacterium acnes, Klebsiella pneumoniae, and diphteroids 
(11,15,16,17,18)
. The majority 
of these organisms belong to the human skin flora. The frequency of contamination with these 
bacteria varies between countries and between blood centers within the same country. Clinical 
sequelae due to transfusion of bacterially contaminated platelets range from no symptoms to 
mild fever to acute sepsis, hypotension and death. 
 
Sources of contamination 
Although the source of contamination of PCs is difficult to trace, it is generally believed that 
contamination can be introduced via blood of the donor, during collection of blood or during 
the blood component manufacturing process 
(20,21,22)
. 
 
Blood donor 
An asymptomatic bacteraemia in donors can be responsible for contamination of collected 
whole blood and subsequent products. Several cases of transfusion associated Salmonella 
sepsis have been reported. A special case of contamination of PCs with Salmonella enterica 
resulting in sepsis in the recipient was described by Jafari et al. 
(23)
. The source of 
contamination was linked to a pet reptile of the donor. This example emphasizes the 
importance of careful selection of donors. 
Also transient bacteremia in the donor may cause transfusion-associated septicemia in 
recipients. Endoscopic examination or dental procedures such as tooth extraction might 
predispose a donor to a transient bacteremia. As a preventive measure, in many countries 
donors who have been submitted to dental procedures are deferred from donating blood for a 
few days to one week. 
 
Blood collection   
Contamination can be due to inadequate disinfection of the skin at the phlebotomy site. 
Dependent on the method and materials used to prepare the donor’s arm, bacteria from the 
surface of the skin can be introduced in the blood collection bag. However bacteria from other 
sources than skin flora may be responsible for contamination as well. For example a fatal 
sepsis due to transfusion of PCs contaminated with Clostridium perfringens was lately 
reported 
(24)
. This bacterium was cultured from the venepuncture site of the arm of one of the 
donors. The donor frequently carried his baby in the crook of his arm after changing nappies.  
It is likely that the skin of the arm of the donor became contaminated by fecal flora in this 
way. This case highlights the importance of optimal skin cleansing methods. 
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Contamination may also arise from disinfectants used to prepare the phlebotomy site. Cases 
of contamination as a result of contaminated disinfectants with B. cepacia were reported by 
Garcia-Erce et al. 
(25)
. 
It has been postulated that coring of skin during the phlebotomy process may facilitate the 
entrance of bacteria into the collection bag. To reduce the rate of contamination through this 
route, several measures have been taken. These include the improvement of methods to 
disinfect the skin of the donor and the diversion of the first 10 - 40 mL aliquots of whole 
blood. This latter method appeared promising as described by De Korte et al. 
(26)
. The authors 
reported a reduction of 0.35% to 0.21% in the prevalence of bacteria after diverting the initial 
volumes of whole blood. The reduction concerned in most cases bacteria belonging to the 
skin surface.   
In another study McDonald et al. 
(27)
 reported a reduction in contamination of 47% when 
diversion of the initial aliquots was applied. The reduction reached 57% when diversion was 
done in combination with an improved donor-arm disinfection procedure. 
To date, diverting the first aliquots of blood is becoming a routine procedure during collection 
of whole blood in many blood centers 
(28)
.  
 
Blood manufacturing 
PCs may be contaminated due to improper manufacturing of blood products or the use of 
unsterile equipment and devices (due to pinholes or unsterile connections). It is also possible 
that samples may become contaminated during inoculation of the culture bottles of the 
BacT/Alert system as part of the quality control (QC) of PCs.  
Although rarely, contaminated equipment, such as blood bags used in blood collection, has 
been implicated as the source of bacterial contamination of PCs 
(29,30).
 To provide safer 
practices all aspects of blood collection, processing, storing, and transfusion are continuously 
improved.  
 
Detection methods 
Metabolic parameters and visual examination 
Bacterial growth typically results in glucose consumption and acid production. This latter 
causes a decrease of pH in the environment where the bacteria reside. Consequently abnormal 
glucose concentrations and low pH have been widely used as indicators of the presence of 
bacteria in PCs. To this end, several glucose devices and pH meters have been employed such 
   
 15 
as multireagent strips (dipstick methods). These methods have been evaluated in several 
studies 
(31,32,33)
. Although these tests are rapid, easy to perform and inexpensive, they are not 
very sensitive, since they detect only levels of at least 10
7
 to 10
8
 CFU/mL of bacteria. 
Moreover, some species of bacteria do not detectably decrease the pH of PCs. Recently, 
Tarrand and coworkers 
(34) 
showed the inability of these reagents to detect Staphylococcus 
epidermidis. The analysis of PCs spiked with 100, 1000 and 10,000 CFU/unit showed no 
change by the reagent strip method after 5 days of routine storage, while all these units were 
culture positive. Metabolic parameters, therefore, are not sensitive enough to be used as a 
screening tool of PCs.   
 
The cessation of platelet swirling has also been used as indicator of bacterial contamination 
(31)
. Swirling is a phenomenon related to the morphology of platelets: fresh platelets are 
discoid. During storage they may undergo a change in shape from disc to sphere. This 
morphologic alteration is thought to be accompanied by a loss of viability. The swirling effect 
occurs as a result of reflection of light scattered by discoid platelets in movement. This 
scattering is reduced or absent in non-discoid spherical platelets. In addition it is generally 
believed that bacterial metabolism produces a lower pH leading to a  morphology change and 
decrease of this swirling effect. However, a bacterial load as high as 10 
7 
- 10 
8  
CFU/mL is 
required to induce this process. The swirling can be recorded semiquantitatively as present, 
absent, or questionably present. Owing to the subjectiveness of interpretation and lack of 
reproducibility, the observation of the swirling effect is not suited to form the basis for routine 
testing of PCs for bacterial contamination. 
 
Microscopy 
Microscopic examination of PCs has been proposed as a mean of screening PCs for bacterial 
contamination. Gram stain and Acridine Orange are commonly used 
(35)
. These staining 
methods are hampered by a low sensitivity, since only high levels of bacterial contamination 
can be detected. The lower limits of detection of Gram stain and Acridine Orange are 10
5 
- 10
6 
and 10
4
- 10
5
 CFU/mL, respectively. 
Other microscopic methods include epifluorescence microscopy. This method combines 
fluorescent nucleic acid staining and automated epifluorescence microscopy. This latter was 
initially evaluated with PCs contaminated with Escherichia coli and Staphylococcus 
epidermidis. The detection limit ranges between 3 to 5 x 10
3 
bacteria/mL. The test is 
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accomplished in about 95 min when analyzing 6 samples. Further validation studies using 
other bacterial strains are necessary to demonstrate the utility of this method 
(36)
.  
Other systems contemplating the use of epifluorescence microscopy are under investigation. 
Among these are the Scansystem (Hemosystem, Marseille, France) 
(37)
. This new approach 
consists of 3 major steps: first, platelet aggregation is induced by a monoclonal antibody. 
Second, DNA is labeled with a specific fluorescent marker. Finally the bacteria are 
concentrated on a membrane surface for enumeration by solid-phase laser scanning 
cytometer. The cytometer is linked to an epifluorescence microscope. This system was 
validated with 9 bacterial species. Dependent on the type of the bacterium present a detection 
limit of 10-10
3
 CFU/mL was recently reported 
(37)
. The test is rapid and the results can be 
obtained in less than 90 min. 
 
DNA/RNA-based methods 
Methods using probes targeting ribosomal DNA or RNA of bacteria are widely employed as 
rapid and sensitive approaches for screening PCs for bacterial contamination. 
An assay with Electrochemiluminescence (ECL)-linked universal bacterial RNA probe has 
been applied. In this assay a specific probe targeting bacterial 16S rRNA, coupled to ECL is 
used. In a study reported by Rider et al. 
(38)
, a sensitivity of approximately 10
5
 CFU/mL was 
obtained. Attempts to enhance the ECL assay sensitivity in a later study conducted by the 
same authors resulted in the improvement of sensitivity to 10
4 
CFU/mL 
(39)
. Nevertheless, this 
sensitivity is not sufficient to detect low initial levels of bacteria. In addition, the complexity 
and the duration make this assay difficult to incorporate into routine use. 
 
Pall Bacteria Detection System 
The Bacteria Detection System (BDS) system (Pall Corporation, NY) relies on measurement 
of oxygen consumption as an indicator of bacterial growth 
(40,41)
. In this system 2 to 3 mL PCs 
sample is filtered to remove platelets and white blood cells and then incubated in a sample 
pouch for at least 24 hours at 35
o
C. Thereafter the percentage of oxygen is measured with an 
oxygen analyzer. An O2 percentage of less than or equal to 19.5 is used as a cut-off value to 
differentiate between contaminated and non-contaminated units. According to a pilot study 
reported by Ortolano et al. it was shown that BDS was able to detect 100 to 500 CFU/mL 
after 24 hours incubation. However, slow growing bacteria may need longer incubation times 
to achieve these levels. This system allows the detection of aerobic and facultative anaerobic 
bacteria. Strict anaerobic microorganisms are not detected. In a recent study reported by Rock 
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et al, a clinical validation of the BDS system was conducted on 12,062 of random donor 
platelets. 5 units were tested positive. This result was confirmed by manual methods. The test 
is easy to perform and requires less than 5 min to be completed. This method is especially 
useful to be used at the hospital shortly before transfusion. 
 
Immunoassay 
Pan Gen Detection (PGD) technology (Verax Biomedical Inc., Worcester, MA) targets the 
conserved antigens lipopolysaccharide (LPS) and lipoteichoic acid (LTA) which are present 
on Gram negative and Gram positive bacteria, respectively 
(42)
. These antigens are present on 
the surface of the bacteria and are present in > 200,000 copies/cell. This technology is used in 
an immunoassay format to detect a wide range of bacteria.  
Preliminary studies showed 100% sensitivity and 100% specificity compared to automated 
culture. The assay is rapid (20 minutes) and is capable to detect approximately 10
3 
CFU/mL. 
Further clinical validation studies are needed to assess the utility of this method. 
 
Automated culture methods 
The BacT/Alert (bioMérieux, Durham, NC) culture system is widely implemented to rapidly 
and feasibly detect microorganisms in blood and body fluids. This fully automated culture 
system is based on the detection of CO2 as marker of bacterial growth. For culturing two 
bottles are used, one for aerobic and the other for anaerobic bacteria. The bottles contain 
appropriate media to support growth and to ensure optimal CO2 production. In the bottom of 
the bottles a CO2 sensor is present separated from the media by a membrane. CO2 production 
by growing bacteria causes a pH decrease. This causes the sensor to change color, which 
results in an increase of red light reflection 
(43)
. 
The system is easy to use and requires only that a culture bottles be inoculated with 5-10 mL 
sample of PCs, after which they are loaded into an incubator. These samples are monitored 
continuously during the incubation (at 35 – 37
o
C) until a positive signal is recorded or for 
maximally seven days. 
 To date, many blood centers (including The Netherlands) have implemented this method as a 
routine means to screen PCs for bacterial contamination. Several evaluations studies with 
spiked samples as well as clinical trials have shown the reliability and sensitivity of this 
system 
(44,45,46,48,49,50,56,57)
. In some countries the use of the BacT/Alert allowed the extension 
of the shelf life of PCs from 5 to 7 days. With the BacT/Alert 1-10 CFU/mL can be detected. 
Most bacterial species can be detected within 24 to 48 hours. However, slow growing 
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bacterial species may require more than 48 hours to be detected 
(54,55)
. During this delay, PCs 
may be issued for transfusion before any contamination has been detected. Possibly the blood 
product may have been infused to a recipient. Furthermore, during inoculation of the culture 
bottles, which implies an open system, contamination may occur, and hence, false-positive 
results. False-negative results have also been reported, due to low initial levels of bacteria 
(56)
. 
These disadvantages constraint the use of this system for monitoring bacterial contamination 
of PCs.  
 
Table 1: Currently available detection methods along with their detection limits and times to 
obtain results.  
 ___________________________________________________________ 
 
Detection system            Detection limit       Rapidity 
                               (CFU/mL)          (min) 
 _________________________________    
Metabolic parameters        10
7 
- 10
8             
< 5 
Swirling                  10
7 
- 10
8
            < 5 
Gram/AO stain             10
4 
- 10
6 
           30  
Epifluorescence             3 - 5x10
3            
95 
Scansystem                10
1 
-10
3 
            90 
DNA/RNA probes           10
4   
              ?
 
   
Pall BDS                  10
2 
               1440 
Immunoassay              10
3 
               20 
BacT/Alert culturing         1-10
1 
              480-1440 
 ____________________________________________________________________________________________ 
 
 
In summary, various approaches to detect bacterial contamination prior to transfusion of PCs 
are possible. Selection of an appropriate method will be based on the combination of the 
sensitivity and the rapidity of an approach (see Table 1). In addition, it is worthwhile to 
balance the benefit, risks and costs of each screening method before introduction into routine 
use. 
 
Pathogen reduction/inactivation  
New methodologies aimed at reducing all pathogens (if present) contaminating PCs, are 
currently under clinical investigations.  These methods are based on photochemical 
inactivation of bacteria and some of these are already available. An example hereof is the 
Intercept technology 
(58)
. This system uses the synthetic psoralen, amotosalen HCL and 
illumination with UVA light. Amotosalen intercalates into helices of DNA and RNA, without 
forming covalent bonds. Upon exposure to UVA light, covalent bonds are formed between 
the amotosalen and the DNA or RNA that results in the permanent inactivation of the nucleic 
   
 19 
acids. The residual amotosalen-HCL and their photodegradation products are removed by 
absorption onto a special device. 
This approach has been tested on apheresis platelets (stored for 5 days) and was shown to be 
effective in inactivating bacteria. In addition, it was effective in inactivating a range of viruses 
(eg. HIV-1, HIV-2, HCV, HBV, HTLV-1, HTLV-2, cytomegalovirus, Parvovirus B-19) and 
parasites (P. falciparum, T. crusi, L. mexicana). This method is attractive, especially for 
preventing the growth of bacteria. 
These preliminary reports are encouraging; however issues of toxicity of residual 
photochemical agents and the effect of inactivation on the platelet quality have to be 
investigated 
(14,59)
.  
 
 
Aim of this thesis 
Bacterial contamination of PCs with an estimated incidence of 1 in 2000 to 1 in 3000 units is 
acknowledged to be the most common transfusion-transmitted infections risk. To detect 
bacterial contamination in PCs prior to transfusion different methods are currently 
implemented, evaluated or under investigations. As mentioned above, each detection method 
has limitations and as yet, no method has gained full acceptance. Therefore, developing an 
‘ideal’ detection method is still a challenge for blood centers. This method should have the 
following characteristics: 1) since initial levels of bacteria that might be present in PCs are 
thought to be low, in the order of 1 to 10 colony forming units (CFU)/mL, a very sensitive 
detection method is required. This is especially necessary when the time of testing is closer to 
the time of collection. Less sensitive method may be used shortly before transfusion. 2) the 
method should be broadly applicable to all species of bacteria. 3) the method should be highly 
specific, as false-results would lead to unnecessary wastage of blood. 4) the method should be 
rapid, allowing detection in a timely manner before issuing of the blood products. 
Furthermore the method should be easy to perform, requiring a minimum of specialized 
training and equipment.  
Developing an assay that would meet these requirements was the main purpose of this thesis. 
Based on 5’Nuclease chemistry, a real-time quantitative PCR assay was designed. In this 
assay a universal probe and primers set was used which specifically detects eubacterial 16S 
rDNA of the Domain Bacteria.  
Initially, the assay was adapted to detect bacterial DNA in PCs. Further optimization resulted 
in the achievement of a sensitivity of 1 CFU equivalent/PCR. However, the performance of 
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this broad-range rDNA PCR when directly applied for screening of bacterial contamination in 
PCs, can be affected by different factors. Among the most important of these is the efficiency 
of DNA isolation from the PCs and the occurrence of false-positive results caused by the 
amplification of DNA not present in the actual PCs sample to be analyzed, but present in the 
reagents used in the PCR. These two issues are addressed in Chapter 1. After solving the 
problem of contaminating DNA in the PCR reagents and optimizing the DNA extraction 
method, an internal control was constructed to monitor the efficiency of automated nucleic 
acid extractions from PCs (Chapter 3). This control relies on the amplification of the generic 
allelic group of the HLA-DQA1 locus. During a preliminary validation of the assay, false-
positive results were generated as a result of contaminating DNA present in the commercial 
nucleic acid extraction kit reagents.  A strategy to circumvent this problem is reported in 
Chapter 4.  Thereafter the clinical validation of the assay was performed as described in 
Chapter 5. The validation was carried out on routinely prepared PCs, in conjunction with the 
BacT/Alert culture system as the gold standard. The study described in Chapter 6 was 
conducted to further determine the optimal sampling time of PCs when using real-time 
quantitative PCR as a screening tool for bacterial contamination. In Chapter 7 amplified 
fragment length polymorphism (AFLP) technique is applied to study the molecular 
relatedness of Propionibacterium isolates derived from PCs and red blood cells concentrates 
(RBCs) from the same donations. This is done in an attempt to identify the source of 
contamination of blood products with Propionibacteria.  Finally, a new approach to study the 
presence and viability of bacteria (E. coli) in growth medium and PCs is developed and 
evaluated in Chapter 8. In this real-time rt-PCR an RNA standard is constructed and used to 
determine the quantities of DNA and RNA as indicators of the presence and state of viability 
of E. coli. The effect of two antibiotics on the DNA and RNA content is also assessed. 
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ABSTRACT 
A real-time PCR assay was developed to allow rapid detection of eubacterial 16S rDNA in 
platelet concentrates. Two DNA isolation methods, the MagNA Pure LC system and the 
NucliSens Extraction kit were used to prepare template DNA from platelet concentrates. Both 
methods proved to have a detection limit of 1 CFU equivalent/PCR. However, contaminating 
DNA present in the PCR reagents can hamper this high sensitivity. Digestion of all PCR 
reagents with the restriction enzyme Sau3A I prior to PCR amplification proved to be 
effective to eliminate this contaminating DNA, while the sensitivity of the assay remained 
unchanged. 
This broad-range PCR assay combined with an automated DNA extraction method provides a 
valuable diagnostic tool for screening of platelet concentrates for bacterial contamination. 
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INTRODUCTION 
Bacterial contamination of blood products is a major cause of transfusion-related morbidity 
and mortality. Due to their storage at 20-24
o
C, platelets are responsible for most of the cases 
of blood component-associated sepsis (1, 7). 
The microorganisms most commonly implicated in contamination of platelet concentrates 
(PCs) belong to the skin flora, among them, Staphylococci, Streptococci, Propionibacterium, 
Bacillus spp, Serratia marcescens, Micrococcus spp, and a number of different Gram-
negative bacteria such as Escherichia coli, Klebsiella pneumoniae and Pseudomonas 
aeruginosa (6). 
To demonstrate the presence of bacteria in PCs different methods have been followed (15). In 
the present study the development of a rapid and sensitive PCR assay based on TaqMan 
technology to detect bacterial contamination in PCs is described. 
 
To assess the presence of microorganisms in blood and other body fluids real-time PCR has 
been widely applied. In these assays primers designed to recognize conserved bacterial 16S 
ribosomal DNA gene sequences are used. Recently, Nadkarni et al. (16) has reported the use 
of a set of universal primers and probe to estimate total bacterial load in clinical samples. Yet, 
the performance of this broad-range rDNA PCR, when directly applied for screening of 
bacterial contamination in PCs, can be affected by different factors. Among the most 
important of these is the efficiency of DNA isolation from the PCs and the occurrence of 
false-positive results caused by the amplification of DNA present in the PCR reagents. 
In the study reported in this paper, two different isolation methods were used to prepare 
template DNA from PCs: a fully automated method with the MagNA Pure LC instrument and 
a manually extraction procedure with the NucliSens Extraction kit.  
The MagNA Pure is a benchtop instrument (10), which offers a standardized, rapid and 
reproducible method for DNA isolation. During purification, the risk of cross-contamination 
is substantially reduced. Together, these characteristics make this system appealing for use in 
routine diagnostic laboratories. 
NucliSens extraction, which is based on the Boom purification method (2, 19), can be 
conducted either fully automated (with a NucliSens Extractor) or manually. The difference 
between both procedures resides in the replacement of the centrifugation step to separate 
silica bound nucleic acid in the manual method by filtration through a silica filter by air 
pressure in the automated method. 
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A major problem associated with the use of universal PCR-based bacterial detection systems 
is the occurrence of false-positive results caused by the amplification of contaminating DNA 
(present in PCR reagents). Several authors have reported on contamination of PCR reagents 
with genomic DNA from microorganisms used in the preparation of enzymes, such as Taq 
polymerase (3, 4, 5, 9). 
Attempts to reduce the amount of contaminating DNA in real-time PCR have been described 
previously (12, 14, 20): 
Kox et al. (11) introduced as first the use of uracil-N-glycosylase (UNG) with dUTP instead 
of dTTP to prevent false-positive results due to amplicon carryover contamination. Other 
strategies included the use of 8-methoxypsoralen and long-wave UV light (13), DNase 
treatment (8, 9), incubation with different restriction enzymes (4, 5, 18), use of reagents 
minimally contaminated with DNA (16). Finally, Yang et al. recently reported on 
ultrafiltration of the PCR mix (21). None of these methods, however, proved very effective, 
especially when low copy numbers of bacterial rDNA have to be discriminated from 
contaminating DNA in the PCR reagents. In addition, the majority of these strategies also 
affect the sensitivity of the real-time PCR. Here two strategies to reduce contaminating DNA 
in real-time PCR amplification are evaluated and found suited to meet the requirement of the 
PCR system to detect bacteria in PCs without affecting the high sensitivity of the assay. 
 
MATERIALS AND METHODS 
Bacterial strains and culture conditions: 
For this study Escherichia coli was used as a prototype. E. coli (ATCC25922) was grown in 
Luria-Bertani broth at 37
o
C to match a turbidity of 0.5 Mc Farland (1.5 x 10
8
 CFU/mL). 
Serial dilutions (10
-1
 to 10
-6
) were made in phosphate-buffered saline (PBS); the suspensions 
were plated on blood agar plates to determine the number of CFU/mL. 
 
Preparation of platelet concentrates (PCs): 
After collection, whole blood is stored for 16-20 hours at room temperature before 
preparation of components. Briefly, with a hard-spin centrifugation step, whole blood is 
separated into plasma, buffy coat (containing leukocytes and platelets) and red cells. The 
buffy coat is used as the source of platelet concentrates (17). 
After separation five buffy coats and one unit of plasma are pooled and centrifuged (soft-
spin). The resulting platelet-containing supernatant is filtered (to remove residual leukocytes) 
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before transfer to a storage bag. The PCs are stored at 20-24
o
C with continuous gentle 
agitation for up to 7 days. 
 
Spiking assay: 1 mL of PCs was spiked with 100 µL of serial dilutions of E. coli. The number 
of bacteria added to the PCs ranged from 10 to 20,000 CFU/mL. 
Spiking of whole blood (WB), red cell concentrates (RCC) and plasma (PL) was performed as 
described for PCs. 
 
DNA extraction: 
MagNA Pure procedure: In this method MagNA Pure Total Nucleic Acid Isolation Kit 
(Roche Diagnostics, Almere, The Netherlands) was used and the purification performed as 
specified by the manufacturer. DNA was extracted from a 200 µL aliquot of spiked material. 
The DNA was eluted in a final volume of 50 µL. With this protocol 32 samples can be 
extracted within 90 minutes. 
NucliSens procedure: The purification was carried out with the NucliSens Extraction manual 
kit (bioMérieux, Boxtel, The Netherlands) according to the manufacturer’s instruction. DNA 
was purified from a 2000 µL aliquot of spiked PCs. The extracted nucleic acid was eluted in a 
final volume of 50 µL (19). This procedure can also be performed in a fully automated way 
with the NucliSens Extractor. The capacity of this instrument, however, is only 10 samples 
per run with a processing time of approximately 45 minutes. 
DNA was also extracted from serial dilutions of a pure culture of E. coli following the same 
MagNA Pure extraction procedure as described above. 
 
 
Real-time PCR assay: 
The PCR was set up to amplify a highly conserved region of bacterial 16S ribosomal DNA 
using the  forward primer 5’-TCCTACGGGAGGCAGCAGT-3’, the reverse primer 5’- 
GGACTACCAGGGTATCTAATCCGTT-3’and the probe (6-FAM)-5’-
CGTATTACCGCGGCTGCTGGCAC-3’-(TAMRA). This universal primers and probe set 
was designed by Nadkarni et al. (16) to amplify a fragment of 466 bp. 
The PCR reactions were performed in a total volume of 25 µL using the TaqMan Universal 
PCR Master Mix (containing 1 x TaqMan Universal PCR Master Mix, AmpliTaq Gold DNA 
Polymerase, AmpErase UNG, dTPs with dUTP, Passive Reference 1 and optimized buffer 
components, Applied Biosystems, Foster city, CA USA). The reactions comprised 900 nM of 
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each of the universal forward and reverse primers and 200 nM of the fluorescent labeled 
probe and 5 µL of template DNA. Negative controls (unspiked PCs) were included 
throughout the procedure. No template controls (NTC) with water instead of template DNA 
were incorporated in each run. 
The PCR reactions were performed under the following conditions: 50
o
C for 2 minutes and 
95
o
C for 10 minutes, and 40 cycles of 95
o
C for 15 seconds and 60
o
C for 1 minute. 
The PCR assay was conducted on the ABI 7700 Sequence Detection System (PE Applied 
Biosystems). Analysis of data was done with the SDS software (version 1.7) supplied by the 
manufacturer. 
 
Pre-treatment of the PCR mixture to reduce contaminating DNA: 
Restriction endonuclease digestion with Sau3A I: Prior to the addition of template DNA, the 
PCR mixture was subjected to digestion with the enzyme Sau3A I (1 Unit per PCR reaction, 
New England Biolabs, Beverly, MA USA). After incubation at 37
o
C for 30 minutes, the 
solution was heat inactivated at 65
o
C during 20 minutes. PCR reactions were subsequently 
performed as described above. The size of the PCR product was verified on 1.5% agarose gel 
stained with ethidium bromide. 
Ultrafiltration: Before the addition of template DNA, the PCR mixture was filtered with an 
Amicon Microcon YM-100 centrifugal filter device (Millipore Corporation, Bedford, Mass. 
USA) as described by Yang et al. The PCR mix was passed through the YM-100 filter unit at 
100 x g for 30 minutes.  
DNase I treatment: DNase I (Amersham Pharmacia Biotech, Roosendaal, The Netherlands) 
was added to the PCR mix (0.2 U/PCR reaction) without template DNA. The solution was 
incubated at 37
o
C for 10 minutes, followed by heat denaturation at 65
o
C for 15 minutes. After 
this treatment template DNA was added and the PCR was carried out. 
 
RESULTS 
Detection limit of the real-time PCR assay: 
To determine the sensitivity of the assay, PCs spiked with serial dilutions of E. coli were 
employed. The result of each PCR reaction is indicated by a threshold cycle (CT) value. The 
CT value is defined as a measure of the fluorescence generated by cleavage of probe against a 
fixed base line threshold and is proportional to the amount of the PCR product. The software 
of the TaqMan system automatically calculates the CT values. As shown in Table 1 the 
detection limit of the assay was 1 CFU equivalent/PCR reaction. This corresponds to 100 
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CFU equivalent/mL spiked PCs when the MagNA Pure kit is used, and to 10 CFU 
equivalent/ml when the DNA extraction is performed with the NucliSens Extraction kit. This 
difference is due to the starting volume of the clinical sample used to extract DNA. Based on 
the size of E. coli, which is 4639 kb, 1 CFU is equivalent to approximately 5 fg DNA. 
 
Reduction of contaminating DNA: 
Routine precautions to prevent contamination of the PCR mixture were always in use (e.g., 
physical separation of the different steps of the PCR assay). Because the initial PCR assays 
showed a high background, as can be deduced from the threshold value of the NTC (Table 1), 
probably due to the presence of traces of bacterial DNA in the enzymes used in the PCR, the 
PCR mixtures were pre-treated in different ways to reduce this source of contamination. The 
initial attempts included predigestion of the PCR mixture with Alu1/Rsa1, withdrawal of 
AmpErase uracil N-glycosylase from the Universal PCR Master Mix, prefiltration of the 
mixture using different columns and membranes. All these strategies were unsuccessful and 
did not result in the removal of contaminating DNA (data not shown).  
 
Digestion of the PCR mixture with Sau3A I reduced the amplification signal of the NTC. As 
shown in Table 2, the CT value increased with two PCR cycles. The CT values of the reaction 
mixtures containing template DNA increased accordingly with 1-2 PCR cycles. This, 
however, did not affect the sensitivity of the assay, since 1 CFU equivalent/reaction was still 
detectable.  
 
 
Table 1.  Detection limit of real-time PCR assay performed with DNA  
isolated from PCs (spiked withE. coli) using either  
MagNA Pure or NucliSens extraction procedure. 
________________________________________________________  
  PC spiked with E. coli      DNA extraction method   CT value
a
 
 (CFU equivalent/PCR) 
________________________________________________________________________________________ 
8 x 10
1
                  NucliSens              27.84 ± 0.43 
 8 x 10
0
                  “                    31.58 ± 0.13 
 4 x 10
0                  
“                      32.80 ± 0.21 
 2 x 10
0
                  “                    33.40 ± 0.26 
 1 x 10
0
                  “                    34.73 ± 0.70 
 2 x 10
2
                  MagNa Pure           31.11 ± 0.42 
 4 x 10
1
                  “                    33.42 ± 0.10 
 4 x 10
0
                  “                    34.83 ± 0.83 
 1 x 10
0
                  “                    35.42 ± 0.45 
________________________________________________________________________________________    
 a Mean ± standard deviation of three independent experiments. 
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Table  2.  Detection limit assay with DNA extracted from a pure culture of E. coli and serially 
diluted
a
.  
_________________________________________________________________________________________  
 
CT for template E. coli DNA in the following units (CFU equivalent/PCR)
b 
Sample type    _____________________________________________________________________________   
 
         NTC     7.5 x 105    7.5 x 104   7.5 x 103   7.5 x 102   7.5 x 101   7.5x100     100 
_________________________________________________________________________________________  
 
Untreated  34.56±0.08 21.39±0.40  25.73 0.24  29.9±0.21  33.37±0.7  34.8±0.27 35.07±1.04  34.58±0.34 
+ Sau3A1  37.46±0.09 22.62±1.32  25.83±0.01 30.2±0.06  33.77±1.69 35.97±1.4 36.61±2.39  36.03±2.80 
+ Filter      40.00±0    22.15±0.03  26.11±0.81 30.51±0.03 34.59±0.11 37.6±0.08 40.00±0     40.00±0 
+ DNase I  24.53±0.08 26.20±0.78  21.95±1.03 23.47±0.20 23.89±0.55 24.8±0.02  24.25±0.2    25.04±0.06 
________________________________________________________________________________________________________________  
a  DNA extraction was done with the MagNA Pure LC instrument. The results of different pretreatments (digestion with 
Sau3AI, filtration, and treatment with  DNase I) are also presented. 
 b Mean  ± standard deviation of  three  independent runs. 
 
Filtration of the PCR mixture through a YM-100 filtration unit resulted in an increase of the 
CT value of the NTC to 40, which indicated that by this step contaminating DNA was 
eliminated. Filtration of the PCR mixture before addition of template DNA, however, also 
reduced the sensitivity of the assay (Table 2).  
Pretreatment of the PCR reaction mixtures with DNase I led to an unexpected decrease in the 
CT values of all PCR reactions, including that of the NTC (table 2).  
Similar results were also found when PCR assays were performed with DNA isolated from 
spiked PCs (table 3).  
Decontamination experiments were also conducted in other blood components, i.e. plasma 
(PL), red cell concentrates (RCC) and whole blood (WB) to find out if the effectivity of the 
pre-treatment was affected by the type of clinical material used. In these assays employment 
of DNase I was omitted. The results are presented in figure 1A, B and C, respectively.  
Digestion with Sau3A I caused an increase of 1-3 PCR cycles in all tested blood components, 
whereas ultrafiltration with YM-100 resulted in an increase of 1-7 PCR cycles.  
Treatment with the restriction enzyme allowed the detection of 3 CFU equivalent/reaction in 
PL and RCC, and 1.5 CFU equivalent/reaction in WB. When prefiltration was applied the 
sensitivity of the assay was reduced to 30 CFU equivalents/reaction in both PL and RCC, and 
to 15 CFU equivalents/reaction in WB. 
 
 
DISCUSSION 
Over the last decade, broad-range real-time PCR has been increasingly used for the detection 
of pathogens in molecular diagnostics. To apply this approach to detect bacterial 
contamination in PCs, two critical factors have to be taken into consideration: the DNA must 
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be extracted as efficiently as possible from the PCs, and the PCR  mixture must not be 
contaminated by DNA, that is not present in the PCs to be tested. A poor efficiency of DNA 
extraction may restrict the sensitivity of the assay, while DNA that is contaminating PCR 
reagents can serve as a template in PCR reactions, producing false positive results. 
In this study two isolation methods have been used to prepare template DNA from PCs: a 
fully automated method with the MagNA Pure LC instrument, and a manual method with the 
NucliSens isolation kit. The PCR performed on DNA obtained by either of both methods was 
very sensitive and as little as 1 CFU equivalent/reaction mixture could be detected. DNA 
extraction with the NucliSens method, however, requires a 10-fold larger volume of PCs than 
with the MagNA Pure, 2000 µL instead of 200 µL. 
The problem of contamination of the PCR mixture by DNA, not present in the actual PCs 
sample to be analyzed, but present in the reagents used in the PCR, was solved by two 
different methods: restriction endonuclease digestion with Sau3A I or removal of DNA by 
ultrafiltration. The aim was to get rid of any contaminating DNA that may be present in the 
reagents to be used in the PCR assay, before the addition of the template DNA, extracted from 
the clinical material. Removal of any trace of DNA from the reaction mixtures allows the 
achievement of a maximal sensitivity of the real-time PCR assay. 
Digestion with Sau3A I proved to be effective in reducing contamination of the PCR mixture, 
as shown by the increase of the mean CT of the NTC. The higher the CT value of the template 
control, the broader the range of the CT values that can be achieved by the PCR reactions  
 
 
 
Table 3.  Detection limit of the assay with DNA extracted from PCs spiked with E. coli DNA without 
treatment and pretreated by Sau3A I, ultrafiltration and DNase I. 
________________________________________________________________________________________________________________________________  
 
CT for template DNA isolated from PCs spiked with E. coli in the following 
amounts (CFU equivalent/PCR)
A 
Sample type _____________________________________________________________     
 
                    NTC         3 × 10
3       
3 × 10
2       
3 × 10
1       
3 × 10
0
 
________________________________________________________________________________________________________________________________  
 
Untreated             34.56 ± 0.08   29.59 ± 1.26   33.40 ± 0.31   34.93 ± 0.66   34.72 ± 0.30 
+ Sau3A1            37.46 ± 0.09   29.82 ± 1.68   33.8 ± 0.36   35.84 ± 0.43   36.01 ± 0.74 
+ Filter               40.00 ± 0     30.55 ± 0.05   34.01 ± 1.11   39.37 ± 0.40   40.00 ± 0 
+ DNase I            24.53 ± 0.08   23.63 ± 0.72   23.00 ± 0.36   23.15 ± 1.08   25.40 ± 0.43 
________________________________________________________________________________________________________________________________  
a CT (threshold cycle) values are the mean of 3 independent runs. NTC: no template control. 
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Figure 1. Detection limit of the assay with E. coli DNA detected in plasma (A), red cell concentrates (B) and whole blood (C) with or without treatment. 
Template DNA was isolated from 1 mL plasma, red cell concentrates or whole blood spiked with E.coli in the amounts (CFU equivalent/PCR) plotted on the x-
axis. The extraction of DNA was performed with the MagNA Pure LC instrument. The CT values for each reaction are represented on the y-axis.The extraction 
methods differ also in the operating time: with the MagNA Pure LC instrument results can be obtained within 4 hours, while the NucliSens Extraction kit 
requires 6 hours. 
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containing template DNA, and hence the better the sensitivity. In the case of pre-treatment 
with Sau3A I, the detection limit of this already very sensitive assay remained 1 CFU 
equivalent/PCR reaction (5 fg DNA).  
Following the prefiltration procedure a mean CT value of 40 was generated for the NTC. 
However the sensitivity of the assay performed with DNA isolated from spiked PCs was 
reduced to 30 CFU equivalents/PCR reaction. Thus, Sau3A I seems to be effective especially 
when detection of only a few molecules of a target DNA sequence is required. When a 
detection limit of fewer than 10 CFU equivalent/reaction is not needed, prefiltration of the 
PCR mixture seems to be more appropriate. 
Both methods can be simply integrated in the PCR procedure to overcome the problem of 
contaminating DNA. Pre-treatment with Sau3A I extends the assay by 50 minutes, whereas 
the prefiltration step prolongs the PCR with 30 minutes. Advantages and disadvantages of 
each strategy should be therefore taken into account when selecting the most convenient 
method. 
Pre-treatment with DNase I resulted in an unexplainable decrease in the CT values of all PCR 
reactions. This nonspecific endonuclease cleaves both DNA strands. During single-strand 
digestions, DNase I causes gaps and nicks that can be repaired by DNA polymerase. Possibly, 
this process makes the target sequence more accessible and the amplification of 
contaminating DNA more efficient. As a result a decrease in CT values of all PCR reactions 
occurred. Since the results of this pre-treatment were not consistent, the use of this enzyme to 
reduce contaminating DNA is not favorable. 
 
To prevent transfusion-associated bacterial sepsis, rapid and sensitive methods are needed for 
pretransfusion screening of PCs. Real-time PCR assay in combination with the automated 
MagNA Pure DNA extraction method meets these requirements: the assay takes only 4 hours 
to be completed and has the capability to detect very small numbers of bacteria. 
When contaminating DNA in the PCR mixture forms a limitation, digestion with Sau3A I can 
be used to solve this problem while preserving the sensitivity of the assay. 
Before this assay can be implemented as a tool to screen PCs for bacterial contamination, 
further validation studies are needed. Currently the performance of this PCR to detect the 
bacterial species most frequently found in PCs is being evaluated and compared with current 
automated culturing methods. 
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Preface to chapter 3 
 
 
Real-Time PCR assays are prone to inhibition by many compounds that might be 
present in clinical materials. Inhibition may cause the generation of false-negative 
results. To avoid false-negative and false-positive results, controls should be 
incorporated in nucleic acid amplification assays. Controls serve to assess the 
integrity of each step of the PCR assay (i.e. extraction and amplification steps). 
Since extraction of nucleic acid is the first step in the 16S rDNA PCR, a suitable and 
reliable control is indispensable to monitor the efficiency of this procedure. The aim of 
the following chapter was essentially to develop such an isolation control. A highly 
conserved region of the generic allelic group of HLA-DQA1 locus was selected and 
used as an endogenous control sequence. During the validation of the PCR assay with 
this target, it was shown that the assay was also suitable to be used as a method to 
estimate the number of residual white blood cells (WBCs) in WBC-reduced PCs. 
Reduction of WBCs in blood products is routinely carried out in blood centers to 
reduce the adverse effects of transfusion associated with WBCs. To determine the 
utility of this method, the performance of this real-time PCR with the set of primers 
and probe designed as internal control, was compared with a method (current gold 
standard) used in most blood centers to count the amount of residual WBCs in PCs. 
Thus, the assay was shown to have two applications: (i) as extraction control, and (ii) 
high-throughput and sensitive assay for monitoring residual WBCs in PCs (as will be 
described in the following chapter). 
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ABSTRACT 
BACKGROUND: A real-time PCR assay based on amplification of the generic allelic group 
of the HLA-DQA1 locus was developed and validated to assess its suitability in quantitating 
low levels of white blood cells (WBCs) in filtered platelet concentrates (PCs). 
STUDY DESIGN AND METHODS: The performance of this assay was characterized by 
assessing its lower limit of detection, accuracy and reproducibility. To determine the detection 
limit serial dilutions of non-filtered PCs with known quantities of WBCs were prepared. DNA 
was isolated with the MagNA Pure LC Instrument. The real-time PCR was performed with a 
set of primers and probe targeting a highly conserved region of the well-evaluated HLA-
DQA1 gene. To determine the analytical sensitivity and accuracy of the assay WBC 
concentrations ranging from 300 to 0.03/ µL were tested with real-time PCR and flow 
cytometry. In addition, 126 random PCs were investigated to assess the capacity of the PCR 
method to quantify residual WBCs in clinical specimens. The intra- and inter-assay variations 
were also evaluated.  
RESULTS: A sensitivity of 0.2 white blood cell equivalent/µL (1.5 x 10
4
 white blood cells 
equivalent/unit) was achieved. The assay was shown to be accurate and the HLA-DQA1 gene 
was reproducibly and consistently amplified in all tested samples (CV less than 5%). Overall, 
the results of the PCR assay correlated well with those of the flow cytometry. Using the PCR 
assay, a concentration of 3 WBC/µL (corresponding to approximately 1 x 10
6 
 WBC per unit) 
was detected with 100% accuracy. 
CONCLUSION: Real-time PCR is rapid, sensitive, accurate and reproducible. Hence this 
approach may prove suitable in routine monitoring of residual WBCs in PCs. 
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INTRODUCTION 
Reduction of white blood cells (WBCs) in cellular blood components is nowadays common 
practice in blood centers. This reduction is beneficial to prevent a variety of transfusion 
complications, including febrile reactions, HLA alloimmunization, immunomodulation and 
transmission of viruses incorporated in leukocytes (1). 
To monitor WBC-reduction efficiency different studies have been performed to count residual 
WBCs in WBC-reduced red cell concentrates and platelet concentrates (2, 3). Microscopy, 
flow cytometry and volumetric capillary cytometry are the most commonly used methods (4, 
5, 6, 7). Although these methods are suitable for counting residual WBCs in blood 
components, high throughput, sensitive and robust methods are desirable.  
As recently shown by Lee et al. (8) amplification of a highly conserved region of the HLA-
DQα gene may be used as a potential strategy to measure residual WBCs in blood 
components.  
In this study a rapid and specific real-time amplification assay of the generic allelic group of 
HLA-DQA1 locus to estimate residual WBCs in filtered platelet concentrates (PCs) is 
described. To investigate the suitability of this approach, for the monitoring of residual WBCs 
in filtered PCs the performance of the PCR assay was characterized and compared to flow 
cytometry. 
 
MATERIALS AND METHODS 
Preparation of WBC-reduced platelet concentrates 
PCs were prepared using the buffy coat method. In brief, 500 mL whole blood was collected 
from healthy volunteers in triple top-and-bottom bag systems (Composelect T2988, Fresenius 
Hemocare, Emmer-Compascuum, The Netherlands) with citrate phosphate-dextrose (CPD) as 
anticoagulant, and saline-adenine-glucose-mannitol (SAGM) as additive solution for red cells. 
After collection, whole blood is cooled to 20-24 
o
C with butane-1,4-diol containing cooling 
elements. After storage during 16-24 hours at this temperature, blood is separated in cell free 
plasma, buffy coat and red cells by applying high-speed centrifugation. The platelet 
concentrates are then isolated from the buffy coat layer by low speed centrifugation. 
Five ABO-identical buffy coats are pooled with one unit of plasma in an integrated system 
consisting of pooling bag, a leukoreduction filter (ImugardIII-PL4P filter, Terumo, Japan) and 
a platelet storage bag. During process control of leukoreduced blood components, residual 
WBCs are counted with conventional methods such as flow cytometry. The number of 
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residual WBCs is determined to verify if they meet the standard, which is defined as less than 
1x10
6
 WBCs/unit in more than 90% of the units (9). 
 
DNA extraction 
DNA extraction was performed in a fully automated system with the MagNA Pure LC 
instrument (Roche Diagnostics, Almere, The Netherlands) according to the manufacturer’s 
instructions. Two hundred µL of each sample was purified with the MagNA Pure Total 
Nucleic Acid Isolation Kit. The nucleic acid was eluted in 50 µL elution buffer. Amplification 
was performed with a real-time PCR assay. With the MagNA Pure LC system 32 nucleic acid 
extractions can be performed in less than 90 minutes. 
 
Primers and probe design 
Primers were designed to amplify a fragment of a highly conserved region of the HLA-DQA1 
gene. This 216 bp fragment spanned the second exon of all currently known alleles at the 
HLA-DQA1 locus. The sequences of the  
alleles were downloaded from the website: http/www.anthonynolan.com/HIG. (10). 
The primer pair consisted of the forward primer 5’-TTGTACCAGTTTTACGGTCCC-3’, the 
reverse primer 5’-TGGTAGCAGCGGTAGAGTTG-3’, the probe was (VIC)-5’-
TTCTACGTGGACCTGGAGAGGAAGGAG-3’-(TAMRA). 
PCR amplification reactions were performed in a final volume of 25 µL with the TaqMan 
Universal PCR Master Mix (1x TaqMan Universal PCR Master Mix, AmpliTaq Gold DNA 
Polymerase, AmpErase UNG, dTPs with dUTP, Passive Reference 1 and optimized buffer 
components, Applied Biosystems, Foster city, CA USA). The reaction mixtures consisted of 
900 nM of each of the forward and reverse primers and 200 nM of the fluorescent labeled 
probe and 5 µL of template DNA. Reaction mixtures with water instead of template DNA 
were incorporated in each run as negative controls (no template controls: NTC). The PCR 
conditions were: 50
o
C for 2 minutes and 95
o
C for 10 minutes, and 40 cycles of 95
o
C for 15 
seconds and 60
o
C for 1 minute. 
The PCR assay was conducted on the ABI 7000 Sequence Detection System (PE Applied 
Biosystems). Analysis of data was done with the SDS software supplied by the manufacturer.  
Amplification, detection and analysis of the results were completed within 2 hours. 
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Assessment of performance of the assay 
The performance of the assay was assessed by determination of the following characteristics:  
detection limit, accuracy and reproducibility. 
Detection limit: to determine the lower limit of detection serial dilutions of non-filtered PCs 
were prepared. The number of WBCs in these PCs was automatically determined with 
Sysmex K1000 (TOA, Tokyo, Japan). In the serial dilution experiments double-filtered PCs 
were used as diluent. 
Accuracy and reproducibility: to determine the accuracy of the PCR assay, its analytical 
performance was compared with that of flow cytometry (as reference method). To accomplish 
this, experiments were carried out with samples containing WBCs concentrations ranging 
from 300 to 0.03/µL. These samples were prepared from a tube of citrated whole blood. After 
collection the number of WBCs in this tube was automatically determined with Sysmex 
K1000. Subsequently the whole blood was serially diluted in PBS to obtain final 
concentrations of 300, 30, 3, 0.3 and 0.03 WBCs/µL. For each dilution six aliquots were 
prepared and counted in duplicate by both PCR and flow cytometry. 
When flow cytometry was applied the number of WBCs in the samples was measured with 
the LeucoCOUNT kit (BD Biosciences, San Jose, CA, USA). This kit included TruCOUNT 
tubes with a lyophilized pellet with a fixed number of fluorescent counting beads. An aliquot 
of 100 µL was added to these tubes including 400µL of LeucoCOUNT reagent. This reagent 
consisted of RNase, a detergent to make the cells permeable for Propidium Iodide (PI) and PI 
for DNA staining. The samples were incubated in the dark at room temperature for 5 minutes. 
Thereafter measurements were performed on a FACSCalibur flow cytometry (10 000 events 
were counted for each sample) according to the instructions of the manufacturer. 
To evaluate the capacity of the PCR method to quantify residual WBCs in PCs, the assay was 
applied to 126 samples of routinely filtered (WBC-reduced) PCs. DNA was extracted from 
these samples and amplified in the real-time PCR. The threshold cycle (CT ) values were 
determined and coefficient of variance (CV) calculated. The CT value is the cycle number at 
which the fluorescence generated by cleavage of probe exceeds a fixed base line threshold. 
To further characterize the assay both intra- and inter-assay variations were studied. Intra-
assay variations were tested by extracting DNA from 20-fold replicates of a sample of WBC-
reduced PC followed by analysis with real-time PCR. To assess inter-assay variations DNA 
was extracted from replicates of five samples of WBC-reduced PCs and subjected to PCR 
amplification in 5 independent runs. The mean, SD, and CV% were determined.   
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N bRESULTS 
To determine the lower limit of detection of the PCR assay, DNA isolated from serial 
dilutions of non-filtered PCs with a known quantity of WBCs (5 x 10
5
 to 5 x 10
0
 WBCs/mL) 
was analyzed by real-time PCR. As depicted in figure 1 the assay was linear between 10
3
 and 
10
0
 WBC equivalent/PCR reaction indicating that 1 WBC equivalent/PCR reaction is the 
lower limit of detection. This is equivalent to 0.2 WBCs/µL (50 WBCs equivalent/mL).  
The analytical accuracy of the PCR method in estimating low numbers of WBCs was assessed 
by comparing the results of the serial dilutions with the expected values. The serial dilutions 
were made in PBS to exclude any contamination with WBCs that could possibly be present in 
the double-filtered PCs leading to higher estimation than expected from the dilution itself. 
The results were also compared with those obtained by flow cytometry. As shown in Table 1 
the PCR values showed high agreement with the expected values. Sufficient correlation was 
also achieved with the flow cytometry. Both methods were able to detect as low as 0.3 
WBCs/µL. The extent to which the observed (measured) results span the expected results is 
given in Table 2. The 95% CI of the observed results was calculated as well. As defined in the 
guidelines of the Biomedical Excellence for Safer Transfusion (the BEST) accuracy was 
considered to be satisfactory when 80% of the observed results were within 20% of the 
expected values (5). 
 
 
 
Figure 1: DNA isolated from non-filtered PCs representing 10
3
, 10
2
, 10
1
 and 10
0
 WBCs/PCR reaction 
were used to determine the detection limit of the HLA-DQA1 PCR assay. Slope: -3,534, Intercept: 
38,583, R
2
: 0,999. The X-axis of the graph represents the starting copy number of the HLA-DQA1 
gene expressed as log WBCs equivalents/PCR reaction. The Y-axis represents the threshold cycle 
(CT). 
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Table 1.  Number of WBCs estimated with flow cytometry and HLA-DQA1  
PCR in samples with known concentrations*. 
 ____________________________________________________________________________________  
 
Observed WBC count/µL 
 ________________________________________________________________ 
 
Expected number 
of WBC/µL               Flow cytometry      HLA-DQA PCR 
   ________________________________________  
                           mean ± SD   CV(%)    mean ± SD     CV(%) 
 _____________________________________________________________   
300                  258 ± 13.4   5.2       300.96 ± 13.06  4.3 
30                   25.3 ± 1.37  5.40      30.35 ± 5.1    17 
3                     2.0 ± 0.3   15       3.28 ± 0.25     7.6 
0.3                    0.2 ± 0.03  15       0.21 ± 0.04    1 9 
0.03                  undetectable           undetectable 
 ____________________________________________________________________________________  
* Results are the mean of six experiments. 
 
 
 
Table 2.  Accuracy of flow cytometric method and the real-time PCR assay. 
 ____________________________________________________________________________________________________  
 
                      Accuracy                95% CI of observed values 
                         ____________________________________________________________________________  
  
Expected number   Flow cytometry  PCR      Flow cytometry   PCR 
WBCs/µL 
 ____________________________________________________________________________________________________  
300             100%          100%     247.5-268.5      290.7-311.2 
30              100%          100%     24.2-26.4        26.4-34.3 
3               40%           100%     1.8-2.2          3.1-3.5 
0.3              70%           70%      0.18-0.22        0.18-0.24 
 ____________________________________________________________________________________________________  
 
 
 
At concentrations above 3 WBCs/µL the expected values of all samples tested with PCR fell 
within the 95% CI of the observed values. In contrast, the flow cytometry demonstrated an 
underestimation of the expected value in all cases. Hence, the accuracy of the PCR assay was 
considered to be better than the flow cytometry.  
At concentrations below 3 WBCs/µL both methods showed reduced accuracy. Only 70% of 
samples gave a result similar to the expected value ± 20%. 
 
Of 126 samples of WBC-reduced PCs the value of residual WBCs ranged between 10-100 
WBCs equivalents/PCR reaction (which is equivalent to 2-20 WBCs/µL), the CT values 
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varied between 33.71 and 34.65. For these samples the flow cytometry yielded values varying 
between 0.1 and 0.2 WBC/µL. 
The results of the assessment of reproducibility demonstrated a consistent and reproducible 
amplification of the HLA-DQA1 fragment. In these experiments the number of WBCs ranged 
again between 10 - 100 WBCs equivalents/PCR. The CV values for both intra- and inter-
assay variations were observed to be less than 5% (data not shown). 
 
 
DISCUSSION 
The amplification of the generic allelic group of HLA-DQA1 locus by real-time PCR proved 
suitable for quantitation of residual WBCs in PCs.  A sensitivity of 0.2 WBC equivalent/µL 
was achieved. This corresponds to 1.5 x 10
4
 WBCs equivalents/unit of 300 mL filtered PCs 
(prepared form 5 donors), which is approximately 100-fold below the maximum tolerated 
level of WBCs in PCs (1 x 10
6
 WBCs/unit) (9). When performing the serial dilutions 
experiments all measured values corresponded well with the expected values. In general 
accuracy was greater for the PCR assay than for the flow cytometry. Discordance between 
observed and expected values was obtained only at concentrations of 0.3 WBC/µL. Overall, 
the findings demonstrated a good accuracy and reproducibility of the PCR assay. 
Although a different set of primers and probe was used, the findings of the study reported 
here support results obtained by Lee et al. (8). In a previous investigation Lee et al. described 
the use of a high-throughput real-time kinetic PCR (kPCR) assay as an approach to assess the 
number of residual WBCs in WBC-reduced whole blood. With the PCR test used in that 
study, the authors could detect 2.4 x 10
3
 to 2.4 x 10
4
 WBCs per unit of WBC-reduced whole 
blood. This kPCR, however, was combined with a manual method to prepare template DNA 
from clinical specimens. Manual extraction procedures are not very attractive when a 
standardized extraction for all tested samples is required. 
Another important difference between the assay described in this report and the assay 
developed by Lee et al. resides in the absence of a specific probe to detect amplified products 
in the test as developed by them. In addition they used Ethidium Bromide for detection and 
subsequent quantitation. This could make the distinction between specific and nonspecific 
amplification difficult.  
Other counting methods such as flow cytometry and microscopy enable enumeration of 1 and 
0.1 WBC/µL, respectively (4, 5, 6). However, they require expensive instruments and are 
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labour-intensive. Besides, the performance of microscopy-based methods is influenced by the 
skills and interpretation of the operator. 
With the assay reported in this study a high-throughput of samples can be reached in a 
relatively short period of time: the automated extraction method is completed within 90 
minutes when processing 32 samples and the amplification and analysis take less than 2 
hours. Moreover, no pre-treatments (e.g. dilutions) are required prior to counting. The 
MagNA Pure extraction system in combination with real-time PCR detection offers a 
standardized, rapid and reproducible assay suited for routine monitoring of residual WBCs in 
PCs. 
Furthermore the generic (universal) nature of the primer and the probe set developed in this 
study makes it amenable to be used as an internal control to monitor efficiency of automated 
DNA extraction from blood samples in routine diagnostics laboratories. 
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ABSTRACT 
Due to contamination of DNA extraction reagents, false-positive results can occur when 
applying broad-range real-time PCR based on bacterial 16S rDNA. Filtration of the nucleic 
acid extraction kit reagents with GenElute Maxiprep binding columns was effective in 
removing this reagent-derived contaminating DNA while the sensitivity of the assay was 
maintained. 
 
A broad-range PCR assay was recently developed, based on real-time PCR technology, to 
monitor bacterial contamination in platelet concentrates (PCs) (Mohammadi et al., 2003). The 
assay is rapid and enables the detection of 1 CFU equivalent/PCR. The assay combines the 
automated MagNA Pure DNA extraction and real-time amplification of a conserved sequence 
of the eubacterial 16S rRNA gene. The availability of fully automated extraction systems 
offers the benefit of standardization, high efficiency of purification and reduction of the 
potential risk of cross-contamination. However, the performance of the assay is compromised 
by a batch-dependent DNA contamination of the DNA isolation kit reagents (Peters et al., 
2004). To achieve optimal sensitivity and reproducibility it is important to remove this 
contaminating DNA. In the present study a method to eliminate contaminating DNA in 
MagNA Pure Total Nucleic Acid kit reagents is described. 
 
The real-time PCR assay was performed on 20 samples of PCs (derived from pools of 5 
individual blood donors each). The presence of bacteria in these PCs was assessed by culture 
of a sample in the BacT/Alert (bioMérieux, The Netherlands). By this automated culture 
system the PCs were deemed to be negative meaning that no bacteria were present. 
DNA was extracted from 200 µL of each sample with the commercially available MagNA 
Pure Total Nucleic Acid Extraction kit (Roche Diagnostics). Amplification and detection 
were performed simultaneously with the real-time PCR on the ABI Prism 7000 Sequence 
Detection System (Applied Biosystems). The PCR were performed in a final volume of 25 µL 
with the TaqMan Universal PCR Master Mix (1 x TaqMan Universal PCR Master Mix, 
AmpliTaq Gold DNA Polymerase, AmpErase UNG, dTPs with dUTP, Passive Reference 1 
and optimized buffer components; Applied Biosystems, Foster city, CA USA). The reaction 
mixtures included 900 nM of each of the universal primers (forward primer 5’-
TCCTACGGGAGGCAGCAGT-3’, reverse primer 5’-
GGACTACCAGGGTATCTAATCCTGTT-3’), 200 nM of the probe (6-FAM-5’-
CGTATTACCGCGGCTGCTGGCAC-3’-TAMRA) and 5 µL template DNA. In each assay, 
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isolation and PCR inhibition controls were incorporated. A negative control (no template 
control (NTC)) with water instead of template DNA was also included. Amplification 
conditions were 50
o
C for 2 min, 95
o
C for 10 min and 40 cycles of 95
o
C for 15 s and 60
o
C for 
1 min. The results were evaluated based on the threshold cycle (CT ) values of each PCR 
reaction.  
Unexpectedly, bacterial DNA was detected in all tested samples (including NTCs): CT values 
ranging from 33 to 34 cycles were obtained.  
Subsequently, the products of the PCR were purified and subjected to automated sequencing 
with the ABI Prism 310 Genetic Analyzer (Applied Biosystems). Sequencing was conducted 
with the same universal primers. Sequence analysis by using the BLAST program 
(http://www.ncbi.nlm.nih.gov/BLAST/) revealed sequence similarities with bacteria 
inhabiting water and moist soil environments. Among these were Burkholderia spp, 
Pseudomonas saccharophilia, Ralstonia spp, Alcaligenes spp, and other related bacteria.  
Since contaminating DNA in the PCR reagents was removed by digestion with Sau3AI 
(Mohammadi et al., 2003) and all measures to prevent cross-contamination were taken 
throughout the whole procedure from processing, DNA isolation to PCR amplification and 
detection, evidence was accumulating for a link between the MagNA Pure isolation reagents 
and the occurrence of false-positive results in the PCR assay.  
 
Three approaches to remove contaminating DNA were evaluated and their effect on the 
sensitivity of the PCR was assessed.  
First, the MagNA Pure Total Nucleic Acid kit reagents (Wash Buffer I, Wash Buffer II, Wash 
Buffer III, Lysis/Binding Buffer and Elution Buffer of the extraction kit) were sonicated 
(Sanyo Soniprep 150). By sonication DNA fragments were generated. Due to their minute 
size these pieces of DNA could not be amplified by PCR. Only target DNA from genuine 
contamination of PCs would be then amplified and detected. The duration of sonication was 
varied between 2 min and 30 min. This, however, did not sufficiently reduce the positive 
signals derived from the contaminating DNA (data not shown).  
In a second attempt to eliminate contaminating DNA, a probe was designed which targeted a 
sequence of the 16S ribosomal RNA gene that is homologous in all Burkholderia spp. and 
related contaminants identified by sequencing. The sequence of the probe was (VIC)-5’-
TAAGCACCGGCTAACTACGTGCCAGC-3’-(TAMRA). This probe was used in 
combination with the universal primers and probe set in a competitive real-time PCR. As the 
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CT values of the PCR reactions were almost equal when both probes were used, it was 
difficult to establish a clear difference between the targets. This strategy was therefore not 
pursued.  
 
A third method consisted of filtration of the reagents of the Total Nucleic Acid kit with the 
aid of the GenElute Plasmid Maxiprep binding columns (Sigma-Aldrich Chemie Gmbh, 
Germany). These silica-based membrane columns are constituents of a kit for the isolation of 
plasmid DNA from bacterial cultures. Except Magnetic Glass Particles and Proteinase K, all 
reagents of the MagNA Pure Total Nucleic Acid Extraction kit were transferred to the 
columns and centrifuged at 5,000 x g for 5 minutes. The flow-through was used in the 
MagNA Pure system to extract DNA from PCs. Compared to the C T values obtained with the 
real-time PCR on DNA extracted with untreated reagents, the CT values of DNA samples 
extracted with the treated reagents were higher (Table 1). This demonstrated the reduction of 
contaminating DNA. The background signals that were still obtained after filtration are 
attributable to the presence of contaminating bacterial DNA in the PCR reagents. This signal 
became completely negative (undetectable) after digestion of the PCR mixture with Sau3AI 
(Table 2). As described in a previous study (Mohammadi et al., 2003) this pretreatment was 
carried out routinely to remove contaminating DNA in the PCR reagents. 
 
The MagNA Pure LC Microbiology kit (Roche Diagnostics) recently became commercially 
available, after which the manufacturer of the MagNA Pure reagents was notified of the 
problem of DNA contamination. All the reagents of this new kit are M
GRADE
 quality, ensuring 
that they are tested for and free of bacterial and fungal DNA contamination.  
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Table 1.  Amplification of 16S rDNA performed with DNA isolated from five separate PCs using 
the indicated MagNA Pure extraction kits. 
________________________________________________________________________________________________________________________________  
 
PCs samples
a
 
Extraction kit  ______________________________________________________________ 
1        2         3         4         5         NTC 
________________________________________________________________________________________________________________________________  
 
Total Nucleic Acid    34.59±0.30 35.32± 0.37 34.57± 0.28 35.58± 0.63 34.52± 0.22 34.77± 0.70 
Total Nucleic Acid     37.30± 0.5  37.3± 0.21  37.58± 0.60 37.73± 0.77 37.07± 1.61 37.13± 0.11 
+ filtration 
M
GRADE
              37.7± 0.63 36.47± 0.54  36.28± 0.48 37.11± 0.35 37.24± 0.60 38.17 ±1.07 
________________________________________________________________________________________________________________________________  
a The results are expressed as CT values. The mean ± standard deviation of three independent runs is given.  
NTC: no template control. 
 
To confirm the purity of the reagents of this kit, DNA was isolated from the same samples as 
described above and the results were compared to the results obtained with the untreated- and 
the column purified reagents. As shown in Table 1, the CT values generated with DNA 
extracted with untreated reagents augmented substantially when the extraction from the same 
samples was conducted with the M
GRADE 
 kit. Comparable results were also found when the 
reagents of the Total Nucleic Acid kit were first filtered with the columns. The included 
controls indicate the efficacy of DNA extraction and the absence of inhibitors of 
amplification. These results indicate that the use of commercial M
GRADE
 
 
reagents or filtration 
of the reagents from the conventional MagNA Pure Total Nucleic Acid Extraction kit are 
equally effective methods to avoid contamination of PCR by DNA present in the extraction 
reagents. 
To assess the effect of filtration on the sensitivity of the assay, PCs were spiked with bacterial 
suspensions to reach a final amount of 10
3
, 10
1 
and 10
0
 CFU equivalent/PCR. The sensitivity 
of the assay performed with reagents that had been passed over the column was not altered: 1 
CFU equivalent/PCR was still detectable (Table 2).    
The use of GenElute columns was also effective for the elimination of contaminating DNA in 
QIAamp manual DNA extraction kits. Performance of PCR with DNA isolated from PCs 
without any pretreatment of the extraction reagents showed a mean CT  value of 36.84 ± 0.9 (3 
independent experiments) although contaminating DNA in the PCR reagents was removed. 
When reagents of QIAmp DNA Blood Mini kit reagents (Qiagen) were filtered with the 
columns prior to their use for the isolation of DNA from PCs (negative by culture), no 
amplification products were observed (mean CT  39.48 ± 0.4) indicating that they were free 
from contaminating DNA. A complete absence of amplification signals was observed when  
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Table  2. CT  values determined by real-time PCR for PCs samples extracted with Total Nucleic 
Acid kit, Total Nucleic Acid kit + filtration and M
GRADE  
kit.  
________________________________________________________________________________________________________________  
 
Extraction kit        NTC         PCs samples
a
         PCs spiked with E. coli  
(No. CFU equivalent/PCR)
b
 
 _________________________________________________________________  
                      1x10
3
         1x10
1
          1x10
0
  
________________________________________________________________________________________________________________________________  
 
Total Nucleic Acid  33.84 (38.93)   34.91 (37.71)  23.74 (23.16)   30.24 (30.01)    32.41 (32.25) 
Total Nucleic Acid  39.28 (und)
c
    37.39 (und)   23.50 (21.41)   31.70 (28.72)    34.96 (34.34) 
+ filtration 
M
GRADE
            37.48 (und)    36.96 (und)   24.80 (22.59)   32.22 (31.31)    36.77(36.32) 
________________________________________________________________________________________________________________________________  
a  Culture-negative specimen was used as a negative control. 
b Real-time PCR results are expressed as CT values. Template DNA was isolated from PCs using Total Nucleic 
Acid kit, Total Nucleic Acid kit + filtration and MGRADE kit. The effect of filtration on the sensitivity of the assay 
was assessed by amplifying DNA extracted from PCs spiked with different amounts of E. coli suspensions. 
Numbers in parentheses are the CT values obtained after digestion of the PCR mixture with Sau3AI. This pre-
treatment was carried out to remove contaminating DNA in the PCR reagents. 
c No amplification signal was detectable. 
 
both filtration of the extraction reagents and digestion of the PCR reagents with Sau3AI were 
carried out. This method may therefore also be employed to eliminate DNA from reagents in 
other diagnostic PCR-based assays with manual DNA extraction methods. 
 
Newly developed, high throughput standardized automated extraction methods that 
substantially improve conventional manual methods are becoming increasingly popular in 
clinical laboratories. However, it is of utmost importance to consider potential pitfalls of these 
methods especially those concerning of false-positive results due to reagent contamination. 
Van der Zee et al. (van der Zee and Crielaard, 2002) and Evans et al. (2003) have previously 
demonstrated the contamination of Qiagen DNA extraction kits with Legionella DNA. 
Hence, DNA contamination should be taken into account when applying both automated and 
manual extraction methods in routine clinical microbiology.  
 
Contamination derived from extraction reagents can result from a number of sources. In this 
study the identified bacteria are inhabitants of a variety of aquatic environments. Other 
authors have reported before that these bacteria are indigenous to ultrapure water in industrial 
systems (Kulakov et al., 2002; Taghavi et al., 1996). Therefore, it is likely that this problem 
originates from the distilling systems of the manufacturer. 
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The method introduced here to overcome the problem of contaminating DNA in the MagNA 
Pure Total Nucleic Acid kit reagents, is easy-to-perform and rapid. There is no significant loss 
of volume after filtration of the reagents. The use of Genelute columns may also prove useful 
for the filtration of other MagNA Pure kits reagents for example the Large Volume Total 
Nucleic Acid kit. In addition it is less expensive to use the columns compared to the M
GRADE
 
kit at present. Moreover, the M
GRADE
 kit is only suited for the processing of 100 µL sample 
volumes whereas the Total Nucleic Acid kit and the Large Volume Total Nucleic Acid kit are 
designed for DNA extraction from samples of 200 µL and 1000 µL respectively. Finally, the 
results indicate that purification of the reagents with the columns did not hamper the 
sensitivity of the PCR assay. 
In conclusion, purification of reagents to be used in DNA-based assays by centrifugation over 
GenElute columns is a generally applicable, easy and fast procedure that can be incorporated 
in large number of protocols, especially in case of possible false-positive results. It can be 
then decided to use the GenElute columns to purify the reagents from contaminating DNA. 
For this pretreatment, modification of optimized procedures and protocols are not necessary. 
 
Acknowledgements 
This study was supported by a grant from Sanquin Blood Supply Foundation, Amsterdam, 
The Netherlands. 
 
 
REFERENCES 
1. Evans, G.E., Murdoch, D.R., Anderson, T.P., Potter, H.C., George, P.M., Chambers, S.T., 
2003. Contamination of Qiagen DNA Extraction Kits with Legionella DNA. J. Clin. Microbiol. 
41, 3452-3453. 
2. Kulakov, L.A, McAlister, M.B., Ogden, K.L., Larkin, M.J., O’Hanlon, J.F., 2002. Analysis of 
bacteria contaminating ultrapure water in industrial systems. Appl. Environ. Microbiol. 68, 
1548-55. 
3. Mohammadi, T., Reesink, H.W., Vandenbroucke-Grauls, C.M.J.E., Savelkoul, P.H.M., 2003. 
Optimization of real-time PCR assay for rapid and sensitive detection of eubacterial 16S 
ribosomal DNA in platelet concentrates. J. Clin. Microbiol. 41, 4796-4798. 
4. Peters, R.P., Mohammadi, T., Vandenbroucke-Grauls, C.M.J.E., Danner, S.A., Van Agtmael, 
M.A., Savelkoul, P.H.M., 2004. Detection of bacterial DNA in blood samples from febrile 
patients: underestimated infection or emerging contamination? FEMS Immunol. Med. 
Microbiol. 42, 249-253. 
5. Taghavi, M., Hayward, C., Sly, L.I., Fergan, M., 1996. Analysis of the phylogenetic 
relationships of strains of Burkholderia solanacearum, Pseudomonas syzygii, and the blood 
disease bacterium of banana based on 16S rRNA gene sequences. Int. J. Syst. Bacteriol. 46, 10-
15. 
  58 
6. Van der Zee, A., Crielaard, J.W., 2002. Qiagen DNA extraction kits for sample preparation for 
Legionella PCR are not suitable for diagnostic purposes. J. Clin. Microbiol. 40, 1126. 
    
 59 
Chapter 5 
 
 
 
Detection of bacteria in platelet concentrates: comparison of broad-range real-time 
16S rDNA PCR and automated culturing 
 
 
T. Mohammadi
1,2
, R.N.I. Pietersz
1
, C.M.J.E. Vandenbroucke-Grauls
2
, P.H.M. Savelkoul
2
, and 
H.W. Reesink
1 
 
Sanquin Blood Bank North West Region
1
, and Department of Medical Microbiology and Infection 
Control, VU University Medical Center
2
, Amsterdam, The Netherlands 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Transfusion 2005;45:731-736 
 
 
  60 
ABSTRACT  
Background: Up to now several methods have been employed to monitor the presence of 
bacteria in platelet concentrates (PCs). Based on real-time PCR technology, a broad-range 
16S rDNA assay was previously developed. In the present study, the assay was validated and 
its performance compared to that of an automated culture system to determine its usefulness 
for rapid routine screening of PCs. 
Study design and methods: The assay was applied to PCs derived from pools of 5 individual 
blood donors each. The presence of bacteria in these PCs was routinely assessed in a 
BacT/Alert automated culturing system. Cultures were maintained until a positive signal was 
detected or for up to seven days when remaining negative. The PCR assay was performed 
with DNA extracted from the same samples as used for culturing. DNA extraction was done 
with the MagNA Pure automated extraction system. PCR amplification was performed with a 
set of universal primes and probe targeting eubacterial 16S rDNA.  
Results: A total of 2,146 PCs were tested. Eighteen (0.83%) samples were found to be 
contaminated. These samples were positive by both methods. All contaminants were 
identified as bacteria belonging to the common human skin flora. These included 
Propionibacterium spp. (n = 7), Staphylococcus spp. (n = 6), Bacillus spp. (n = 2), 
micrococcus spp. (n = 2), and Peptostreptococcus spp. (n = 1). All microorganisms were 
detected within 3 days, except Propionibacterium spp. and Peptostreptococcus spp. that 
required longer (3 to 5 days) anaerobic culturing to be detectable by BacT/Alert. By real-time 
PCR these contaminants were detected within a CT range of 24.4-36.9. Estimation of the 
bacterial load in PCs by real-time PCR showed that the initial levels of contamination varied 
between 13.6 and 9x10
4
 CFU equivalents/PCR reaction. Taking into consideration the nature 
and growth characteristics of bacteria present in the PCs on one hand and the fact that real-
time PCR detect DNA from both viable and nonviable bacteria on the other hand a correlation 
between a high initial bacterial load and a decreased time to detection by BacT/Alert was 
calculated.   
Conclusions: This study showed that, compared to culture in the BacT/Alert system, the PCR 
assay had a sensitivity of 100% and a specificity of 100%. This real-time PCR assay has a 
much shorter turnaround time of four hours, which offers the possibility to test and obtain 
results on PCs before release or the day they are transfused. This would permit the withdrawal 
of contaminated PCs before transfusion.   
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INTRODUCTION 
Transfusion of platelet concentrates (PCs) contaminated with bacteria may cause serious 
septic reactions that can be fatal to the recipient. Prevention or reduction of the occurrence of 
these septic reactions is therefore a major challenge faced in blood banking and transfusion 
medicine (1, 2). Up to now various techniques, like pretransfusion bacterial screening of PCs, 
have been adopted by blood centers to reduce the risk of transfusion-associated septic 
reactions (3, 4, 5, 6). These techniques vary from manual and visual methods to automated 
blood culture systems (7, 8, 9, 10, 11, 12). Many of these methods have proven to be useful 
for identification of bacterially contaminated PCs but have also proven to be inconvenient 
because of the time they require to indicate the presence of bacteria, their low specificity, and 
their lack of sensitivity when the initial levels of contaminating bacteria are low. 
To be useful as an optimal tool for routine screening of PCs, a dependable assay is desirable. 
The assay should be simple, sensitive enough to detect all clinically significant levels of 
bacteria, highly specific and rapid to allow the release of PCs for clinical use within hours (5, 
13).  The aim of the present study was a test that would meet all these criteria. As reported in 
a previous study (14), a broad-range 16S rDNA PCR assay, was developed and optimized, 
based on real-time PCR technology. In brief, in this assay the 5’nuclease activity of DNA 
polymerase is exploited to cleave a dual-labeled DNA probe after hybridization to its target 
during the elongation step of the annealed primers. After cleavage a fluorescent signal is 
generated that allows real-time detection of the amplified DNA (15, 16). As described before 
(14) this very rapid 16S rDNA-targeted real-time PCR has an analytical sensitivity of 1 
colony forming unit (CFU) equivalent/PCR reaction in PCs. To assess the applicability of this 
method for routine use in blood centers, the PCR assay was compared with an automated 
blood culture system. Routinely produced PCs were therefore screened by both methods. 
 
MATERIALS AND METHODS 
Processing of PCs and screening for bacterial contamination 
Leukoreduced PCs were routinely prepared following the buffy coat method. Briefly, after 
collection, whole blood was stored for 16-20 hours at room temperature before preparation of 
components. With a hard-spin centrifugation step, whole blood was separated into plasma, 
buffy coat (containing leukocytes and platelets) and red cells. The buffy coat was used as the 
source of platelet concentrates (17). After separation five ABO-identical buffy coats and one 
unit of plasma were pooled and centrifuged (soft-spin). The resulting platelet-containing 
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supernatant was filtered to remove residual leukocytes before transfer to a storage bag. The 
PCs are stored at 20-24
o
C with continuous agitation for up to 7 days. 
The presence of bacteria in these PCs was routinely assessed in the BacT/Alert automated 
culture system (bioMérieux, Durham, NC). A sample was obtained within 2 hours after 
preparation of PCs via a sample pouch integrated in the storage bag. Under aseptic conditions, 
standard aerobic and anaerobic BacT/Alert bottles were inoculated with 5-10 mL aliquots of 
PCs from the sample pouch through the integral needle. The samples were cultured until a 
positive signal was detected or for up to seven days if they remained negative. Positive culture 
bottles were subcultured for confirmation and identification of microorganisms (6). 
During the sampling procedure, duplicate samples were drawn, as used for inoculation of the 
BacT/Alert bottles, for the PCR assay. These aliquots were frozen at -70
o
C until further 
processing. 
 
Nucleic acid extraction from PCs  
DNA was isolated from aliquots of PCs using the MagNA Pure LC automated extraction 
system (Roche Diagnostics, Almere, The Netherlands). Prior to DNA extraction, the reagents 
of the MagNA Pure Total Nucleic Acid kit were filtered with the GenElute Maxiprep columns 
(Sigma-Aldrich Chemie Gmbh, Germany). This pretreatment is necessary to eliminate 
contaminating bacterial DNA present in the reagents of the extraction kit (personal 
communication). Two hundred µL aliquots of PCs were then loaded in the MagNA Pure and 
extracted according to the manufacturer’s instructions. Extracted nucleic acid was eluted in 
50µL elution buffer. 
 
Real-time PCR amplification and detection 
A 466-bp fragment of the bacterial 16S rDNA was amplified with a broad-range probe and 
primers set designed and described previously by Nadkarni et al. (18). The sequence of the 
forward primer and the reverse primer were 5’-TCCTACGGGAGGCAGCAGT-3’ and  5’- 
GGACTACCAGGGTATCTAATCCTGTT-3’ respectively. The fluorescent probe had the 
following sequence: (6-FAM)-5’-CGTATTACCGCGGCTGCTGGCAC-3’(TAMRA). The 
PCR reactions were performed in a total volume of 25 µL comprising the TaqMan Universal 
PCR Master Mix (containing 1 x TaqMan Universal PCR Master Mix, AmpliTaq Gold DNA 
Polymerase, AmpErase UNG, dTPs with dUTP, Passive Reference 1 and optimized buffer 
components, Applied Biosystems, Foster city, CA USA), 900 nM of each of the forward and 
the reverse primers, and 300 nM of the probe and 5 µL of template DNA.  
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The PCR mixture was subjected to digestion with the enzyme Sau3AI prior to the addition of 
template DNA. Also this pretreatment is necessary to eliminate possible traces of bacterial 
DNA present in the enzymes used in the PCR (14). 
No-template controls (NTC) with sterile water instead of template DNA were included in 
each run. The amplification was carried out under the following conditions: 50
o
C for 2 min, 
95
o
C for 10 min and 40 cycles of 95
o
C for 15 min and 60
o
C for 1 min. The PCR assay was 
conducted on the ABI 7000 Sequence Detection System (Applied Biosystems). Analysis of 
data was done with the SDS software (version 1.0) supplied by the manufacturer.  
 
Controls 
The efficacy of DNA extraction was assessed by coamplification of the human HLA-DQA 
gene in all reactions (19). The sequence of the forward primer was 5- 
TTGTACCAGTTTTACGGTCCC-3’ and the reverse primer 5’-
TGGTAGCAGCGGTAGAGTTG-3’. For the detection of the 216-bp amplicon a probe with 
the following sequence 5’-TTCTACGTGGACCTGGAGAGGAAGGAG-3’ was designed. 
This probe was labeled on the 5’end with VIC, and with TAMRA on the 3’end.  
To ensure that there was no PCR inhibition, control DNA from Bordetella avium DNA (5 µL, 
equivalent to 50 CFU) was added to the PCR reactions with template DNA. The extraction 
and inhibition controls were performed in the same reaction in parallel with the reactions 
performed with DNA extracted from the PCs aliquots. In addition negative isolation controls 
with water instead of PCs and negative reagent controls (NTC) without template DNA were 
incorporated throughout the whole procedure of extraction and amplification. 
Standard calibration curve for quantification 
Staphylococcus aureus (ATCC 25923) DNA was used to generate a calibration curve. DNA 
was purified from tenfold-dilution series of bacterial suspensions with known amounts of 
CFU. The extraction was conducted following the same procedure as described above. A 
calibration curve was incorporated in each PCR run and was used for determination of 
bacterial load in contaminated PCs. 
 
RESULTS 
Comparison between real-time PCR and BacT/Alert: 
A total of 2,146 PCs was sampled and assessed for the presence of bacteria by both the PCR 
assay and the BacT/Alert culturing system. After PCR amplification of DNA isolated from 
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PCs a threshold cycle (CT ) value was generated for each reaction. A CT value is defined as 
the PCR cycle number at which fluorescence generated by cleavage of probe exceeds a fixed 
baseline threshold level.  A high CT value corresponds to a low input of target DNA. The CT 
values were used to interpret the results of the PCR assay.  
First, a cut-off value for positivity was determined to differentiate between contaminated and 
non-contaminated PCs. Based on the controls and the analytical validation of the assay a 
result was considered positive when the CT value was less than 37 (corresponding to 
approximately 1 CFU equivalent/PCR reaction). CT values above this cycle number were 
considered negative. This interpretation of the results was valid only when DNA extraction 
was efficient and no PCR inhibition was observed. This implied that the HLA-DQA gene was 
consistently amplified (CT  range 33-34) and that the amplification of the B. avium DNA 
added to the PCR reactions with template DNA was not inhibited (a CT range between 33.63 
and 34.99 was required). If HLA-DQA1 was not amplified or the PCR appeared inhibited a 
new aliquot of the same sample of PCs was re-extracted and re-amplified. With regard to the 
BacT/Alert results, a culture was deemed as positive when a microorganism was identified in 
the culture bottles. 
Eighteen samples were identified as positive by both real-time PCR and BacT/Alert.  All 
specimens that remained negative in the BacT/Alert system were also negative in the PCR 
assay. Therefore, there was perfect agreement between BacT/Alert and PCR assay. 
 
Estimation of the bacterial load in contaminated PCs:   
From the dilution series of the S. aureus suspension a standard curve was generated. This 
curve was used to estimate the bacterial load (reflected as CFU equivalent/PCR reaction) in 
the PCs. An example of a representative standard curve is depicted in Fig.1. The curve was 
linear between 10
5 
and 10
0 
CFU/PCR reaction. By extrapolation of CT values of the PCs 
samples absolute quantities were calculated. A summary of the identified bacteria, time to 
detection of each microorganism by the BacT/Alert, and estimation of bacterial load  
is presented in Table 1. The majority of the microorganisms identified in the contaminated 
PCs were Gram-positive bacteria belonging to the common human skin flora. 
Propionibacterium spp. (n = 7) were most  
frequently isolated, followed by Staphylococcus spp. (n = 6). Dependent upon the 
microorganism involved, the  
 
 
    
 65 
 
 
 
 
 
 
Figure 1. Standard curve generated with DNA extracted from serial dilutions of a pure culture of  
S. aureus. The assay was linear over a wide range varying between 1 x 10
0 
and 1 x 10
5 
CFU 
equivalents/PCR reaction. Slope: -3.326, Intercept: 38.704 and R
2
: 0.999. The X-axis represents the 
starting copy number expressed as log CFU equivalents/PCR reaction. Threshold cycle (CT) values 
are plotted on the Y-axis. 
 
 
 
bacterial load varied between 15.4x10
0 
and 1x10
5
 CFU equivalent/PCR. Although a relatively 
high initial amount of CFU was estimated by the real-time PCR, the BacT/Alert required 4 to 
6 days to detect the presence of Propionibacterium spp. The fastest detection times were 
recorded for S. epidermidis (n = 2): 23.5 to 2x10
2  
CFU equivalent/PCR reaction were 
detected within 2 days. 
Micrococcus spp. (n = 2) were detected in the BacT/Alert in approximately 3 days, the 
bacterial load was 13.6 and 30 CFU equivalent/PCR. Bacillus spp. (n = 2) was detected after 
approximately 5 days of culturing in the BacT/Alert.  The presence of Peptostreptococcus 
was detected in one case after 6 days of anaerobic culturing. For the sample contaminated 
with this bacterium a bacterial load of 2x10
4
 CFU equivalent/PCR was determined.  
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Table 1. Estimation of bacterial load by real-time PCR and time to detection of PCs signaled positive 
by BacT/Alert 
____________________________________________________________________________________________  
                                  Real-time PCR 
 ________________________________________________              
                              BacT/Alert                      Bacterial load 
 ____________________ ________________________    
Sample Bacterium     Time to detection (hrs) Detection*     Ct     CFU/PCR   CFU/mL    
____________________________________________________________________________________________________________________________________   
1  Propoinibacterium spp.     42              N          24.4    10
5          
5x10
6  
2  Propionibacterium spp.     46.8            N          36.7    3.5        175 
3  Propionibacterium spp.     57.6            N          27.9    7.1x10
4    
3.6x10
6
 
4  Propionibacterium spp.     61.2            N          32.7    10
2
        5x10
3
  
5  Propionibacterium spp.     62.4            N          26.7    9x10
4
      4.5x10
6
  
6  Propionibacterium spp.     63.6            N          36.2    3.8        1.9x10
2
  
7  Propionibacterium spp.     70.8            N          35.8    17.4       8.7x10
2
 
8  S. epidermidis            18.5            A/21
b
 N     35.8    23.5       1.2 x 10
2 
9  S. epidermidis             19.2            A/24.8 N    35.9    41.9       2.1 x 10
3 
 
10 S. epidermidis            20.2            A          33.9    2x10
2
      10
4
  
12 S. epidermidis            40.8            N          35.2    43.6       2.2x10
3
 
11 S. schleiferi              34.8            A          36.5    15.4       7.7x10
2
 
13 S. capitis                49             N          34.6    325.2      1.6x10
4
  
14 Bacillus spp.             52.8            A          34.1    38.2       1.9x10
2
 
15 Bacillus spp.             58.8            A          35.2    23.7       1.2x10
2
 
16 Micrococcus luteus        37             A          36.9    13.6       6.8x10
2
 
17 Micrococcus spp.          42.3            A          36.6    30.08      1.5x10
2
 
18 Peptostreptococcus spp.    62.4            N          26.3    2x10
4
      10
6
 
____________________________________________________________________________________________________________________________________  
*  N = detected in the anaerobic culturing bottle of BacT/Alert (N); A = detected in the aerobic culturing bottle of 
BacT/Alert . 
b These bacteria were also detected in the anaerobic bottles at the indicated time.  
 
 
DISCUSSION 
Currently, automated culturing is considered to be the gold standard in most blood centers to 
assess the presence of bacteria in PCs. Although this method is sensitive, it requires up to 48 
hours to yield (positive) results for most microorganisms. While the culture is still ongoing, 
PCs might already be issued (as negative to date) to the hospital and be administered to a 
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recipient. In addition, a large sample of 5-10 mL is required to inoculate both culturing bottles 
of the BacT/Alert. This large inoculum is lost from the blood product. In view of these 
disadvantages an alternative, faster method to test PCs for bacterial contamination was 
desirable. A 16S rDNA-targeted real-time PCR was previously developed and optimized. In 
the present study the performance of this assay was compared to that of automated culture. 
The results of the real-time PCR were in agreement with those obtained with the BacT/Alert. 
The PCR assay showed the same sensitivity and specificity as culture, with the advantage of a 
much shorter turn around time. In addition, the PCR permitted an estimation of the number of 
CFU present in the PCs samples that were tested.  
 
The microorganisms that were detected as contaminants in PCs were: Propionibacterium 
spp., Staphylococcus spp., Bacillus spp., Micrococcus spp. and Peptostreptococcus spp. 
Various studies have reported these bacteria to be the common contaminants found in PCs 
(20, 21, 22, 23). In the current validation study the majority of these bacteria were detected by 
culture within 3 days, except most Propionibacterium spp., which needed 4 to 6 days to be 
detected in the anaerobic culture bottles of the BacT/Alert. This longer time was needed, 
despite the high bacterial load that was present in the starting culture (estimated by real-time 
PCR). It is known that Propionibacterium spp. have a prolonged lag phase. Consequently, the 
bacterium requires long time to proliferate before it becomes detectable with the BacT/Alert. 
 
Although the 16S rDNA-targeted real-time PCR was designed as a sensitive and rapid 
alternative to blood culture to detect contaminated PCs on a qualitative basis, its real time 
character provided the opportunity to examine the relationship between number of bacteria 
present in contaminated PCs and time to detection in the BacT/Alert. A high initial 
concentration of bacteria did not invariably correlate with a short detection time in the 
BacT/Alert. Two factors may explain this finding. First, the real-time PCR detects DNA from 
both viable and nonviable bacteria, while the BacT/Alert is based on detection of CO2 
produced by growing bacteria. Second, since the PCR was performed on samples taken on 
day 1 of storage of PCs (day 0 is day of collection), it is likely that only few microorganisms 
were recovered in the sample incubated in the BacT/Alert. Dependent on the growth kinetics 
of the bacterium present the time needed for detection with the BacT/Alert can vary. 
On the other hand, quantitation results determined by real-time PCR support the results 
obtained by others. Studying bacterial surveillance of platelet concentrates Blajchman et al. 
(24) concluded that all true positive could be detected in units sampled on day 3. Brecher et 
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al. (25) have reported on the low detection efficiency of the BacT/Alert when bacteria are 
present in numbers below 10 CFU/mL. Hence, it was suggested that 2 to 3 days incubation is 
needed to allow bacteria to proliferate before reliable detection can occur. In other studies it 
was observed that all bacteria could be detected within 3 days when starting concentrations of 
10 to 100 CFU/mL were used (26).  
 
In summary, the real-time PCR assay, in combination with the automated MagNA Pure 
nucleic acid extraction system provides a standardized, rapid and sensitive method to monitor 
bacterial contamination of PCs. The assay offers various benefits above most commonly used 
systems. Among these the use of closed-tube chemistries, which reduces the risk of 
contamination of samples during the assay. In addition, with this assay it is possible to 
process a large number of specimens (96-well format can be used) in a timely manner. The 
results can be obtained within 4 hours. This is especially favorable when 100% testing of PCs 
is mandatory.  
The short turnaround time of this assay will reduce the risk of transfusion of bacterially 
contaminated units: PCs can be tested before release or the day they are transfused. To 
determine the most convenient time for sampling additional evaluation studies of the PCR 
assay in conjunction with the BacT/Alert are in progress.  
The PCR assay does not depend on the growth kinetics of bacteria. This feature permits the 
extension of the storage time of PCs from 5 to 7 days without compromising the risk of 
transfusing contaminated units. 
However, this broad-range 16S rDNA PCR assay could become a source of false-positive 
results if no sufficient measures to prevent contamination are taken. These include the use of 
separate rooms for sampling of PCs, for nucleic acid extraction and for setting up PCR 
reactions. Other sources of contamination with bacterial DNA like PCR enzymes and 
extraction reagents must also be precluded. In addition, the use of dedicated devices and 
disposables needed during the whole procedure of extraction, amplification and detection may 
greatly increase the costs of the assay. Accordingly, before implementing such an assay as a 
routine screening tool in a blood center it might be recommended to conduct a cost-benefit 
analysis. 
In conclusion, real-time PCR proved a rapid and reliable method to test PCs for prevention of 
transfusion of contaminated units. 
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ABSTRACT 
Background and Objectives: A universal quantitative Real-Time (RT) PCR, based on 
bacterial 16S rDNA to detect bacterial contamination of platelet concentrates (PCs), was 
developed previously and compared to automated culturing. In the present study, this RT-
PCR method was evaluated to determine the optimal sampling time for screening of bacterial 
contamination in PCs.  
Materials and Methods: Routinely prepared PCs were spiked with suspensions of 
Escherichia coli, Bacillus cereus, Staphylococcus epidermidis, Pseudomonas aeruginosa and 
Propionibacterium acnes to 1, 10 and 100 CFU/mL and stored at room temperature for 7 
days. The presence of bacteria in these PCs was monitored by quantitative Real-Time PCR. 
As reference method (additional control) BacT/Alert automated culturing was used. For PCR 
1 mL aliquots were drawn from all (spiked) PCs on day 0, 1, 2, 3, 6 and 7 of storage. As a 
control, triplicate samples (10 mL) were inoculated in aerobic and anaerobic BacT/Alert  
culture bottles immediately after spiking (day 0) and after storage of 1, 2, 3, 6 or 7 days.   
Results: With quantitative Real-Time PCR all tested bacteria species were reproducibly 
detected on day one after inoculation at original concentrations of 10 and 100 CFU/mL. Initial 
concentrations of 1 CFU/mL were also detected on day 1 except for E. coli which was 
detected only in 1 of the 3 samples and P. aeruginosa which was not performed on day 1.  
With the reference method bacteria were detected in culture bottles (inoculated on day 0) 
within a mean time of 20.1 hours, with exception of P. acnes which was detected in a mean 
time of 102.3 and 49.3 hours (for 10 and 100 CFU/mL respectively).  
Conclusions: PCR enables rapid detection of low initial numbers of bacteria in PCs. For 
reliable detection, our results support that sampling of PCs for RT-PCR screening should not 
be carried out earlier than one day after preparation (48 h after blood collection). Importantly, 
the RT-PCR approach has the potential to be used before release of PCs from the blood centre 
or shortly before they are transfused in the hospital.  
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INTRODUCTION 
Screening platelet concentrates (PCs) for bacterial contamination by means of automated 
culturing is becoming a routine procedure in many blood centres over the world. Studies 
evaluating the performance of the BacT/Alert have shown the ability of this automated culture 
system to reliably detect as little as 1-10 CFU/mL [1, 2, 3 ,4]. The detection of the majority of 
bacterial species implicated in contamination of PCs can be realized within 24-48 hours. 
However the detection of slow growing bacteria like Propionibacterium acnes requires 
considerably more incubation time to be detected [5, 6, 7]. To circumvent this inconvenience 
a Real -Time (RT) PCR-based method was developed and validated to detect bacterial DNA 
in PCs; this method was published in previous studies [8, 9]. With this universal Real-Time 
quantitative  PCR it is possible to detect analytically 1 CFU equivalent of bacterial DNA (i.e. 
50 CFUequiv./ml) within 4 hours. The assay can be performed immediately after preparation 
of the PCs, before their release to hospitals or shortly before they are transfused. The current 
study was conducted to determine the optimal sampling time after PCs preparation using this 
PCR assay. To this purpose PCs were spiked with different concentrations of five 
microorganisms frequently associated with bacterial contamination of PCs. The presence of 
these bacteria was monitored over time with the PCR assay and by culturing in the 
BacT/Alert system (as reference method).  
 
MATERIALS AND METHODS 
Bacterial strains and culture conditions 
The study was conducted with 5 microorganisms frequently associated with contamination of 
PCs. These included Escherichia coli (ATCC25922), Bacillus cereus (ATCC 11778), 
Staphylococcus epidermidis (clinical isolate), Pseudomonas aeruginosa (ATCC 27853) and 
Propionibacterium acnes (clinical isolate). The bacterial strains were grown in Brain Heart 
Infusion Broth aerobically or anaerobically (in case of P. acnes). The bacteria were cultured 
until a turbidity of 0.5 McFarland (1.5 x 10
8
 CFU/mL) was reached. From these suspensions 
serial tenfold dilutions were made in PBS. The suspensions were plated in triplicate on blood 
agar plates to determine the actual number of CFU/mL. From appropriate dilutions aliquots 
were drawn and used for inoculation of the PCs. The recovered concentrations were counted 
by plating and the results are presented in Table 1.  
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Inoculation of PCs: 
For each bacterium six routinely prepared buffy coat-derived leukocyte reduced PCs 
(preparation is performed 22-24 hours after blood collection) units in plasma (of 300 mL 
each)[8] were pooled and then divided into 12 smaller pools of 150 mL. Three of these pools 
were used as negative controls (without spiking) and the other 9 were spiked with appropriate 
bacterial suspensions to obtain a final concentration of 1, 10 and 100 CFU per mL (3 separate 
150 mL PCs pools per concentration). To monitor the presence of bacteria in these units, 10 
mL aliquots (according to the European manufacturer’s product insert) from each spiked PCs 
bag were transferred immediately after spiking (day 0), or after storage of 1, 2, 3, 6, or 7 days 
to both BacT/Alert standard aerobic and standard anaerobic culture bottles (bioMérieux, 
Boxtel, The Netherlands). Inoculation of the bottles on day 1, 2, 3, 6 or 7 was performed only 
when bacteria in one of the triplicate PCs bags were not yet detected after 1, 2, 3, 6 or 7 days 
of incubation (see flow diagram in Fig. 1). The inoculated culture bottles were incubated at 
35
o
C in the BacT/Alert either until the system gave a positive signal or for up to 7 days if they 
remained negative. As negative control aliquots of unspiked PCs were also used to inoculate 
the culture bottles of the BacT/Alert. 
The bags with the remainder of the (spiked) PCs were stored at room temperature with 
continuous agitation for up to 7 days. 
The presence of bacteria in the (inoculated) PCs bags was monitored by universal quantitative 
Real-Time PCR. For this application aliquots of 1 mL were drawn from all units during 
storage. Each PCs bag was sampled on day 0 (day of preparation of PCs and inoculation, this 
was 24 h after blood collection), day 1, day 2, day 3, day 6 and day 7 after inoculation and 
tested in parallel with the BacT/Alert. Inoculation of the BacT/Alert bottles was ended when a 
positive signal was noted from culture bottles of earlier time point inoculations. 
 
Quantitative Real-Time PCR 
DNA extraction 
DNA extraction of samples drawn throughout storage at different time intervals from 
inoculated PCs was done with the MagNA Pure LC System (Roche diagnostics, Almere, The 
Netherlands). DNA was extracted from 200 µl aliquots using the MagNA Pure Total Nucleic 
Acid Isolation Kit according to the manufacturer’s instructions. According to the standardized 
protocol, DNA extraction takes 90 minutes for 32 samples and the nucleic acids were eluted 
in a final volume of 50 µL. Extraction reagents were subjected to the same pretreatment as 
reported earlier [8].  
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Figure 1: Flow diagram representing how a sample of PCs was inoculated with each bacterium 
species and time points of inoculations and sampling for BacT/Alert and PCR. For all three 
concentrations (1, 10 and 100 CFU/mL) the inoculations were conducted in triplicate. (T= Time in 
days) 
 
T = 0 
T = 1 
T = 2 
T = 3-7 
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PCR amplification: 
The DNA was amplified following the same procedure as described earlier [8]. Briefly, the 
PCR was performed with universal primers and probe set. The sequence of the forward and 
the reverse primer were 5’- TCCTACGGGAGGCAGCAGT-3’ and 5’- 
GGACTACCAGGGTATCTAATCCTGTT-3’ respectively [9]. The sequence of the probe 
was (6-FAM)-5’- CGTATTACCGCGGCTGCTGGCAC-3’ (TAMRA)[9]. 
Amplification was carried out in a total volume of 25 µL containing 12.5 µl 2X TaqMan 
Universal PCR Master Mix (consisting of  AmpliTaq Gold DNA polymerase, AmpErase 
UNG, dNTPs with dUTP, Passive Reference 1 and optimized buffer components, Applied 
Biosystems, Foster City, CA USA), 900 nM of each of the forward and the reverse primers, 
and 200 nM of the probe and 5 µL of template DNA. 
As described before [9] the PCR mixture was subjected to digestion with the enzyme Sau3AI 
prior to the addition of template DNA, to eliminate possible contamination of PCR reagents 
with traces of bacterial DNA.  
In addition to DNA extraction and PCR inhibition controls, no template controls (NTC) with 
sterile water instead of template DNA were included in each run. The thermal cycling 
program was as follows: 50
o
C for 2 min, 95
o
C for 10 min and 40 cycles of 95
o
C for 15 min 
and 60
o
C for 1 min. Real-time detection of the PCR products was performed in 90 minutes on 
the Sequence Detection System (ABI 7000, Applied Biosystems). 
 
RESULTS 
Inoculation of PCs 
The recovered concentrations of bacteria are shown in Table 1. Based on the bacterial 
concentration of 0.5 McFarland the triplicate culturing results show that the initial inoculation 
amount were very reproducible. For B. cereus , E.coli and S. epidermidis the amount varied 
slightly under the amount of 10 and 100 CFU/mL. For P.  
acnes and P. aeruginosa the amount of 10 and 100 CFU/ml were somewhat lower. For all 
bacteria the 1 CFU/mL inocula were correct whereas the amount of 10 CFU/mL showed the 
most differences. 
 
Automated culturing 
All day 0 inoculated samples cultured in the aerobic bottles were signalled positive by the 
BacT/Alert system, except when PCs were spiked with P. acnes (at all concentrations) and 
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with 1 CFU/mL of E. coli. The samples cultured in the anaerobic bottles gave a positive 
signal for all bacterial species tested, except when inoculated with 1 CFU/mL of E. coli, P. 
acnes or P. aeruginosa. Mean times to detection of each bacterial species in PCs by the 
BacT/Alert inoculated at day 0 are summarized in Table 2. 
The bacteria were detected in both bottles within a mean time of 20.1 hours post-inoculation. 
Time to detection for most samples in the anaerobic bottles was faster or equal to the time to 
detection in the aerobic bottles (except for P. acnes). Overall, the data in Table 2 indicate that 
time to detection in both culture bottles of the BacT/Alert declined when the amount of the 
inoculated bacterium increased. Excluding results from P. acnes, a minimum and a maximum 
difference between ten-fold dilutions of other strains ranged between 0.8 and 2.52 hours 
respectively.  
In case of E. coli at 1 CFU/mL no positive signal was detected in both culture bottles.  
However, when the culture bottles were inoculated with PCs samples of day 1, the signal 
became positive within 12.18 h in the aerobic bottle and 11.38 h in the anaerobic bottle (data 
not shown). 
When Inoculation with P. aeruginosa was carried out on day 2 (on day 1 no inoculation was 
performed) a mean time to detection of 12.18 h in the aerobic bottle and 11.94 h in the 
anaerobic bottle was achieved (data not shown). 
PCs spiked at 1 CFU/mL with P. acnes could only be detected in the culture bottles 
inoculated on day 6 of storage. All strains of bacteria spiked at an inoculum of 10 and 100 
CFU/mL gave a positive signal after 1 day of storage of the PCs (i.e. 48 h after blood 
collection and 24 h after spiking). 
During culturing for up to 7 days no positive signal was recorded by the BacT/Alert system 
for samples taken from all unspiked PCs (negative controls).  
 
Quantitation by Real-Time PCR 
The bacterial load determined over time of storage by quantitative RT- PCR for PCs spiked 
on day 0 at an initial inoculum of 1, 10 and 100 CFU/mL is presented in Table 3.  
On day 0 all samples inoculated with 100 CFU/mL, that is 2 CFU equivalents/PCR, were 
detected by RT- PCR. In a previous study [10] the detection limit of the PCR assay was 
determined as 50 CFU/mL (i.e. 1 CFU equivalent/PCR), therefore the present results were in 
agreement with what was expected. This implies that numbers of bacteria below 50 CFU/mL 
(the detection limit of the PCR) cannot be detected. However with B. cereus and E. coli an  
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Table 1: Recovered concentrations of bacteria used to inoculate PCs. 
_____________________________________________________________________ 
 
Recovered concentrations of 1, 10 and 100 CFU/mL 
 ____________________________________________________________________   
  
  Bacterium      source       1         10         100 
_____________________________________________________________________ 
 B. cereus       ATCC11778   1  (1/3)    8-10 (3/3)    95-100 (3/3) 
 E. coli         ATCC25922   1-2 (2/3)    4-10 (3/3)    71-100 (3/3) 
 S. epidermidis   Clinical isolate  1-1 (2/3)    4-10 (3/3)    84-100 (3/3) 
 P. acnes       Clinical isolate  3  (1/3)    6-7  (3/3)    90-95  (3/3) 
 P. aeruginosa   ATCC27853   1  (1/3)    5-8  (3/3)    79-98  (3/3) 
_____________________________________________________________________ 
PCs were inoculated in triplicate with bacterial suspensions to achieve initial  
concentrations of 1, 10 and 100 CFU/mL. The upper and lower range of triplicate  
samples of the recovered concentrations is given. The number of reactive plates is  
given in parentheses. 
 
 
inoculum of 10 CFU/mL was also detected. No amplification signal was observed for samples 
taken from control (unspiked) PCs (data not shown). 
Detection of E. coli in the RT-PCR with an inoculum of 1 CFU/mL was positive for only 1 of 
the triplicate samples whereas none of the cultured E. coli gave a positive result for to up to 7 
days with the same number of bacteria (and on day 0).  
In general, from day 1 of storage (i.e. 48 h after blood collection) the presence of bacteria in 
PCs was detected by PCR in all tested samples and the corresponding bacterial load could be 
estimated. The quantitative results of the RT-PCR fluctuated and were not always in 
agreement with the increased inocula. The bacterial load of the culture however increased 
during storage of the PCs bags to reach a maximum in most cases on day 6 or 7 of storage 
according to the growth characteristics of the microorganism tested. 
Finally, the RT-PCR procedure was completed within 4 hours including DNA isolation, 
amplification, detection and interpretation. 
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Table 2:  Mean time to detection (hrs) in the BacT/Alert culture bottles of bacteria inoculated into 
platelet concentrates on day 0 at an inoculum of 1, 10, and 100 CFU/mL. 
____________________________________________________________________________  
                  Aerobic bottles                     Anaerobic bottles 
 ____________________________ ________________________     
                  mean
a
 (range)     reactive            mean (range)      reactive  
                                  bottles
b                            
bottles 
____________________________________________________________________________    
1 CFU/mL: 
B. cereus          15.7 (15.3 - 16.1)   2/3                14.3 (13.6 - 15.1)    3/3 
E. coli            -
c
               0/3                -               0/3 
S. epidermidis      20.1 (20.0 - 20.2)   2/3                19.2 (16.3 - 24.2)   3/3 
P. acnes           -                0/3                -                0/3 
P. aeruginosa      13.7 (13.1- 14.0)   3/3                -                0/3 
10 CFU/mL: 
B. cereus          13.6 (13.2 - 13.4)   3/3                13.6 (12.3 - 14.4)   3/3 
E. coli            12.3 (12.2 - 12.5)   3/3                11.5 (11.2 - 12.1)   3/3 
S. epidermidis      19.3             1/3                18.3 (18.2 - 18.4)   2/3 
P. acnes           -                0/3                102.3            1/3 
P. aeruginosa      14.9 (14.3 - 15.5)   3/3                15.4 (14.5 - 16.2)   2/3 
100 CFU/mL: 
B. cereus          12.1 (12.1 - 12.1)   3/3                11.9 (11.4 - 12.2)   3/3 
E. coli            10.7 (10.6 - 11.1)   3/3                10.4 (10.3 - 10.6)   3/3 
S. epidermidis      17.8 (17.4 - 18.1)   3/3                17.5 (15.2 - 20.2)   3/3 
P. acnes           -                0/3                49.3 (48.2 - 50.4)   2/3 
P. aeruginosa      13.1 (13.0 - 13.2)   3/3                12.8 (12.4 - 13.0)   3/3 
_____________________________________________________________________________________________________________________________________________  
a The values present the means of 3 units spiked with the same inoculum. The range (lower and upper limits) of detection is 
also given. 
b Number of BacT/Alert bottles signalled positive.  
c No growth of bacteria was detected. 
 
 
 
DISCUSSION 
Previously a quantitative Real-Time PCR method was developed to screen PCs [10] for 
bacterial contamination. The method was shown to be rapid, specific and highly sensitive [8]. 
To evaluate the application of this method and to determine the optimal time for sampling 
PCs, the current study was conducted in conjunction with the BacT/Alert as a reference. 
On day 0 the presence of bacteria was detected at all inocula with the automated culturing 
system within 20.1 hours for all species tested, except for E. coli and P. acnes which were not 
found in initial inocula of 1 CFU/mL in both bottles. Although P. acnes is considered of no or 
low clinical significance, three clinical incidents of contamination of PCs with P. acnes have 
been reported by Schneider et al. [11]. Transfusion of these PCs caused septicaemia in the 
recipients. Therefore it seems important to detect this bacterial species to improve the safety 
of transfusion of PCs. 
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Table 3: Bacterial load (CFU equivalents/PCR reaction) determined at different time intervals by 
quantitative real-time PCR for PCs inoculated on day 0 at 1, 10 and 100 CFU/mL
a
 
____________________________________________________________________________________________________________________________   
Days post-inoculation of PCs 
 ____________________________________________  
                                t = 0    t = 1     t = 2     t = 3     t = 6     t = 7 
 Microorganism 
_______________________________________________________________________________  
1 CFU/mL : 
B. cereus                     -
b
      7.8x10
2
  7.5x10
4
  4.5x10
4   
2.3x10
3   
1.4x10
4
 
E. coli                      -       4.2      1.2x10
2
   71.5     20.4     37.6 
S. epidermidis                -       3.9      1.2x10
4
   1.4x10
2
  6.2x10
6
  3.4x10
6 
P. acnes                     -       1.4      4.3      2.7      4.7x10
3
  4.2x10
3
 
P. aeruginosa                -       ND
c
     1.9x10
4
   1.8x10
5
   1.4x10
7
   3.1x10
7
 
10 CFU/mL :  
     B. cereus                   5.3      80.6     3.4x10
5
   7.2x10
4 
   2.1x10
3
   2.3x10
4
 
     E. coli                     3.1      42.4     3.6x10
5 
  4.4x10
5
   5.8x10
5
   1.4x10
5
 
     S. epidermidis                -       5.7      1.9x10
3
  2.2x10
3
  2.7x10
6
  1.2x10
6
 
     P. acnes                     -       2.7      3       9.8x10
2
  9.6x10
3
   1.7x10
4 
     P. aeruginosa                -       ND      29.1     2.8x10
5
   9.7x10
6
   1.7x10
6
 
100 CFU/mL : 
     B. cereus                   9.1      4.8x10
3
   3.6x10
5
   1.9x10
4
   1.3x10
3
   2x10
4
 
     E. coli                     5.8      62      3x10
5
    2.5x10
5
  8.2x10
5
   3x10
5
 
     S. epidermidis               6       2x10
3
    1.6x10
3
   2.5x10
4  
3x10
6
    7.7x10
6
 
     P. acnes                    15.1     4.7      3       4.6x10
2
  5.8x10
3
   1.6x10
4 
     P. aeruginosa               52.4     ND      4.9x10
5
   1.5x10
5
   7.9x10
6
   1.7x10
6
  
____________________________________________________________________________________________________________________________  
a PCs were spiked in triplicate with each inoculum. The results are the means of triplicate inoculations. Bacteria were 
detected in all triplicate samples, except E. coli at an inoculum of 1 CFU/mL that was detected in only one sample at day1, 2, 
3 and 6.   
b No amplification signal was detectable. c ND:  not determined.  
 
 
On day 1 of storage of the PCs, the automated culturing system recorded the presence of all 
strains of bacteria at all concentrations, except P. acnes at 1 CFU/mL, which was detected 
only on day 6 of storage in the anaerobic culture bottle. 
The use of a quantitative Real-Time PCR to monitor the presence and growth of bacteria in 
PCs demonstrated the ability of this assay to detect reproducibly all bacteria on day 0 (day of 
PCs preparation and spiking) when an inoculum of 100 CFU/mL in the original PC bag, was 
applied (Table 3). The detection of less than 100 CFU/mL was only possible for B. cereus and 
E. coli.  These species have a short generation time (20-30 min in broth) and could therefore 
reach the number which can be detected by PCR more easily. However other species like S. 
epidermidis and P. aeruginosa can also double in 30 minutes. Knowing that the time between 
inoculation and sampling of PCs did not exceed 2 hours, it is probable that these bacteria have 
an extended proliferation time in PCs A possible bacteriocidal effect from the PCs on these 
strains might be responsible for this effect resulting in a reduction of the amount of viable 
bacteria. The remaining viable organisms will grow subsequently in the following days. On 
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the other hand, the detection depends not only on the detection limit of the PCR assay but also 
on the probability of the presence of a bacterium in the sample taken from the PCs bag. 
Although the analytical sensitivity of the RT-PCR is 1 CFUequivalent /PCR (50 CFU 
equivalents/mL) the clinical sensitivity in the PCs may be somewhat different due to the 
effect of the specimen. Based on the maximum sensitivity only the 100 CFU/mL inoculum 
would be detectable. However because of a probabilistic effect also some 10 CFU/mL 
samples were positive. This also explains the fact that there is no difference in quantification 
between the 10 CFU/mL and the 100 CFU/mL quantitative results since this is both at the 
limit of the sensitivity.  
Remarkably P. acnes could be detected directly with the PCR assay after inoculation of 100 
CFU/mL on day 0, whereas with automated culturing a positive signal was recorded after 49.3 
hours of incubation in the anaerobic bottles only. Although growth conditions (medium, 
temperature) in the culture bottles of BacT/Alert are more favourable for growth of most 
bacteria than when they are stored in PCs at room temperature, the detection with PCR was 
faster than in the BacT/Alert. This demonstrates the sensitivity of the PCR assay in detecting 
slow growing microorganisms.  
 
With the PCR assay all tested bacteria could be consistently detected one day after spiking, 
regardless of the size of the inoculum. The bacterial load increased as the storage time was 
prolonged to achieve a maximum when bacteria enter the stationary phase of growth. 
Compared to other bacteria, P. acnes exhibited slower growth and the bacterial load reached 
no more than approximately 2x10
4
 CFU equivalents/PCR at the end of 7 days of storage. This 
is in accordance with the results of the BacT/Alert where this microorganism showed the 
longest time to detection. 
Interestingly, all PCs contaminated with 1 CFU/mL could be reliably detected by PCR after 
one day of storage (day 1) in all tested samples except E. coli which was detected only in one 
of the three inoculated samples. In BacT/Alert this amount required an incubation time of at 
least 20.1 hrs to reach a detectable threshold. The efficacy of detection with PCR may offer 
the possibility of removing contaminated PCs prior to issue to hospitals. In this case two 
advantages of this approach can be mentioned being the time to results and standardized 
procedures. As described in the methods section the whole procedure (DNA isolation, 
amplification and detection) is standardized and is completed within 4 hours (extraction 90 
min for 32 samples, amplification 90 min and analysis 5 min, sampling and pipetting 30 min). 
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The whole procedure is carried out in closed systems with ready-to-use DNA isolation 
reagents and commercial RT-PCR master mixes. In addition, the use of Real Time PCR 
prevents any post-amplification handling. Therefore, in general, the RT-PCR is suited for 
routine performance. However it should be mentioned that PCR detects DNA from both 
viable and non-viable bacteria. The detection of non-viable bacteria by PCR may affect the 
specificity of the assay. Nevertheless in routine this is of no importance as long as the 
sensitivity of PCR is good enough to use this screening test as a qualitative criterion to release 
PCs. 
As the input of a sample in the RT-PCR was approximately 100 fold less than in the 
automated culturing system, RT-PCR has the potential to become more sensitive when the 
input volume will be increased. 
 
In summary, the findings of this study show that the PCR assay has the advantage of 
providing results in a short time (within 4 hours):. Contamination can be detected after 
preparation of PCs, though the initial amount of some bacteria is low (less than 1CFU 
equivalent/PCR reaction). Based on the available literature the initial contaminating amount 
of bacteria is thought to be in the order of 1-10 CFU/mL blood [14]. In some cases (as 
detailed above) this amount could be missed if testing is performed immediately after 
preparation of PCs since the detection level of the RT-PCR is 50 CFU equivalents/ml. 
Therefore to assure optimal detection of all relevant bacterial species by PCR, it is reasonable 
to sample (routinely prepared) PCs at least one day after preparation (i.e. 48 hours after blood 
collection). At this time point the PCR has the potential to detect bacteria present in PCs even 
at low initial concentrations. 
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ABSTRACT 
Propionibacterium acnes is implicated in most cases of bacterial contamination of platelet 
concentrates (PCs). To determine the source of contamination, amplified fragment length 
polymorphism (AFLP) analysis was applied. This DNA fingerprinting technique was used to 
study the molecular relatedness of 44 isolates derived from 22 PCs and 22 corresponding red 
blood cells concentrates (RBCs) from the same whole blood donations. The AFLP results 
together with sequencing analysis of the 1200 bp of the 16S ribosomal RNA gene revealed 
the existence of three main groups: two groups (group 2 and 3) (55%) consisting of isolates 
that did not originate from skin flora and another group (group 1)(45%) comprising bacteria 
belonging to the skin flora. This latter group showed complete homology with reference 
strains of P. acnes. Therefore these isolates can be considered as P. acnes strains. In contrast, 
contaminants from group 2 and 3 were shown to be molecularly unrelated to P. acnes that 
belongs to the surface of the skin. 
The AFLP is reproducible and gave invaluable information about the nature of 
Propionibacteria contaminating PCs. To gain more insights into the source of contamination, 
this technique could be exploited in further studies to determine the molecular relatedness of 
different bacteria commonly found in blood products. 
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INTRODUCTION 
Despite major efforts to reduce the rate of transfusion-transmitted bacterial infections, 
contamination of blood products with bacteria still occurs. Platelet concentrates (PCs) are 
frequently associated with transmission of bacterial infections. Yet, little is known about the 
source and mechanisms of the contamination, although the donor has often been recognized 
as the source. Contamination can either originate from the skin surface during venipuncture, 
caused by inadequate disinfection of the donor arm at the phlebotomy site or from transient 
bacteraemia (Blajchman et al, 2004). 
The majority of the microorganisms implicated in contamination are part of the skin flora. As 
shown in various studies, Propionibacterium is the most frequently implicated organism 
(Mohammadi et al, 2005). Propionibacterium is a Gram-positive, non-spore forming 
anaerobic bacterium. This opportunistic pathogen is found predominantly in the cutaneous 
flora. Since this bacterium is considered to be of low clinical significance (Wilson et al, 
2004), its presence in blood is usually interpreted as (extraneous) contamination and not as 
the result of true infection. However, different studies have reported the involvement of 
Propionibacteria spp. in serious infections such as endocarditis, post-operative 
endophthalmic infections (Hykin et al, 1994; Jakab et al, 1996; LePage et al, 2003), 
osteomyelitis, arthritis and sarcoidosis (Ishige et al, 1999). Recently, a case study reported by 
Schneider et al. (2000) documented the clinical sequelae of three incidents of platelet 
contamination by P. acnes. The authors assumed that contamination could be the result of 
insufficient skin disinfection at the venipuncture site during the phlebotomy process.  
In general, all these cases emphasise the importance of knowing whether the detection of 
Propionibacterium in PCs is mere contamination or represents a genuine infection. 
 
In the present study, amplified-fragment length polymorphism (AFLP) analysis, was used to 
study possible sources of contamination of PCs with Propionibacteria. In brief, this technique 
combines simultaneous restriction-ligation and selective PCR amplification (Vos et al, 1995; 
Savelkoul et al, 1999). Genomic DNA is digested with two restriction enzymes, and then 
double-stranded oligonucleotide adapters are ligated to the DNA fragments. Subsequently 
selective PCR amplification is performed with adapter-specific primers. At the 3’ends of 
these primers selective nucleotides (one to three) are included to amplify a subset of the 
ligated fragments. 
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AFLP has been widely applied to identification and genotyping of various organisms. 
Because of its high discriminatory power and reproducibility this DNA fingerprinting method 
was employed to study the molecular relatedness of Propionibacterium species responsible 
for contamination of PCs and corresponding red blood cells concentrates (RBCs) from the 
same whole blood donations.  
 
MATERIALS AND METHODS 
Bacterial strains: 
Clinical strains of Propionibacterium spp. isolated from contaminated platelet concentrates 
(PCs) and corresponding (i.e from the same whole blood donations) red blood cells 
concentrates (RBCs) were obtained from the department of Bacteriology of the Slotervaart 
Hospital (Amsterdam, The Netherlands). These strains were cultured from PCs and RBCs 
produced at the blood bank and sent to the hospital for confirmation and identification of the 
bacteria implicated in the contamination. Processing of PCs and RBCs and screening PCs for 
bacterial contamination were done according to the procedure detailed in a previous study 
(Mohammadi et al, 2005). The presence of bacteria in RBCs was assessed using the same 
procedure as described previously for PCs. In brief, standard aerobic and anaerobic culture 
bottles of the automated culture system (BacT/Alert) are inoculated with 5 to 10 mL aliquots 
of RBCs. The aliquots are incubated in the BacT/Alert until a positive signal was recorded or 
for up to 7 days if they stayed negative. Positive culture bottles were subcultured for 
confirmation and identification of microorganisms. Positive units of PCs and corresponding 
RBCs were recalled from inventory and/or from hospitals (if already issued).  
For this study 44 strains cultured from PCs and corresponding RBCs (22 from PCs and 22 
from RBCs) were obtained. In addition, 6 strains from PCs without RBCs counterparts and 5 
strains from RBCs without PCs counterparts were included. The strains were collected during 
one year. 
 
Other clinical laboratory strains of Propionibacterium acnes (n = 11) were obtained from the 
Department of Medical Microbiology and Infection Control of the VU University Medical 
Centre (Amsterdam, The Netherlands). These bacteria originating from normally sterile body 
fluids (such as cerebrospinal fluid and blood) of patients with severe infections were collected 
over 3 years. The isolates were cultured on blood agar at 37
o
C under anaerobic conditions. 
These isolates were identified by conventional biochemical techniques. Seven other strains 
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representing different transient bacterial species of Propionibacteria from skin flora of 
healthy volunteers were also included. 
 
Propionibacterium acnes (DSM 1897, ATCC 6919), Propionibacterium avidum (DSM 4901, 
ATCC 25577), Propionibacterium granulosum (DSM 20700, ATCC 25564) and 
Propionibacterium propionicus (DSM 43307, ATCC 14157) were included in this study as 
reference strains. These strains were purchased from Deutsche Sammlung von 
Mikroorganismen und Zellkulturen (DSMZ) (Braunschweig, Germany) and cultured under 
anaerobic conditions as specified by the manufacturer. 
 
DNA extraction:  
Prior to extraction of DNA , pure bacterial colonies were resuspended in 100 µL TE (10mM 
Tris-HCL, 1mM EDTA, pH 8.0) buffer and adjusted to match a turbidity of 0.5 McFarland. 
The suspension was then incubated with 10 mg/mL lysozyme at 37
o
C for at least 1 hour. 
Thereafter DNA was isolated following the tissue protocol of the QIAmp DNA mini kit 
(QIAGEN, GmbH, Hilden, Germany). Finally, the nucleic acid was eluted in 100 µl AE 
buffer of the extraction kit and stored at -20
o
C until needed.  
 
Genotyping of Propionibacterium strains: 
Amplified fragment polymorphism analysis 
Amplified fragment polymorphism (AFLP) analysis was applied for genotyping of 
Propionibacterium strains. DNA was restricted with two enzymes, and two adapters were 
ligated to the restriction sites in the same reaction. The reaction mixtures consisted of 10 ng 
DNA, of 1xT4 DNA ligase buffer, 0.5 M NaCl, 0.5 µg bovine serum albumin, 2 pmol of the 
EcoRI adapter (Isogen Bioscience BV, Maarssen, The Netherlands), 20 pmol of the MseI 
adapter (Isogen Bioscience), 80 U of T4 DNA ligase, 0.2 U of EcoRI, 1 U of  MseI. After 
incubation at 37
o
C during 3 hours, the mixtures were diluted 1:20 in 0.1 X TE buffer. All 
other enzymes were purchased from New England Biolabs (Beverly, Mass.) 
 
For amplification of the restriction fragments, five µL of the diluted mixture was added to 5 
µL of PCR mixture which consisted of 1 x PCR buffer (Applied Biosystems, Foster city, CA), 
2 mM dNTPs (Promega Benelux, Leiden, The Netherlands), 15 mM MgCl 2 (Applied 
Biosystems) , 1 U AmpliTaq DNA polymerase (Applied Biosystems), and 20 ng of  Eco-A 
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primer (5’- GACTGCGTACCAATTCAC-3’) and 60 ng of Mse-C primer (5’- 
GATGAGTCCTGAGTAAC-3’). Eco-A was fluorescently labelled with FAM (Eurogentec, 
Maastricht, The Netherlands). Amplification was carried out in a GeneAmp PCR System 
9700 (Applied Biosystems) under the following conditions: 2 min at 72
o
C, followed by 12 
cycles of 30 sec at 94
o
C, 30 sec at 65
o
C and 1 min at 72
o
C and then 23 cycles of 30 sec at 
94
o
C, 30 sec at 56
o
C and 1 min at 72
o
C, ended by a single extension at 72
o
C for 1 min. 
Before analysis on an ABI Prism 3100, 2.5 µL of each PCR product was added to 22 µL Hi-
Di formamide and 0.5 µL GeneScan-500 ROX standard (Applied Biosystems). Data were 
analysed with the BioNumerics software package, version 3.0 (Applied Maths, Sint-Martens-
Latem, Belgium). Similarity coefficients were calculated with Pearson correlation and 
dendrograms were obtained by the unweighted -pair group method using arithmetic averages 
(UPMGA) clustering. 
 
Amplification and sequencing 
PCR was performed using the universal primers described in a previous study which target a 
conserved region of 16S ribosomal DNA (Mohammadi et al, 2005). A 20 µL PCR mixture 
consisting of 2.5 µL 10xPCR buffer, 0.5 µL 10mM dNTPs, 1.5 µL 25 mM MgCl2, 25 pmol of 
each of the forward (5’-TCCTACGGGAGGCAGCAGT-3’) and reverse (5’-
GGACTACCAGGGTATCTAATCCTGTT-3’) primer (Eurogentec), 0.2 µL Amplitaq gold (5 
U/µL) and 5 µL template DNA was amplified under these conditions: 10 min at 95
o
C 
followed by 30 cycles of 30 sec at 95
o
C, 30 sec at 60
o
C and 45 sec at 72
o
C and a final step of 
10 min at 72
o
C. PCR products were analysed on 2% agarose gel in 1xTBE buffer (Life 
technologies ltd, Paisely, Schotland). After amplification the PCR products were purified 
using the Quiaquick PCR purification kit (Qiagen). 
The purified products were sequenced using primers covering a 466 bp fragment from the 16S 
rDNA. The primers gd1 (5’-TGCTTTCGATACGGGTTGAC-3’) and bak 4 (5’-
AGGAGGTGATCCARCCGCA-3’)(Dasen et al, 1998) were also employed. These primers 
amplify a Propionibacterium-genus 900 bp fragment. Primers were obtained from Eurogentec 
(Maastricht, The Netherlands). 
Sequencing was performed using Big Dye terminator sequencing kit (Applied Biosystems). 
The program consisted of: 10 sec at 96
o
C, 5 sec at 56
o
C and 4 min at 60
o
C for 25 cycles. The 
sequence products were purified and then subjected to analysis on an ABI 3100 automated 
DNA sequence analyser (Applied Biosystems). Sequence homology analysis was done by 
using the BLAST program.  
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RESULTS  
Reproducibility of the AFLP profiles 
The reproducibility of the AFLP results was assessed by subjecting duplicate samples to the 
same extraction, restriction/ligation and amplification procedures. AFLP patterns of all 
duplicate samples clustered with a similarity level of more than 90% (Fig. 1). Based on these 
results a cut-off value of 90% was chosen for definition of identical strains.  
 
Definition of windows of similarity 
Analysis of unrelated clinical laboratory isolates of the species P. acnes showed that the 
patterns of these strains were homologous among each other: patterns clustered in a window 
of similarity between 55 to 90%. The ATCC strains P. avidum, P. granulosum and P. 
propionicus separated at a similarity level of less than 30%.  
Based on these results 4 windows of similarity were determined: the first between 90 and 
100% defines identical strains within a species, the second between 55 and 90% defines 
different strains of the same species, the third between 30 and 55% defines related species 
(possibly different subspecies) and the fourth below 30% distinguishes different species. 
 
AFLP analysis of the isolates 
To determine the precise length of the PCR fragments the ABI Genescan analysis software 
was used. AFLP patterns were analysed for the fragments with sizes between 200 and 500 
base pairs. The AFLP profiles were then imported in the Bionumerics software package. After 
normalization (to the internal size standard that was included in each sample)(see Materials 
and Methods), the degree of similarity between AFLP profiles were determined by using the 
Pearson correlation coefficient. Clustering was performed with the UPGMA method. 
The primer combinations Eco-A and Mse-C generated the dendrogram shown in Fig. 2. Based 
on this dendrogram, the isolates described in Materials and Methods could be classified into 
three main groups. Group 1 comprised all P. acnes strains isolated from patients with 
bacteraemia (n = 11), laboratory isolates from healthy volunteers (n = 7) and isolates from 
PCs (n = 10) and RBCs (n = 14). Group 2 comprised isolates from 10 PCs and 7 RBCs 
(derived from the same donations), while group 3 enclosed the remainder of the tested isolates 
(7 PCs and 6 RBCs). One PC isolate (P33) exhibited a totally different banding pattern, which 
indicated that this strain belonged to a different species. Interestingly, the strains isolated from  
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Figure 1.  Assessment of the reproducibility of the AFLP protocol. Duplicate samples derived from the 
skin flora (denoted with S) were subjected to the same procedures. The banding patterns were obtained 
by using the ABI Genescan analysis software. After normalization AFLP profiles were compared using 
the Pearson correlation coefficient and clustered by the unweighted pair group with mathematical 
average (UPGMA) method. All duplicates clustered with similarity levels higher than 90%. I: 90 to 
100% homology illustrates identical strains, II: 55 to 90% homology indicates different stains within 
the same (sub)species, III: 30 to 55% homology demonstrates possible different subspecies, IV: less 
than 30% homology indicates different species within the same genus. 
 
 
patients with bloodstream infections and skin contaminants formed a cluster (group 1) that 
was clearly separate from the majority of the isolates derived from the blood products, which 
clustered in groups 2 and 3. 
As expected the cutaneous species (ATCC reference strains) P. acnes, P. avidum, P. 
granulosum, and P. propionicus differed from each other and exhibited different banding 
patterns (window IV). All isolates in group 1 clustered with the reference strain P. acnes with 
a similarity level between 55 and 90%. Therefore these isolates can be considered as P. acnes 
strains.  
Sequence analysis of 1200 bp of the 16S ribosomal RNA gene of representatives of this group 
showed 99% homology with P. acnes (GenBank accession number AB097215) and 99% 
homology with P. acnes ATCC 6919 (GenBank accession number AB042288). Two bases 
did not match those of these references (Table 1, P19). This suggests that these were possibly 
distinct strains within the same species. 
Based on AFLP profiles the isolates categorized as group 2 and 3 showed 55 to 90% 
homology, which implies that these bacteria belong to the same (sub)species. Sequence 
analysis of these strains revealed 97 to 98% homology with the 16S ribosomal RNA gene of 
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P. acnes (GenBank accession number AB097215) and P. acnes ATCC 6919 with 13 and 11 
mismatches respectively.  
Among the isolates that were classified in group 2, 7 that were derived from PCs were 
identical (90% homology) to their RBCs counterparts. Isolates P2, P5 and P7, which had no 
RBCs counterparts separated also with similarity levels ranging between 55 and 90%. 
Within group 3, 5 of the 7 PCs isolates showed banding patterns identical (90% homology) to 
those derived from RBCs originating from the same donations. Only isolates P12 and R18 
clustered separately from their counterparts R12 and P18 which clustered in group 1. 
In summary, 13 PCs isolates were identical to their counterparts in RBCs. On the other hand, 
9 PCs isolates differed at the strain level from the isolates found in corresponding RBCs.  
Sequence analysis of the 16S ribosomal DNA suggested that the isolates in group 1 were most 
closely related to the ATCC strain 6919. Compared to the nucleotide sequence of strain 
ATCC 6919, 2 mismatches were observed for a representative of group 1 (P19), 1 to 11 
mismatches for representatives of group 2 and 2 to 7 mismatches for representatives of group 
3 (see Table 1). These nucleotide variations could indicate the existence of a subspecies of P. 
acnes at the same similarity level as P. avidum and P. granulosum. 
Sequence homology analysis of P33 revealed a 97% homology with both P. acnes (18 
mismatches) from the GenBank and P. acnes ATCC 6919 (17 mismatches). This implies that 
this isolate is a different species. For this PC isolate, no related RBC isolate was available for 
AFLP typing and sequencing analysis. 
 
Overall, the DNA fingerprints of the isolates together with sequencing analyses demonstrate 
that only 45% of all cases of contamination of PCs in the studied collection are caused by P. 
acnes strains most closely related to the strains derived from skin surface flora. This suggest 
that the strains (or subspecies) of P. acnes that account for most instances of contamination of 
PCs and corresponding RBCs are derived from other sources. 
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Fig.2. Unweighted - pair group method using arithmetic averages (UPGM) dendrogram derived from the AFLP 
patterns of all 55 isolates of platelet concentrates (PCs) and red blood cells concentrates (RBCs). The analysis 
was performed between 200 and 500 bp. PCs and related RBCs are denoted with the same number beginning 
with P and R respectively. P2, P5, P7, P17, P28 and P33 have no RBCs counterparts. R20, R22, R24, R26 and 
R31 have no PCs counterparts. The isolates from the bloodstream infections are represented with I and the 
isolates from skin flora with S. The reference strains are also given. I: 90 to 100% homology illustrates identical 
strains, II: 55 to 90% homology indicates different stains within the same (sub)species, III: 30 to 55% homology 
demonstrates possible different subspecies, IV: less than 30% homology indicates different species. 
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Table 1. Comparison of the nucleotide sequences of the 16S RNA gene of  
ATCC 6919 and Propionibacterium spp. isolates from PCs. 
________________________________________________________________________________________________________ 
 
                                   Isolates from platelet concentrates* 
   
   ___________________________________    
Nucleotide       Reference strain      
Position         ATCC 6919       P1  P3  P14  P16  P19  P33             
__________________________________________________________________  
433            g               .    .    .     .     .     a  
434            a               .    .    .     .     .     g 
435            c               .    .    .     .     .     t 
445            c               .    .    .     .     .     a 
449            t                .    .    .     .     .     a 
459            t                .    .    .     .     .     c 
471            c               .    g   .     .     .     . 
472            g               .    c   .     .     .     .  
475            g               .    c   .     .     .     . 
548            c               .    g   .     .     .     . 
549            g               .    c   .     .     .     .  
574            c               .    .    .     .     .     g 
581            a               .    .    .     .     c    . 
609            g               .    .    .     .     .     a 
628            c               .    .    .     .     .     . 
640            c               .    .    .     t     g    .  
655            a               .    .    .     c    .     . 
671            c               .    .    .     g    .     .  
673            t                .    a   .     .     .     . 
674            c               .    .    t     .     .     . 
694            t                .    .    .     .     .     c 
697            g               .    .    .     c    .     . 
710            g               .    .    .     a    .     . 
719            a               .    .    .     n    .     .  
827            a               g   .    .     .     .     . 
947            a               .    .    .     .     .     t 
976            c               .    .    .     .     .     t 
985            g               .    .    .     .     .     a 
997            a               .    .    .     .     .     g 
1011           a               .    .    .     .     .     g 
1012           g               .    .    .     .     .     a 
1134           g               .    .    .     .     .     a 
1226           c               .    a   .     .     .     t 
1243           c               .    .    t     t     .     . 
1282           a               .    g   .     .     .     .  
1297           g               .    t    .     .     .     . 
1305           a               .    t    .     .     .     . 
1442           g               .    t    .     .     .     . 
________________________________________________________________________   
* Representatives isolates of group 1, group 2 and group 3 were aligned with the reference  
strain P. acnes from the GenBank.Dots indicate the same nucleotide residues as the ATCC strain. 
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DISCUSSION 
Propionibacterium spp. is frequently associated with contamination of PCs. In an attempt to 
identify the source of bacterial contamination of blood products with Propionibacterium spp. 
AFLP fingerprinting was applied. This typing method is based on the comparison of patterns 
of DNA restriction fragments derived from the total bacterial genome. With this 
fingerprinting method the molecular relatedness of Propionibacteria found in PCs and their 
corresponding RBCs was analysed. Based on the AFLP profiles, isolates of PCs and 
corresponding RBCs could be grouped into three main AFLP profile groups that were 
designated group1, group 2, and group 3 (Fig.2). In group 1 both fingerprinting and 
sequencing results revealed (almost) complete homology of PCs and RBCs isolates with 
bacteria isolated from skin (clinical laboratory strains of P. acnes). Therefore it is conceivable 
that these isolates originated from skin flora of the donor. The isolates of this group may have 
been introduced in the blood bags during the collection procedures, i.e. by inadequate 
disinfection of the donor’s arm or the introduction of skin surface commensals through the 
needle during venipuncture.  
 
Representatives of group 2 and 3 showed clearly different banding patterns and sequencing 
results indicated that the contaminants are distinct from Propionibacteria belonging to the 
transient skin flora. The isolates varied also among each other. This was also observed by 
Kunishima et al.  (2001) when they analysed P. acnes isolated from PCs by using random 
amplified polymorphism DNA (RAPD).  
Of note is the difference at strain level between the isolates derived from PCs and 
corresponding RBCs (from the same donations). This difference indicates that these 
contaminants do not originate from whole blood but are introduced in PCs and RBCs 
separately. It is possible that contamination of these blood products occurred during sampling 
of the PCs to inoculate both BacT/Alert culture bottles. This procedure is part of the QC of 
PCs and is carried out to screen PCs for bacterial contamination.  
The difference could also be due to the fact that PCs and RBCs are stored in different media 
and temperatures (PCs at 22
o
C and RBCs at 4
o
C). It is conceivable that the storage conditions 
favour the growth of one bacterial strain more than another if both originate from the same 
source.  
 
Provided that the contaminants of group 2 and 3 were shown to be molecularly unrelated to P. 
acnes derived from the surface of the skin, it is likely that they originate from another habitat. 
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The source of these contaminants is still unclear. Since isolates from PCs and related RBCs 
clustered in the same main group (except for isolates from 2 PCs), it is apparent that they 
originated from whole blood of the donor and not from extraneous contamination as generally 
assumed. In the later case, the differences between the various isolates would be larger. 
The contaminants of PCs and RBCs could also be derived from deeper layers of the skin 
containing the sebaceous glands and hair follicles. During the phlebotomy process, these 
bacteria could be introduced in the collected blood through the needle.  
Up to now, several strategies have been followed by many blood centres to reduce the rate of 
bacterial contamination of blood products. Among these are the improvement of donor-arm 
disinfection methods and the diversion of the first 10-20 mL of blood from the collection 
bags. Since the majority of contaminants are not skin (surface) derived, it is probable that 
these methods would not result in entire elimination of contamination of blood products with 
Propionibacterium spp. This means that when these strategies are applied only skin derived 
commensals (45%) may be removed, but the majority (55%) is already present in the 
collected whole blood or introduced inadvertently during manufacturing.  
The findings of this study are in accordance with the results obtained by McDonald et al. 
(2004), who studied the effect of diversion of the initial 20 mL blood from the collection bag 
and of an improved donor-arm disinfection method in reducing bacterial contamination of 
donated whole blood. They reported a reduction of 47% when diversion of the initial aliquots 
of blood was applied. The reduction reached 57% when diversion was done in combination 
with an improved donor-arm disinfection procedure. A reduction of contamination (from 
0.35% to 0.21%) was also reported by De Korte et al. (2002) after diversion of the initial 10 
mL aliquots of blood. Remarkably, in their study only a reduction in the rate of contamination 
with Staphylococcus spp. was observed. The rate of contamination with Propionibacterium 
spp. remained similar. In view of this and of the AFLP results it is apparent that improving 
these methods will not result in eradication of contamination of blood products. Therefore, it 
might be necessary to focus on other steps in the collection and manufacturing of blood 
especially on the needle used in the first step of blood collection. 
In addition, since PCs and RBCs from the same donation may contain different bacterial 
strains as alluded to above, it might be necessary to take sufficient precautions to prevent 
inadvertent contamination after collection. 
In conclusion, the AFLP technique provided reproducible and invaluable epidemiological 
information for Propionibacteria found in blood products, although the source of 
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contamination of PCs with these bacteria was not completely traced. This information cannot 
be obtained when using for example only sequencing of the 16S ribosomal RNA gene. The 
difference resides in the fact that AFLP patterns represent the whole genome, whereas 
sequencing covers only the 16S ribosomal RNA gene. 
The AFLP method appears as very promising for further studies to determine the source and 
the molecular relatedness of bacteria implicated in contamination of blood products. Such 
studies would help blood centres in designing measures to prevent or to reduce the rate of 
bacterial contamination of cellular blood products. 
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Chapter 8 
 
 
 
Quantitation of 16S ribosomal DNA and RNA as a new approach to 
monitor the presence and state of viability of Escherichia coli 
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ABSTRACT 
A method, based on quantitation of DNA and RNA, was developed to detect not only the 
presence but also the viability of Escherichia coli. For reproducible quantitation a reliable and 
stable standard was needed. Therefore, an armored RNA standard with 16S rRNA of E. coli 
as target was constructed and assessed in real-time PCR. With this standard the analytical 
sensitivity of the real-time PCR was 14 copies/PCR. The standard was further employed to 
quantify 16S ribosomal DNA and RNA during the growth of E. coli in broth as well as in 
platelet concentrates (PCs). DNA was detected during the whole life cycle of bacteria: the 
amount of DNA increased in the logarithmic phase, remained stable during the stationary 
phase and declined slowly during the death phase.   
The quantity of 16S rRNA in the cell culture correlated with the viability of bacteria: the 
amount of RNA increased during the logarithmic phase as the amount of DNA increased, it 
remained stable during the stationary phase and then diminished much more rapidly than 
DNA to undetectable levels, which coincided with loss of viability. 
The effect of two antibiotics on the 16S rDNA and 16S rRNA content was also assessed. 
When bacteria were exposed to chloramphenicol, a bacteriostatic drug, during the logarithmic 
phase of growth, the amount of RNA stayed constant for two hours, declined thereafter and 
then disappeared completely. In contrast, the DNA content showed a slight decrease but 
remained detectable. Upon further incubation in antibiotic-free medium, the bacteria started to 
grow again and RNA became detectable again. A similar effect was also observed when 
bacteria were treated with amikacin, albeit that due to bactericidal effect of this antibiotic, 
RNA disappeared faster than with chloramphenicol and growth did not resume in antibiotic-
free medium. This could be monitored by the total lack of reappearance of RNA. This 
approach may prove useful to monitor the effect of antibiotics during treatments of infections 
with bacterial pathogens.   
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INTRODUCTION 
Ribosomal, messenger and transfer RNA can be used as indicators of viability of bacteria. To 
detect RNA sequences in clinical samples various techniques such as reverse transcription 
(rt)-PCR, nucleic acid sequence-based amplification (NASBA) and branched chain DNA 
have been adopted by most molecular diagnostics laboratories (1, 2, 3). In addition to the 
inclusion of internal controls to monitor the process of extraction, reverse transcription, 
amplification, and detection these RNA-based methods require the use of standards for 
quantitation. To date, most of the standards are developed only for assays to detect viral RNA 
and to assess the effect of antiviral therapies. However, such assays would also be very 
valuable to monitor the response to antibiotics when treating patients for infectious diseases 
with bacterial pathogens. Recently, armored RNA controls were commercially developed as 
internal controls for viral Real-Time PCR assays (4). Armored RNA permits the production of 
ribonuclease-resistant RNA particles (5). In the present study this technology was exploited to 
construct an RNA standard to quantify 16S ribosomal RNA of E. coli. Simultaneous 
quantitation of DNA and RNA was subsequently used as a new approach to monitor not only 
the presence but also the viability of bacteria both in a bacterial cell culture as well as in 
platelet concentrates (PCs) for transfusion. 
 
MATERIALS AND METHODS 
Construction of 16S Armored RNA standard 
RNA from a suspension of E. coli (ATCC 25922) was isolated with the RNAqueous kit 
(Ambion Inc, Austin, Texas USA) following the instructions of the supplier. The RNA was 
converted to cDNA with RETROscript kit (Ambion Inc.). The rt- reaction was performed in a 
total volume of 40 µl with Random Decamers according to the recommendation of the 
manufacturer. The universal forward primer (5’-TCCTACGGGAGGCAGCAGT-3’) and the 
reverse primer (5’-GGACTACCAGGGTATCTAATCCGTT-3’) were then used in the PCR 
reaction to amplify a highly conserved 466bp fragment of the bacterial 16S rDNA (6). The 
resulting PCR product was cloned into pGEM-T easy vector (Promega) as specified by the 
manufacturer. The presence and the integrity of the insert sequence were confirmed by DNA 
sequence analysis. Sequencing was conducted with the same universal forward and reverse 
primers. Thereafter the plasmids harbouring the 16S rDNA sequence of E. coli were packaged 
into MS2 coliphages. To this end, a plasmid containing cDNA of MS2 bacteriophage was 
constructed. After digestion of this plasmid with BbvCI (New England Biolabs), the target 
was inserted downstream of the coat protein sequence of the MS2 (7, 8) and cloned into 
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pGEM-T easy vector. The system was induced with 1mM IPTG and bacteriophage particles 
were assembled. The phage-particles were fractionated on a CsCl gradient (5). The purified 
RNA was treated with RNases A and T1 and DNase I to assess its resistance to nucleases (5). 
Bacteriophage titer analysis showed that the armored RNA preparation contained 7x10
4 
copies of 16S rRNA/µL. 
 
Reverse transcription-PCR sensitivity for 16S RNA standard 
The RNA particles were used as a standard in a quantitative Real-Time PCR. For this 
purpose, serial dilutions of the armored RNA in TSM buffer (10 mM Tris (pH 7.0), 100 mM 
NaCl, 1 mM MgCl2 , 0.3% sodium azide and 0.1% gelatin) were made. RNA was isolated 
from 200 µL of each dilution with the same kit as described above. The RNA was eluted in a 
total volume of 50 µL. Twenty µL (2/5 of the extracted RNA) of this volume was used to 
produce cDNA. Ten µL cDNA (1/5) was used as template in Real-Time PCR. The PCR 
amplification (in 25 µL total volume) was performed in an ABI 7000 system (Applied 
Biosystems) as described in a previous study (6) with a universal primers (900 nM each) and 
probe (200 nM)(FAM-5’-CGTATTACCGCGGCTGCTGGCAC-3’-TAMRA) set and the 
TaqMan universal PCR Master Mix.  
 
Quantification of DNA and RNA 
To quantify the presence and the viability of bacteria in a molecular growth curve, samples 
from suspensions of E. coli grown in LB medium and taken at different stages of growth were 
analyzed. Total Nucleic Acid was extracted at each stage with the automated MagNA Pure 
system (Roche Diagnostics) from 200 µL duplicate samples according to the manufacturer’s 
instructions. Nucleic acid was eluted in a total volume of 50 µL. Fifty µL was subjected to 
DNase I treatment using the DNA-free kit (Ambion Inc). The resulting RNA was assessed 
with gel electrophoresis and spectrophotometry. cDNA was generated as detailed above. 
Total ribosomal DNA and synthesized cDNA were amplified by Real-Time PCR, the armored 
16S rRNA was used as a standard. 
  
Effect of antibiotics on DNA/RNA content of E. coli 
The effect of two antibiotics on the quantities of DNA and RNA detected during the 
molecular growth curve of E. coli was monitored. These antibiotics were chloramphenicol, a 
bacteriostatic agent, member of the miscellaneous family of antibiotics, and amikacin as a 
representative of the bactericidal aminoglycosides. E. coli (ATCC) was grown at 37
o
C in LB 
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medium to the logarithmic phase. The culture was then divided into 3 equal fractions; 
chloramphenicol (30 µg/mL) was added to the first and amikacin (30 µg/mL) to the second 
fraction. The third fraction remained untreated and served as control. The doses of antibiotics 
were chosen, based on the resistance breakpoints of the National Committee for Clinical 
Laboratory Standards (NCCls) guidelines. The bacteria were then incubated further at 37
o
C 
until the decline (death) phase. During incubation samples were taken each 30 minutes. In 
each sample, 16S rDNA and 16S rRNA were quantitated by extraction as described above 
and Real-Time (rt)-PCR assays. 
To assess the recovery of bacteria from the effect of antibiotics, the amount of 16S rDNA and 
16S rRNA were determined after inoculation of the antibiotic-treated fractions  into fresh LB 
medium with no drugs and further incubation for up to two hours. 
 
Viability of E. coli in platelet concentrates 
To determine the utility of the assay for detection of viable bacteria in clinical samples, DNA 
and RNA content of E. coli grown in human platelet concentrates (PCs) was determined. PCs 
were spiked with E. coli at an inoculum of 100 CFU/mL and monitored during a storage 
period of 7 days at 20 - 24
o
C. On day 0 (day of spiking of PCs) 1, 2, 3, 6 and 7 samples 200 
µL were analysed for the presence and viability of bacteria.  
 
RESULTS  
Sensitivity of the assay:  
To quantify the amount of bacterial RNA in a sample, a stable RNA standard was needed. For 
this purpose, a fragment encoding 16S rRNA of E. coli was synthesized, cloned and packaged 
as armored RNA in MS2 coliphages. 
The sensitivity of the rt-PCR was evaluated with limiting dilutions of the RNA standard. As 
shown in Fig.1 the assay was linear between 1.4x10
4 
and 1.4x10
1 
copies/reaction indicating 
that 14 copies of E. coli RNA per PCR  
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Fig.1: cDNA produced from serial dilutions representing 1.4x10
4
, 1.4x10
3
, 1.4x10
2
 and 1.4x10
1
 
copies/reaction were used to determine the detection limit of the quantitative real-time rt-PCR for 
Armored 16S rRNA standard. The X-axis represents the starting copy number of the 16S rRNA 
expressed as log 16S rRNA/PCR reaction. The Y-axis represents the threshold cycle (CT ). 
 
was the lower limit of detection. This corresponds to a detection limit of 70 copies in the 
starting volume in the extraction procedure. The same results were also obtained when the 
particles were first incubated at 70
o
C for 5 min to release the RNA from the phage (data not 
shown). 
 
DNA/RNA content during growth of E. coli in LB medium and in PCs:  
As depicted in Fig.2 the levels of DNA and RNA were dependent on the growth phase of E. 
coli: the amounts of both nucleic acids increased during growth to achieve a maximum at the 
end of the log-phase (Fig. 2). After the stationary phase the amounts decreased to a minimum 
(or undetectable levels). Since DNA originates from both viable and non-viable bacteria this 
nucleic acid was detectable in all stages of the growth curve, whereas 16S rRNA was detected 
only during the logarithmic and the stationary phase, but disappeared completely during the 
last phase (after 5 hours) of the growth curve, while in this phase DNA was still detectable. 
This implies that the bacteria were not viable any more. The results were reproducible in 
independent assays. Hence, these preliminary data demonstrate that determination of the 
DNA and RNA content provides information about the absence or presence and the state of 
viability of bacteria.  
A correlation between viability and 16S rRNA content was also observed when E. coli was 
cultured in PCs (Fig. 3). RNA increased during growth to achieve a maximum at day 2 (day 0 
is the day of spiking) of storage. 
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Figure 2: Quantitation of 16S ribosomal DNA and RNA during the growth curve of E. coli in LB 
medium at 37
o
C. The X-axis reflects the time points when the samples were taken. The number of 
copies/µL is represented on the Y-axis. 
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Figure 3: Quantitation of 16S ribosomal DNA and RNA during growth of E. coli in platelet 
concentrates. PCs were spiked with a suspension of E. coli at an inoculum of 100CFU/mL. PCs were 
stored at room temperature for up to seven days. The amounts of DNA and RNA were determined 
directly after spiking, on day 1, 2, 3, 6 and 7 of storage. The time points of sampling are reflected on 
the X-axis and the number of copies/µL is represented on the Y-axis. 
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Thereafter the RNA content diminished considerably and became undetectable on day 7 of 
storage. At this stage, DNA was still detectable. This suggests that although bacteria were 
present they were not viable.  
  
Effect of antibiotics at the molecular level: 
The effect of chloramphenicol and amikacin on the RNA content of E. coli is represented in 
Fig. 4. Addition of amikacin led to an immediate diminution of the number of RNA copies, 
compared to untreated culture. This amount persisted during one hour, thereafter no RNA was 
detectable any more. When bacteria were exposed to chloramphenicol during the logarithmic 
phase the content of 16S rRNA remained constant for two hours and then decreased to 
undetectable levels.  
The DNA content was also affected: in comparison to the untreated samples, DNA declined 
with approximately 19 orders of magnitude after one hour exposure to the antibiotic. 
Thereafter the quantity of DNA remained relatively constant during three hours and declined 
thereafter.  
When the treated cultures were inoculated in fresh LB broth without antibiotics, 16S rRNA 
became detectable again after two hours of incubaation only in cultures that had been exposed 
to the bacteriostatic antibiotic chloramphenicol. In contrast, in a culture of bacteria treated 
with amikacin in fresh broth no  16S rRNA could be detected. This suggests that bacteria 
recovered from the effect of chloramphenicol and started growing again, while the effect of 
amikacin was bactericidal.  
With regard to the 16S rDNA content of the antibiotic-treated cultures, DNA was detected in 
both cultures: after amikacin treatment the DNA content did not change during incubaction in 
fresh broth, whereas after chloramphenicol treatment the detection of 16S rRNA was 
accompanied by an increase in the 16S rDNA content (Fig.5). 
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Figure 4: Effect of chloramphenicol and amikacin on the growth of E. coli. The plots represent the 
amount of RNA estimated by real-time PCR in untreated culture (-) and in cultures exposed to 
chloramphenicol (Cm)(30 µg/mL) or amikacin (Ac)(30 µg/mL). These antibiotics were added at time 
point 2. The sampling time is reflected on the X-axis and the number of copies/µL on the Y-axis. 
 
 
 
DISCUSSION 
In the present study, the hypothesis that simultaneous determination of DNA and ribosomal 
RNA could provide an indication of the viability of bacteria present in a sample was tested. 
DNA was quantified by amplification of the 16S rDNA gene and comparison to a standard 
curve, generated by simultaneous determination of colony forming units. To quantify the 
amount of bacterial ribosomal RNA, a standard curve was also needed. To this end, a stable 
armored ribosomal RNA was devised and used as standard for quantitating RNA, as well as 
internal and inhibition control in the rt-PCR protocols.  
The use of this standard allowed the monitoring of the growth of E. coli in LB medium by 
quantifying both DNA and RNA. These quantities corresponded well with the presence and 
viability of bacteria. Since RNA was detectable during the logarithmic phase of growth and 
disappeared during the decline phase, this nucleic acid can be used as indicator of viability. 
The DNA/RNA content can be employed to predict the metabolic state (living or dying) of 
bacteria.  
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Figure 5: Assessment of the presence of DNA and RNA of E. coli grown in LB medium at 37
o
C (A), 
upon exposure and recovery from antibiotics. During the logarithmic phase of growth the cell culture 
was divided into three fractions. The first fraction remained untreated (A), chloramphenicol was added 
to the second fraction (B) and amikacin to the third fraction (C). The antibiotics were added at time 
point 2 of fraction (A). After point 3 of B and C the cultures were transferred to fresh LB medium with 
no antibiotics.
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The assay was further exploited to monitor the effect of two distinct antibiotics on the growth 
curve of E. coli. A correlation between viability and the number of 16S rRNA copies was 
observed: addition of the bacteriostatic antibiotic chloramphenicol resulted in considerable 
decrease of number of copies of 16S ribosomal RNA, to undetectable levels after 4 hours of 
incubation, indicating a loss of viability. A similar effect was also achieved when amikacin 
was added. However, with this bactericidal agent the decrease was more rapid. This might be 
due to the difference in effect on the turnover of ribosomal RNA between these antibiotics, 
sincechloramphenicol is bacteriostatic while amikacin is bactericidal. Chloramphenicol 
inhibits bacterial growth without killing; as a result the synthesis of new RNA is slow while 
degradation is rapid. Amikacin leads to the death of bacteria, which results in the absence of 
the synthesis of RNA and rapid degradation of already present nucleic acid. 
In addition the recovery of the synthesis of 16S rRNA from the effect of chloramphenicol was 
demonstrated after inoculation of bacteria in broth with no drugs. As expected, no recovery 
from the effect of amikacin was detected although detectable levels of 16S rDNA were 
present. This indicates that the presence of DNA is independent of the viability of bacteria as 
with this assay DNA can be detected in both viable and non-viable bacteria. 
 
To demonstrate the utility of this approach, the presence of viable bacteria was also studied in 
PCs as clinical material. Transfusion of these blood therapeutics can be associated with 
transmission of bacterial infections. Storage of PCs at room temperature for up to seven days 
facilitates proliferation of bacteria. To ensure safety of transfusion, PCs have to be sterile 
before administration. Recently, a method based on detection of 16S rDNA was developed 
and used to screen PCs for bacterial contamination. However, this method cannot distinguish 
between living and dead bacteria. By determining the DNA and RNA content, it was possible 
to demonstrate the presence of E. coli in PCs and its state of viability. This approach can 
therefore be applied to estimate the clinical significance of the presence of bacterial DNA in 
blood products and improve the management of PCs transfusions. 
 
The universal nature of the primers and the probe set used in this real-time PCR renders it 
useful to determine the viability of noncultivable bacteria in clinical samples. Quantitation of 
DNA and RNA could also be used to monitor the effects of antibiotics during treatments of 
infections with bacterial pathogens. This specific application of this real-time PCR merits 
further investigation and may lead to new insights in optimization of antimicrobial therapy. 
  112 
Finally, the RNA standard is suitable for all real-time amplification protocols. Since the 
armored RNA standard withstands nucleases degradation, it can be added to clinical samples 
prior to nucleic acid extraction to monitor the whole process of isolation, reverse transcription 
amplification and detection.  
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Summary and general discussion 
Platelets, the smallest anucleated cells of blood, are important in hemostasis (cessation of 
bleeding). In the blood stream, platelets circulate as disc-shaped cell fragments. Following 
external damage to blood vessels, they adhere to subendothelial substances such as collagen. 
Upon exposure to collagen, platelets become activated and change from discoidal to spheres. 
This shape transition is followed by forming of aggregates or haemostatic plugs, which are 
indispensable for stopping bleeding. 
Platelets are used in the management of patients suffering from bleeding disorders, for 
example thrombocytopenic patients, patients receiving chemotherapy or patients submitted to 
bone marrow or stem cells transplantation. 
Platelets are issued as concentrates. Platelets concentrates (PCs) are routinely prepared from 
donated whole blood. Once collected in an integrated system of plastic bags, whole blood can 
be converted to its components (i.e. plasma, platelets, and red blood cells) by application of 
two step-centrifugation. Dependent on the speed and the length of each step PCs can be 
obtained using the platelet-rich plasma (PRP) or the buffy coat (BC) method. After 
preparation, PCs are stored at 20 - 24 
o
C for a shelf life of 5 to 7 days.  
PCs, stored at room temperature, are attractive for growth of bacteria. Consequently, 
contamination with bacteria may turn transfusion of PCs from a life-saving into a life-
threatening therapy.  
To date, bacterial contamination of PCs is acknowledged as the most frequent transfusion-
associated infectious risk. To reduce and prevent this risk from occurring, methods to limit 
and detect bacterial contamination of PCs prior to transfusion are required. 
Over the last decades, major improvements have been made in the development of detection 
strategies. The available methods vary from simple to very sophisticated. A brief synopsis of 
existing approaches to assess the presence of bacteria in PCs was given in Chapter 1. As 
detailed in the general introduction each approach has advantages and disadvantages and an 
‘ideal’ method is as yet lacking.  
Automated blood culture methods are being used currently in several countries. In some of 
these the implementation of this culture system in routine use has led to the extension of the 
shelf life of PCs from 5 to 7 days. For automated culturing of PCs different protocols are 
currently in use. In some countries culturing is performed shortly after preparation of blood 
components, whereas in others it is done only for platelets that have not been transfused by 
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day 3 of storage. In addition, some countries maintain a quarantine period of 24-48 hours after 
culturing, before issuing to hospitals.  
In The Netherlands a BacT/Alert automated culture system is incorporated into routine 
practice to screen all PCs for bacterial contamination since November 2001. An aliquot of 5-
10 mL PCs, prepared following the BC-method, is used to inoculate both culture bottles of the 
BacT/Alert. Inoculation is carried out within 3 hours of preparation of PCs (22-24 h after 
whole blood collection or within 12 h of apheresis). The culture bottles are incubated until a 
positive signal is detected or for up to 7 days if they remain negative. During incubation PCs 
are issued to hospitals as ‘negative to date’ (i.e. at the time of issue of PCs to hospitals, the 
culture was negative). When a positive signal is detected, the involved culture bottles, the 
sample bag (with PCs used to inoculate the bottles) and the original PC (if available) are sent 
to a microbiology laboratory for confirmation and identification of contaminants. A PC is 
deemed contaminated when a microorganism is identified in the culture bottles. The 
implicated PCs and related blood products are then returned to the blood bank via a recall 
procedure. 
Although automated culturing has proven to be sensitive and robust in detection of bacterially 
contaminated PCs, it requires 24-48 hours to yield (positive) results for most organisms. 
During this incubation time PCs might be already issued and be administered to a recipient. 
The work described in this thesis was, therefore, devoted to develop an alternative tool that 
overcomes the limitations of the current detection strategy to screen PCs for bacterial 
contamination. 
 
Based on real-time quantitative PCR technology, a broad-range 16S rDNA PCR assay was 
developed and adapted to detect bacterial DNA in PCs. The performance of this PCR assay 
was dependent on two critical factors: the efficiency of the method used to extract DNA from 
PCs and the amplification procedure. To achieve optimal sensitivity with this assay a 
convenient method to prepare template DNA from PCs was required. Two isolations methods 
were assessed and compared as described in Chapter 2. Since PCs have a short shelf life (5-7 
days) a rapid assay was desirable. For this reason, these 2 extraction methods were mainly 
judged according to their sensitivity and rapidity to obtain results. Both NucliSens extraction 
method as automated MagNA Pure LC instrument proved to have a detection limit of 1 
colony forming unit (CFU) equivalent/PCR. Given the higher throughput and the shorter 
  116 
processing time, the fully automated MagNA Pure system was preferred. Furthermore, this 
system provides a standardized and reproducible method for nucleic acid isolation, which is 
amenable for routine practices. 
During the course of the analytical validation of the PCR assay, a major problem was 
encountered. The problem manifested in the occurrence of false-positive results caused by the 
amplification of contaminating DNA present in the PCR reagents (but not in the actual sample 
of PCs to be analyzed). Owing to this common limitation of PCR assays, efforts made by 
several investigators in the past to develop a PCR-based detection method were abrogated.  
This background contaminating DNA was effectively reduced by following two strategies. 
These were described in Chapter 2 and their effect on the sensitivity of the PCR assay was 
also discussed. 
 
Before amplification, bacterial DNA must be extracted from the specimen to be analyzed. 
This extraction procedure is the first and most critical step in real-time PCR assays. 
Therefore, effective methods of DNA extraction are warranted in order to prevent variation in 
(real-time) PCR results. To monitor the efficiency of nucleic acid extraction with the MagNA 
Pure, an internal control was included in each extraction. This control amplified a conserved 
region of the human HLA DQα gene. As described in Chapter 3, a set of primers and probe 
targeting a highly conserved region of the generic allelic group of HLA-DQA1 locus was first 
designed. The real-time amplification of this locus was then validated with an array of 
samples of PCs. Since each white blood cell (WBC) contains 2 copies of the target gene, the 
HLA-DQA1 could be extracted and amplified from the same sample of PCs. External 
addition of the control to PCs specimen was not needed. This is especially beneficial in 
reducing the amount of clinical material used to isolate DNA and hence the processing time 
and the corresponding costs. Furthermore with this control the risk of the introduction of 
contamination into the samples to be tested is reduced. Moreover amplification and detection 
of both this internal control and bacterial-specific DNA can be accomplished in the same 
reaction.  
Because the HLA-DQA1 was reproducibly and consistently amplified in all tested samples, 
the assay was also adapted to count residual WBCs in filtered PCs. As detailed in chapter 3 
reduction of these cells is necessary to prevent a variety of transfusion complications. 
Nowadays, several strategies have been institutioned in blood centers to estimate the number 
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of WBCs in filtered PCs as part of the QC of PCs. Compared to flow cytometry (current gold 
standard); the assay was shown to be sensitive, accurate and rapid. These characteristics make 
it very suitable for routine monitoring of residual WBCs in PCs.  
Thus, performing this study a double purpose was attained: the universal nature of this HLA-
DQA1 assay is suitable to monitor efficiency of automated nucleic acid extraction from blood 
samples in routine diagnostics laboratories, and also for blood centers for estimating the 
number of WBCs in PCs. 
Once all critical aspects of the 16S rDNA real-time PCR were optimized, and the assay was 
complete a clinical validation was commenced. Unfortunately preliminary results of screening 
PCs for bacterial contamination revealed the rise of false-positive results yet again. This time 
contamination came from an unexpected quarter: the source was tracked to contaminating 
DNA present in the commercially available reagents of the MagNA Pure nucleic acid 
extraction kit. Considering the nature of bacteria found in the reagents, it was conceivable that 
contamination originates from the distilling systems of the manufacturer. Elimination of this 
contaminating DNA has proved very difficult. Nevertheless, a strategy reported in Chapter 4 
was successfully applied to remove this reagent-derived contamination while the sensitivity of 
the assay was maintained.  
As discussed above to achieve optimal sensitivity of the PCR assay, standardized DNA 
extraction procedures, with high-quality nucleic acid purification are needed. So far, the 16S 
rDNA PCR in combination with the MagNA Pure automated DNA extraction seemed to meet 
this requirement.  
To assess the applicability of this method for routine use in blood centers, the PCR assay was 
validated in an extensive survey of 2,146 routinely produced PCs. This was done in 
conjunction with the BacT/Alert automated culture system, which is regarded as the gold 
standard. The findings of the assay as reported in Chapter 5 were in complete agreement with 
those obtained with the BacT/Alert. The PCR assay showed the same sensitivity and 
specificity as culture, with the advantage of a shorter turnaround time (4 hours). 
Subsequently, PCs can be tested before release or the day they are transfused. Unlike culture, 
detection with real-time PCR does not depend on the growth kinetics of bacteria. This feature 
permits the extension of the storage time of PCs from 5 to 7 days without compromising the 
risk of transfusing contaminated units. However, it is worthwhile to mention that the PCR 
detects both viable and non-viable microorganisms. Up to now the clinical significance of 
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receiving dead bacteria is unclear; the use of this approach may result in unnecessary wastage 
of a limited blood resource. Taken together, combining automated DNA extraction and 
sample amplification with real-time PCR has made possible the development of an assay that 
was shown to be rapid and sensitive. This PCR assay offers an alternative to the BacT/Alert 
system for the screening of PCs. Before implementing such an assay in routine use it might be 
essential to conduct a cost-benefit analysis.  
 
The amount of bacteria (when present) changes with storage time of PCs. As a result 
confirmation of contamination becomes complicated. If a sample is taken on day 1 after 
preparation with low levels of bacteria, most detection systems (no matter how sensitive) 
would fail to assess their presence. On the other hand if sampling is carried out from day 2 of 
storage or longer, the majority of systems regardless of their sensitivity 
will indicate the presence of bacteria. Accordingly the sensitivity of detection systems is 
related to time when a sample was taken for testing. Another important facet, when testing for 
bacterial contamination, is the volume of sample used for culture and the probability of the 
presence of a bacterium in the sample taken from the PCs bag.  
To determine the optimal time for sampling PCs when real-time quantitative PCR is 
employed to detect bacterial contamination, an evaluation study (Chapter 6) was carried out 
with the BacT/Alert as reference method. PCs were spiked with suspensions of E. coli, B. 
cereus, S. epidermidis, P. aeruginosa and P. acnes to 1, 10 and 100 CFU/mL. With the PCR 
assay all spiked bacterial species (at different concentrations) could be reliably detected one 
day after inoculation and preparation of PCs regardless of the size of the inoculum. Whereas 
in the BacT/Alert all concentrations required an incubation time of at least 20.1 hours. This 
indicates the efficacy of detection with PCR and offers the possibility of removing 
contaminated PCs prior to issue.  
Currently, in the routine of the blood bank PCs are sampled within 3 hours after preparation 
for culturing in the BacT/Alert and issued as negative to date. Based on the findings of this 
study, it would be recommended to sample the PCs at least one day after preparation when 
using either BacT/Alert or PCR to guarantee detection of all possibly contaminated units. This 
may contribute to further improving the safety of PCs supply and limiting the consequences 
of the policy of issuing as negative to date. 
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Summarizing (Chapter 2 through 6), the PCR assay was shown to meet the requirements of 
the ideal detection methods defined in the introduction (Chapter 1). The findings 
demonstrated a sensitivity of 1 CFU/mL (50 CFU/mL) of the PCR assay, which is an 
improvement of the currently used methods. The results are provided within 4 hours. The 
assay can be performed one day after preparation of PCs and can be used before release of 
PCs to hospitals or when carried out in the hospital immediately before they are administered 
to patients.  
 
Propionibacterium acnes is implicated in most cases of bacterial contamination of PCs. It is 
generally thought that this bacterium originates from skin flora. Chapter 7 was confined to 
determine the source of contamination using amplified fragment length polymorphism 
(AFLP) analysis. Propionibacterium isolates from PCs and RBCs from the same donations 
were analyzed. The isolates could be classified into 3 groups: group 1 including 45% of the 
isolates belonging to the surface of the skin flora, group 2 and group 3 (55% together) 
different from each other and from group 1 originating from another habitat. These 2 groups 
could be subspecies of P. acnes. However evidence could not be obtained from the results. 
Since only 45% of the isolates were shown to belong to the surface of the skin flora, it should 
be apparent to reconsider the efficacy of introducing measures such as improving skin 
cleansing methods and diverting. Other studies are needed to determine the molecular 
relatedness of different species of bacteria commonly found in blood products. Exploiting the 
AFLP technique for further typing of bacteria found in whole blood (e.g. before and after 
discarding the first aliquots), plasma, PCs, and RBCs would presumably provide more 
insights into the nature and possibly the source of contamination. Adequate measures would 
be then taken by blood centers to allay this problem. 
 
Real-time PCR is a convenient way to detect pathogens. It allows the simultaneous 
amplification, detection and quantification of target nucleic acid. Nevertheless, the 16S rDNA 
PCR assay has a limitation: it does not distinguish between living and dead organisms. This 
distinction might be important to study the clinical significance of receiving blood 
components contaminated with bacteria. Furthermore, it would be possible to study the 
survival of bacteria (particularly at low initial levels) during storage of PCs. Based on 
quantitation of DNA and RNA a method was developed and adapted to study the presence 
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and viability of E. coli in both broth as well as PCs (Chapter 8). For quantitation an armored 
RNA standard, with 16S rRNA of E. coli as target, was developed and employed in the assay. 
The standard was resistant to degradation by nucleases. Applying this, it was possible to 
determine the RNA/DNA content to predict the state (viable or non-viable) of viability of 
bacteria. The effect of 2 distinct antibiotics on the molecular growth curve of E. coli was also 
monitored. With this new approach a twofold objective was achieved: (i) the method can be 
used to monitor the effects of antibiotics during treatments of infections with bacterial 
pathogens. This may contribute to monitoring the efficacy of antimicrobial therapy in 
patients, which currently relies on cell culture techniques (ii) the standard may also be 
suitable to be used as internal and inhibition control in real-time quantitative RT-PCR assays. 
To improve the versatility, this approach may be enlarged with standards targeting different 
pathogens and tests in different clinical materials. 
However, due to the high costs at present, a widespread use of this assay in routine 
diagnostics laboratories may be restricted.  
 
Follow up studies 
Developing a suitable method to detect bacteria in PCs for use under routine blood banking 
conditions is challenging, because the method must not only be sensitive, specific and rapid 
but must also provide logistic and economic efficiency. Next to the high costs, the time to 
obtain results of the current developed 16S rDNA real-time PCR may still be long. An initial 
cost-benefit analysis may therefore not be favorable. Nevertheless the assay forms an 
improvement to current detection methods, at least to the automated culturing with regard to 
sensitivity and duration. Furthermore the potential to automate and standardize the critical 
steps in the amplification procedures of the assay, the manufacturing of DNA-free reagents, 
and the use in a large scale may presumably accelerate the time to obtain results and reduce 
the costs of the assay. 
In addition, the universal nature of detection of the assay may be suitable for generalized 
bacterial screening of other blood components (e.g. RBCs and plasma). Therefore it is 
necessary to adapt and optimize detection in RBCs and plasma with this broad-range PCR.  
  
The approach developed to study the viability of bacteria, while technically demanding for 
routine use, may be simplified and standardized to afford a potentially convenient method for 
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distinction between viable and non-viable bacteria when present in PCs. Besides, this 
approach offers the possibility to investigate the bactericidal effect of plasma on bacteria 
contaminating PCs, in comparison with other platelet additive solutions (used as alternatives 
of plasma).  
The differentiation of viable and non-viable bacteria could be applicable to several clinical 
materials and useful in the diagnosis and treatment of infections. The assay has the potential 
to allow the monitoring of the effect of antibiotics. This would prevent the unnecessary use of 
antibiotics, a better management of patients and finally a reduction of health costs. However, 
further extensive studies with other clinical materials and a wide array of antibiotics are 
needed to determine the clinical utility of this approach.
The safety of blood components supply is a major public health concern. To remedy the risk 
of transfusion-transmitted bacterial infections, most attempts have been focused on pre-
transfusion detection of contamination. Several detection techniques have shown value, 
however, it is virtually impossible to guarantee ‘bacteria-free’ platelets supply. Therefore it 
would be worthy to combine different approaches contemplating current technologies. 
Attention should be given to the prevention of contamination by investigating for example 
other conditions to store PCs: 
Platelets are stored at room temperature for a regulated short storage period of maximal 7 
days. Next to the risk of bacterial contamination, platelets undergo during storage a number of 
changes that adversely affect their viability and hemostatic function (often referred as platelet 
storage lesion) after transfusion. Why platelets lose viability during storage has preoccupied 
several investigators in the past. It has been postulated that platelet possesses an intact 
mechanism of apoptosis. This mechanism is somehow enhanced during storage. Hitherto, 
must studies of apoptosis have been performed in nucleated cells, in which the nucleus is 
involved in the apoptotic process. However, 7 years ago Vanags et al. 
(1)
 reported on the 
existence of such a process in platelets (anucleated cells). Recently, Bertino et al 
(2)
. 
speculated that apoptosis is accelerated during storage at 37
o
C. It was also suggested that this 
process was responsible for the rapid decline in platelet cellular viability. 
In nucleate cells, it is well known that apoptosis includes two main pathways: one is triggered 
through death receptors, and the other is initiated by mitochondrial changes. Both pathways 
are not clearly understood, and involve the participation of a cascade of molecules. Fas is one 
of the most important molecules in death receptor-mediated pathway. The Bcl-2 family 
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proteins are involved in the mitochondrial-mediated pathway. Alterations in the ratio between 
pro-apoptotic (e.g. Bak, Bax, Bid) and anti-apoptotic (e.g. Bcl-XL) proteins are thought to be 
responsible for regulation of the apoptotic process 
(3,4)
. 
During a pilot study (not incorporated in the chapters of this thesis) Fas and Bcl-XL were 
employed as markers to study apoptosis during storage of PCs under standard blood banking 
conditions (i.e. room temperature for up to 7 days), and at 4
o
C and 37
o
C. Fas and Bcl-XL 
expression was studied using Pre-Developed Assay reagents (PDARs) in a reverse-
transcription Real-Time PCR. During storage the parameters to assess the viability of PCs 
(e.g. pH measurements, gas exchange and glucose metabolism) were monitored. 
Initially, the critical steps of the assay including the isolation of RNA from PCs, extraction 
and amplification efficiencies were optimized. Hypoxanthine ribosyl transferase (HPRT) was 
used as an endogene control for gene expression. 
The results demonstrated no significant differences in the expression of Bcl-XL over time and 
under different storage temperatures. On the other hand, a decrease in the expression of this 
marker was observed after 7 days at both room temperature and 37
o
C. These observations 
were in agreement with what was found by Bertino and coworkers 
(2)
.  
The expression of Fas was not found in routinely prepared PCs stored at room temperature, at 
4
o
C or at 37
o
C for up to 7 days. The expression was only detected in PCs stored at 37
o
C in the 
presence of anisomycin (an apoptosis inducer), although no alterations were registered in the 
loss of viability. However, the significance of these preliminary findings requires further 
investigations and extensive studies with different markers to establish a model for platelet 
apoptosis. Understanding apoptotic processes responsible for platelet storage lesion might 
provide insights into possibilities for inhibition of this phenomenon. This could be done by 
taking advantage of the availability of new advanced technologies such as RNA-interference 
(RNAi). Silencing genes involved in the decision to undergo apoptosis might result in 
extending the storage of platelets. 
Studying apoptosis in relation to loss of viability under different storage conditions remain to 
be carried out. These studies should be also aimed at reducing bacterial contamination while 
prolonging platelet shelf life. To achieve this, storage at lower temperatures (e.g. 4
o
C) seems 
more favorable. Storage at this temperature would be expected prevent bacteria from 
proliferating. Hoffmeister and collegues 
(5)
 described recently in a breakthrough study a 
simple in vitro method to maintain survival of platelets while stored at 4
o
C. It is well known 
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that cooled platelets are cleared rapidly after transfusion. This is due to the fact that on the 
surface of cooled platelets clusters of proteins form a receptor complex. This latter is 
recognized and phagocytozed. This process could be prevented by inducing glycosylation by 
adding Uridine Diphosphate-Galactose (UDP-G) before or after storage at 4
o
C 
(5)
. 
These promising developments may offer new perspectives in managing both the issue of the 
short shelf life of platelets and the concern of bacterial contamination in the foreseeable 
future.  
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Samenvatting  
Bloedplaatjes, ook wel trombocyten genoemd, zijn de kleinste ‘cellen’ in het bloed. Deze 
celfragmenten van voorlopercellen uit het beenmerg (megakaryocyten) zijn onontbeerlijk 
voor het in gang zetten van de hemostase (stoppen van bloedingen). 
In de bloedbaan circuleren bloedplaatjes als schijf-vormige celfragmenten. Bij beschadiging 
van de bloedvatwand vormen zij uitsteeksels, kleven aan elkaar (aggregatie) en aan de 
bloedvatwand (adhesie) en storten biochemische substanties uit waardoor stollingsfactoren 
worden geactiveerd. Eerst vormt zich een prop van bloedplaatjes die het gat voorlopig sluit, 
later dicht een stolsel het gat definitief.  
Bloedplaatjes worden toegediend aan patiënten met een ernstig tekort aan trombocyten 
(trombocytopenie) of aan patiënten met niet goed werkende bloedplaatjes en een verhoogd 
risico op bloedingen bijvoorbeeld tijdens een operatie, transplantatie of tijdens een 
behandeling met chemotherapie. 
 
Bloedplaatjes worden als concentraten getransfundeerd. Deze plaatjesconcentraten (PC) 
worden gemaakt van vol bloed. Na het doneren van ½ liter bloed door een gezonde 
vrijwilliger in een steriel systeem van bloedzakken, wordt het bloed gescheiden d.m.v 
centrifugatie in drie verschillende componenten: plasma, buffycoat en rode bloedcellen. In de 
buffycoat, de laag tussen plasma en rode bloedcellen, zijn de meeste bloedplaatjes en witte 
bloedcellen aanwezig. Voor een transfusie aan een volwassene worden vijf buffycoats 
samengevoegd met een eenheid plasma, dit mengsel wordt nogmaals gecentrifugeerd om een 
plaatjesconcentraat te krijgen. 
Na bereiding kunnen PC maximaal 7 dagen schuddend bij kamertemperatuur bewaard 
worden. Deze bewaarcondities maken de PC geschikt voor de groei van bacteriën. Transfusie 
van PC waarin bacteriën aanwezig zijn kan ernstige bloedvergiftiging (sepsis) bij ontvangers 
veroorzaken met soms dodelijke afloop. Om dit risico te verkleinen worden tijdens de afname 
en bereiding allerlei maatregelen genomen om binnendringen van bacteriën te voorkomen. 
Omdat die maatregelen niet altijd afdoende zijn, zijn methoden (technieken) nodig die met 
grote gevoeligheid en snelheid de aanwezigheid van bacteriën in PC kunnen aantonen vóór 
transfusie. 
In de afgelopen jaren zijn diverse methoden ontwikkeld en geïmplementeerd. Echter een 
ideale methode is nog niet beschikbaar. 
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In Nederland is sinds 1 november 2001 bacteriële screening van alle plaatjesconcentraten 
ingevoerd. Deze screening wordt gedaan met behulp van een geautomatiseerd kweeksysteem 
(BacT/Alert). Hiertoe wordt een PC monster van 5-10 mL geïnoculeerd in twee kweekflesjes 
van de BacT/Alert. Het ene flesje is bedoeld om bacteriën die zuurstof nodig hebben om te 
groeien aan te tonen en het andere om bacteriën die zonder zuurstof groeien aan te tonen. Het 
kweken duurt max. 7 dagen of totdat een positief signaal is gedetecteerd. PC worden 
uitgegeven op basis van “negative to date” criterium. Dit wil zeggen dat op het moment van 
uitgifte van de PC van de bloedbank aan het ziekenhuis, de kweek negatief is. 
Bij een positief resultaat van de kweek, worden PC en alle afgeleide bloedproducten (plasma 
en rode bloedcellen) van de betrokken donaties geblokkeerd of teruggeroepen voor 
respectievelijk, kweken, bevestiging (confirmatie) en identificatie van de gevonden bacteriën. 
Hoewel met de BacT/Alert de aanwezigheid van bacteriën opgespoord kan worden, is het 
resultaat meestal pas na 24-48 uur beschikbaar. Dit heeft als nadeel dat tijdens de 
incubatietijd, PC al uitgegeven en mogelijk 
getransfundeerd kunnen zijn. Het voornaamste doel van dit onderzoek was dan ook het 
ontwikkelen van een alternatieve methode die de beperking van het huidige kweeksysteem 
ondervangt. 
 
Zoals beschreven in hoofdstuk 2 werd een assay, gebaseerd op de real-time 16S rDNA PCR, 
ontwikkeld en geoptimaliseerd om bacterieel DNA in PC te detecteren. De eerste en tevens de 
belangrijkste stap in deze assay was het isoleren van het nucleïnezuur (DNA) uit het gewenste 
PC monster. Om een optimale gevoeligheid met deze assay te verkrijgen werden twee 
verschillende methoden om DNA te isoleren uit PC vergeleken. Met zowel de Nuclisens als 
de MagNA Pure methode werd een detectie limiet van 1 CFU/PCR bereikt. Rekening 
houdend met de bewerkingstijd, standaardisatie en reproduceerbaarheid, werd de voorkeur 
gegeven aan het volledig geautomatiseerd MagNA Pure systeem als het meest geschikte 
systeem voor isolatie van bacterieel DNA uit PC in routine. 
De gevoeligheid van de PCR assay kan beïnvloed worden door het ontstaan van vals-
positieve resultaten als gevolg van vermenigvuldiging (amplificatie) van contaminerend DNA 
aanwezig in PCR reagentia. Dit probleem deed zich voor tijdens de analytische validatie van 
de test. Om deze achtergrond contaminatie te reduceren werden twee strategieën gevolgd. Het 
effect van deze methoden op de gevoeligheid van de test is ook beschreven in Hfd 2. 
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De 16S rDNA PCR assay bestaat uit twee belangrijke stappen: de extractie van het nucleïne 
zuur uit het klinische materiaal gevolgd door de amplificatie van de gewenste target DNA 
sequentie. Om contaminatie in (real-time) PCR resultaten te voorkomen, is een efficiënte 
methode om DNA te isoleren vereist. De efficiëntie van extractie van DNA kan gemonitored 
worden door een isolatiecontrole tijdens het extractieproces mee te nemen. In Hfd 3 is het 
gebruik van de amplificatie van het HLADQα gen als isolatiecontrole beschreven. Dit gen is 
aanwezig in 2 kopieën in witte bloedcellen (WBC). Door gebruik te maken van een 
geconserveerd gedeelte van het HLA-DQA1 locus, kan de integriteit van het extractiesysteem 
getest worden. De test was reproduceerbaar en bleek ook geschikt te zijn als methode om het 
restant aantal WBC in PC waaruit leukocyten verwijderd zijn, te tellen. Omdat WBC in 
bloedproducten schadelijke effecten kunnen hebben voor de ontvangers, worden zij 
verwijderd tijdens de bereiding. Het restant aantal WBC moet minder dan 1 x 10
6 
zijn. Een 
vergelijkende studie tussen de real-time HLA-DQA1 PCR en WBC-telling met flow 
cytometrie (huidige gouden standaard) heeft laten zien dat de assay gevoelig, accuraat en snel 
is. Deze eigenschappen maken de HLA-DQA1 PCR test zeer geschikt om gebruikt te worden 
in de routine van PC screening op restant aantal WBC. 
Samenvattend kan de test twee doelen dienen: enerzijds kan het gebruikt worden als 
extractiecontrole van geautomatiseerde systemen uit bloed(producten), anderzijds als test om 
het restant aantal WBC in PC in bloedbanken te bepalen. 
 
Na het optimaliseren van alle stappen, was de 16S rDNA assay geschikt om gebruikt te 
worden om PC, in routine gemaakt, te screenen op de aanwezigheid van bacteriële 
contaminatie. Echter tijdens de eerste studies ontstond een probleem van vals-positieve 
resultaten. De bron was mogelijk het waterzuiveringsysteem van de fabrikant die de reagentia 
voor de extractie van DNA leverde. Reductie van deze contaminatie werd succesvol opgelost 
door de methoden beschreven in Hfd 4. 
De resultaten van de validatie van de PCR assay zijn beschreven in Hfd 5. Hierbij werden 
2.146 PC getest. Bacteriële screening werd gedaan met zowel PCR als met de BacT/Alert. De 
bevindingen van de PCR test waren in complete overeenstemming met die van het 
kweeksysteem m.b.t de gevoeligheid en specificiteit. De PCR assay heeft het voordeel van 
een korte opwerkingstijd (4 uur). Hiermee is het mogelijk om PC te testen vóór uitgifte of 
vlak vóór transfusie (in het ziekenhuis). Een belangrijk verschil tussen beide methoden, is dat 
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de PCR DNA detecteert dat afkomstig is van zowel levende als niet-levende bacteriën. Dit 
zou kunnen leiden tot onnodige verspilling (vernietigen) van schaarse bloedproducten. 
Alvorens besloten kan worden om deze methode te implementeren wordt daarom aanbevolen 
om een kosten-baten analyse uit te voeren. 
 
De gevoeligheid van een systeem om bacteriën te detecteren is verbonden aan twee factoren, 
i) het tijdstip van monstername: Tijdens de opslag van PC kan het aantal bacteriën (indien 
aanwezig) veranderen. Hierdoor wordt confirmatie ingewikkeld. Met andere woorden 
wanneer een monster wordt genomen op de dag van bereiding (dag 1) zal het merendeel van 
de detectiesystemen (hoe gevoelig dan ook) de aanwezigheid van bacteriën niet detecteren 
indien het aantal zeer laag is. Echter, wanneer bemonstering van PC plaats vindt vanaf dag 2 
(ongeveer 24 uur na bereiding), zal de meerderheid van systemen de aanwezigheid van 
bacteriën aantonen, ongeacht de gevoeligheid. 
ii) het volume van het genomen monster voor screening en de kans dat een bacterie aanwezig 
is in dit genomen monster. 
Om de optimale tijd te bepalen voor monstername van PC voor bacteriële screening werd een 
evaluatie van de PCR assay gedaan (Hfd 6). Hierbij werden PC gespiked met suspensies van 
E. coli, B. cereus, S. epidermidis, P. aeruginosa en P. acnes in (eind)concentraties van 1, 10 
en 100 CFU/mL. Met de PCR assay werden alle bacteriële species gedetecteerd binnen 4 uur, 
in monsters die genomen waren ongeveer 24 uur na inoculatie en bereiding onafhankelijk van 
de grootte van het inoculum. Daarentegen vereiste de detectie van bacteriën in de BacT/Alert 
een incubatie tijd van minstens 20.1 uur. 
In de routine van de bloedbank, geschiedt bemonstering van PC binnen 3 uur na bereiding 
voor het kweken in de BacT/Alert. Op basis van de resultaten van deze studie verdient het 
aanbeveling om de monstername een dag na bereiding uit te voeren. Wanneer beide methoden 
worden gebruikt om mogelijk gecontamineerd PC op te sporen en zo de veiligheid van 
transfusies van trombocyten te verbeteren, geeft de PCR het snelste een resultaat. 
Samenvattend, de PCR test voldoet aan de eisen van een ideale detectie methode als 
gedefinieerd in de introductie (Hfd 1). De assay heeft een gevoeligheid van 1 CFU/PCR (50 
CFU/mL), en is een verbetering van de huidige kweekmethode. De resultaten zijn binnen 4 
uur beschikbaar. De test kan uitgevoerd worden 1 dag na bereiding van PC. Het kan gebruikt 
worden vóór uitgifte of vlak voor toediening aan patiënten in het ziekenhuis. 
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Om onderscheid te maken tussen levende en dode bacteriën met de real-time PCR, werd een 
standaard ontwikkeld. Deze standaard werd in de test gebruikt (beschreven in Hfd 8) om 
gelijktijdig DNA en RNA te kwantificeren. Met deze kwantificering was het mogelijk om de 
groeifase van bacteriën in klinisch materiaal te bepalen. Tevens kon het effect van antibiotica 
op de groei van bacteriën gevolgd worden . Deze methode is 
geschikt voor het bepalen van de effectiviteit van antimicrobiële therapie in patiënten. Dit kan 
leiden tot het optimaliseren, aanpassen en verbeteren van behandelingsmethoden. 
In de Sanquin bloedbank regio Noordwest is Propionibacterium acnes verantwoordelijk voor 
de meeste gevallen van bacteriële contaminatie van PCs. Verondersteld wordt dat dit 
microorganisme afkomstig is van de huidflora van de donor. Verschillende maatregelen 
waaronder het verwijderen van de eerste 10 mL volbloed, en het verbeteren van desinfectie 
methoden van de arm van de donor hebben wel geleid tot een verlaging van het totaal aantal 
contaminaties maar niet tot een vermindering van contaminatie met Propionibacterium 
species. Een studie om de bron en de aard van de contaminanten te identificeren werd in Hfd 
7 uitgevoerd. M.b.v amplified fragment length polymorphism (AFLP) werden 
Propionibacterium isolaten uit  PCs en bijbehorende RBCs geanalyseerd. De isolaten konden 
in drie groepen ingedeeld worden. Groep 1 van de isolaten behoorde tot flora van het 
oppervlak van de huid en toonden complete homologie met P. acnes. Isolaten van groep 2 en 
3 verschilden op moleculair niveau van groep 1 en vielen waarschijnlijk onder een ander 
(sub)species. Wat de bron van deze contaminanten was bleef onbeantwoord. Vervolgstudies 
zijn nodig om andere bacteriën die geassocieerd zijn met contaminatie van bloedproducten te 
typeren. Inzicht krijgen in het mechanisme van contaminatie kan resulteren in het nemen van 
adequate maatregelen om contaminatie te voorkomen of in ieder geval te verminderen. 
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Résumé 
Les plaquettes ou thrombocytes sont des cellules sanguines anuclées produites dans la moelle 
osseuse par la fragmentation des mégacaryocytes. Elles sont responsables de la coagulation 
du sang. Quand il y a une lésion dans un vaisseau sanguin, les plaquettes adhèrent entere elle 
et au site de lésion, formant ainsi un « clou plaquettaire », suivie après par la formation d’un 
caillot sanguin. Ce dernier est indisponsable pour l’arrêt de saignement. 
Les plaquettes sont utilisées pour la transfusion des patients souffrant de thrombopénie ou de 
troubles de la fonction plaquettaire. Elles sont également administrées en cas d’augmentation 
du risque hémorragique pendant certaines interventions chirurgicales lourdes. 
 
Les plaquettes sont préparées à partir de sang total par centrifugation et séparation des 
composants sanguins. Le don de sang total prélevé au donneur est soumis à une centrifugation 
rapide, aboutissant à la séparation d’un concentré de globules rouges (CGR), d’une unité de 
plasma et entre les deux d’une couche leuco-plaquettaire (buffy coat). Pour une dose 
thérapeutique adulte les couches leuco-plaquettaires provenant de cinq dons de sang sont 
melangées avec une unité de plasma. Ce mélange subissait ensuite une seconde centrifugation 
(douce) pour obtenir enfin un concentré plaquettaire (CP). 
Le concentré de plaquettes est stocké entre 20 et 24
o
C sous agitation lente et permanente 
pendant 5 jours jusqu’ à  7 jours si un système de dépistage de CP contaminés est implementé. 
Ces conditions de stockage sont propices au proliferation des bactéries (lorsqu’elles sont 
présentes). 
 
La contamination bactérienne des CP constitue aujourd’hui le risque infectieux le plus 
important de la transfusion sanguine. Pour prévenir, ou du moins réduire, ce  risque plusieurs 
méthodes ont été mises en oeuvre pour identifier les CP contaminés. 
Aux Pays-Bas le système de culutre automatisée (automate: BacT/Alert) est utilisé depuis 
novembre 2001 pour dépsiter les CP contaminés. Après la prépartion des CP, un échantillon 
(5-10 ml) est inoculé dans les deux flacons de culture aéro- et anérobie de l’automate. Les 
cultures sont poursuivies 7 jours. Quand la survenue d’une culture positive est signalée le CP 
et tous les composants sanguins homologues (issus des mêmes dons) sont mises en 
quarantaine et envoyés pour confirmer et identifier les bactéries présentes. La faisabilité et la 
capacité de cette méthode pour la révélation des CP contaminés ont été demontrés. Or, le délai 
    
   133    
long pour obtenir des résultats (24 -48 heurs) constitue l’inconvénient principal de la culture 
automatisée: comme la distribution des CP repose sur le critère du « negative to date » des 
résultats positifs peuvent survenir après l’utilisation des CP. Ce qui représente un risque vital 
pour le patient transfusé. 
L’objectif principal de cette thèse était de développer une nouvelle méthode de détection qui 
permet le dépistage rapide des CP contaminés et qui évite les limitations de la culture 
automatisées. 
Une méthode moléculaire faisant appel à la technologie de la réaction de polymérisation en 
chaîne (PCR) en temps réel a été développée. Cette méthode repose sur la détection de 
l’ADNr 16S de bactéries par PCR quantitative en temps réel. Les étapes de développement et 
d’optimisation sont décrites aux chapitres 2, 3 et 4. les résultats démontrent la révélation de 
détecter 1 UFC/PCR (50UFC/mL) par l’ADNr 16S PCR. Les résultats sont disponibles en 4 
heures. Pour valider la méthode l’analyse sur 2146 CP a été realisée (chapitre 5). Cette 
validation a été menée en conjonction avec la culture automatisée. La performance de ce test 
en ce qui concerne la sensibilité et la spécificité est comparable à celle de la culture 
automatisée. L’avantage de la méthode est sa rapidité: on peut obtenir les résultats en 4 heures 
ce qui permet d’utiltiser le test immédiatemet avant la distribution ou la transfusion des CP.  
Pour déterminer le moment le plus convenable pour le prélèvement de l’échantillon à 
analyser, une étude (chapitre 6) était réalisée sur des CP volontairement contaminés avec des 
inoculums de 5 souches, afin d’obtenir une concentratin finale égale à 1, 10 et 100 UFC/mL. 
La culture automatisée était utilisée comme référence. Après 24 h de stockage d’incubation le 
PCR test a révélé la détection de toutes les souches dans 100% des cas en 4 heures. 
Cependant, la révelation par l’automate BacT/Alert nécessitait une incubation de 20.1 h (au 
minimum). Basé sur les résultats de cette étude il est donc préférable de prélever un 
échantillon pour l’analyse par le PCR un jour après la préparation des CP. 
 
La méthode de PCR quantitative ne permet pas de différencier entre l’ADN de bactéries 
viable et l’ADN de bactéries non viable. Pour distinguer entre les deux, une méthode basée 
sur la Transcription Inverse RT-PCR quantitative en temps réel a été developpée (chapitre 8). 
Cette méthode pourrait aussi être utilisée pour déterminer la sensibilité aux antibiotiques. En 
effect, la faisabilité de ce test reste a être démontrée. 
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Propionibacterium acnes est fréquemment impliquée dans la contamination des CP.  Cette 
bactérie est rarement considérée comme pathogène. Elle est vu comme un contaminant 
exogène de produits sanguins. Cette contamination pourrait être introduite au moment de 
prélèvement de sang total, particulièremnt lors de désinfection de la peau, à l’étape de la 
préparation des CP ou au moment de l’ensemencement des flacons de cultures de système 
BacT/Alert.  
Lors ce project, une étude a été menée pour identifier l’origine de la contamination des CP par 
P. acnes. Des souches de Propinibacterium provenant des CP et des CGR homologues (issus 
des mêmes dons) ont été alors analysées par la technique de l’AFLP (Polymorphisme de 
Longueur de Fragments Amplifiés). Sur la base des donnnées de l’AFLP (chapitre 7) les 
souches se retrouvent dans 3 groupes différents : le premier groupe  incluant la plupart des 
souches de P. acnes présentes à la surface de la peau. Le deuxième et le troisième groupe 
contenant des souches sont différents de premier groupe au niveau moléculair ce qui suggère 
que ses souches sont possiblement d’origine différente. Afin de mieux comprendre le 
mécanisme de contamination bactérienne des CP, d’autres études seront nécessaires pour 
mettre en évidence la diversité génétique des bactéries liées à la contamination de produits 
sanguins labiles. Une meilleure connaissance et caractérisation moléculaire des espèces 
impliquées dans la contamination pourrait améliorer la prévention du risque, au du moins la 
réduction de contamination bactérienne des CP. 
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Dankwoord 
Het onderzoek, beschreven in dit proefschrift, is uitgevoerd op verschillende locaties. Op 
iedere locatie heb ik veel aardige mensen leren kennen. Ieder heeft op zijn eigen manier 
bijgedragen aan de totstandkoming van dit boekje. Aan al deze mensen wil ik graag mijn dank 
betuigen. 
 
Prof.dr.C.M.J.E.Vandenbroucke-Grauls, promotor. Christina, toen ik aan dit 
promotieonderzoek begon, had ik geen promotor, geen co-promotor, geen werkplaats en geen 
lab om experimenten te doen. Het enige wat duidelijk was, was dat ik alleen drie jaar had om 
dit project af te ronden. Ik wil je daarom bedanken voor het feit dat jij mijn promotor wilde 
zijn en voor het bieden van de mogelijkheid om dit onderzoek binnen jouw afdeling uit te 
kunnen voeren. Dank voor de gedetailleerde reacties en correcties op mijn stukken. Ik heb er 
veel van geleerd. 
Dr. H.W. Reesink, co-promotor, ik ben u dankbaar dat u me de kans hebt gegeven om een 
promotieonderzoek te doen. Bedankt voor het vertrouwen en het respect waarmee u mij altijd 
heeft behandeld. Ik waardeer het zeer hoe snel (binnen drie dagen!) u ieder keer mijn stukken 
van commentaar hebt voorzien. 
Dr. P.H.M. Savelkoul, co-promotor. Paul, je was mijn ‘directe en echte’ begeleider. Zonder 
jou was dit project nooit tot een goed eind gekomen. Tijdens de eerste maanden (toen ik nog 
nergens bij hoorde) heb je de verantwoordelijkheid genomen om mij te begeleiden. Ik heb je 
begeleiding als zeer prettig en motiverend ervaren. Ik waardeer het zeer hoe je mij de ruimte 
en vrijheid gaf om op eigen wijze mijn eigen ‘stijl’ te ontwikkelen. Ik heb bewondering voor 
je grote inzicht en kennis. Heel erg bedankt voor alles en voor je steun vooral het afgelopen 
jaar. Je bent een bijzondere begeleider en een bijzonder mens! 
 
De leden van de leescommissie bestaand uit Prof.dr. P.C. Huijgens, Prof.dr. J.L.M. Meijer, 
Prof.dr .M.A. Blankenstein, Prof.dr. A. van Belkum, Dr. H.L. Zaaijer en Dr. T.M. Cuypers 
bedankt voor jullie tijd om mijn proefschrift te lezen en te beoordelen.  
 
Sanquin Bloedbank Noordwest:  
Ruby Pietersz (manager O&O&O), ik wil je graag bedanken voor al je hulp en steun bij het 
creëren en inrichten van mijn eigen ‘labjes’ binnen de bloedbank. Jij hebt altijd gezorgd dat ik 
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mij thuis voelde op jouw afdeling ook al was ik niet altijd aanwezig. Jouw inzicht in de 
bloedbankwereld en veel kennis op het gebied van trombocyten en bloedproducten hebben 
mij erg geholpen bij de opbouw en planning van mijn experimenten, maar ook bij het 
benaderen van de andere afdelingen/organisaties. Daarnaast wil ik jou bedanken voor het 
kritisch lezen van mijn stukken en voor je suggesties en adviezen. 
Pieter van der Meer, jij hebt mede gezorgd voor mijn aanstelling. Bedankt hiervoor en voor 
de samenwerking, interesse en collegialiteit. 
Mijn collega’s en kamergenoten: Marijke Kroonsberg, Marjan Eijzenga, Margriet Dijkstra-
Tiekstra, Lara Liefting en Leny Scholtalbers en ook Ido en Willy, bedankt voor de 
samenwerking en de prettige sfeer. Lara, Marjan en Leny bedankt voor jullie waardevolle 
bijdrage en assistentie bij het verzamelen van trombocyten. Leny bedankt ook voor jouw 
betrokkenheid bij mijn onderzoek en je bijdrage aan hfd. 6. Jullie waren allen altijd bereid om 
mij te helpen. Mijn hartelijke dank hiervoor. 
Moud Habibuw, ik weet niet hoe ik jou moet bedanken. Ik kan altijd op je rekenen. Bedankt 
voor je luisterend oor, vertrouwen en altruïsme. Ik hoop dat onze vriendschap voor altijd zal 
duren. Bahram Badlou bedankt voor de samenwerking en succes met het afronden van je 
proefschrift. 
 
Wil Dekker van de afdeling Kwaliteitscontrole wil ik bedanken voor haar geduld tijdens het 
zoeken en doorgeven van de positieve kweken. Ik weet dat ik jullie daarmee extra werk heb 
bezorgd. Ik wil ook van deze gelegenheid gebruik maken om jouw team bestaande uit 
Kenneth, Elita, Samina, Roselyn, Regina, Sjahnaz, Annet en Nejla te bedanken voor hun 
bereidwilligheid en grote inzet om monsters voor mij te nemen. Deze monsters dienden als 
basis voor hfd. 5. 
 
Daarnaast wil ik ook mijn collega’s van de afdeling Bewerking, Conny, Güner en Rashid 
hartelijk bedanken voor het regelen van trombocyten ook in tijden van schaarste.  
Mijn KB collega’s Els, Jan, Ina, Irma, Yvonne en Carola bedankt voor de leuke tijd op onze 
afdeling (die nu helaas niet meer bestaat). Els en Ina bedankt voor jullie steun en vriendschap. 
Verder wil ik Ronald Rombouts, Eric Jansen, Peter van den burg, Hans Vrielink, Guus 
Verhoeven, John Jongerius, Leo van den Thillart, Geert Ronduite, Harry Maring bedanken 
voor hun interesse. Frits Fijen en Erik Ludwig bedankt voor jullie hulp met de 
computerproblemen. Desanka Heidsieck bedankt voor al je hulp bij het regelen van afspraken, 
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voor het beantwoorden van allerlei vragen en vooral voor je sympathie. Titia, Michelle, alle 
meiden van het Lab, Ikram El Hamdaoui en Aïcha Ait soussan bedankt voor jullie 
collegialiteit.  
 
CLB: 
Theo Cuypers wil ik graag bedanken voor zijn steun en belangeloze hulp tijdens de eerste 
maanden. Eigenlijk was je ook een beetje mijn begeleider (vooral tijdens de eerste maanden). 
Ik kon altijd bij je terecht met mijn vragen en problemen. Je hebt me vaak op nieuwe ideeën 
gebracht. Ik wil je ook bedanken voor de ruimte (D010) die je beschikbaar hebt gesteld om 
mijn DNA isolaties uit te kunnen voeren.  
Marco Koppelman bedankt voor je hulp met de Nuclisens methode en veel succes met 
schrijven! 
 
Slotervaart Ziekenhuis, afdeling Bacteriologie: 
Loes Buisman en Mildred Moi-Thuk-Shung, ik ben jullie zeer erkentelijk voor het leveren 
van de positieve kweken en Propioni isolaten (een zeer grote klus!) voor hfd. 5 en 7 van dit 
proefschrift.  
 
Medische Microbiologie & Infectiepreventie (VUmc): 
Hans Zaaijer bedankt voor de rol die je voornamelijk gespeeld hebt bij het initiëren van dit 
project. Ook heb je gezorgd dat ik de eerste experimenten op de BacLab kon doen. Dankzij 
jou ben ik in contact gekomen met Christina en Paul. Daarnaast wil ik jou en Yvet ook 
bedanken voor het feit dat ik tijdelijk een kamer met jullie mocht delen.  
Khalil en Remco Bedankt voor de samenwerking en heel veel succes met het afronden van 
jullie proefschriften. Nog even doorbijten! 
Mijn dank gaat ook uit naar Arnold, Johan, Xander, Janet, Irma en alle andere van het BacLab 
en Naïma, Hans en Kishor van de mediabereiding. Gerda en Hinke bedankt voor jullie hulp 
bij het maken van diverse afspraken. 
Op de faculteit wil ik Ben en Wilbert bedanken voor de gastvrijheid. Mijn kamergenoten 
Monique, Paul Eijk, Marian en Marlies wil ik bedanken voor de prettige sfeer. Marlies, 
bedankt dat je mijn paranimf wilde zijn en voor je hulp, betrokkenheid en zorgzaamheid. Jij 
hebt ervoor gezorgd dat ik mijn plaats op de faculteit altijd bleef behouden. Bedankt voor de 
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leuke tijd en gesprekken en heel veel succes met jouw onderzoek. Madelon, bedankt voor jou 
hulp bij de AFLP experimenten. Mijn overige kamergenoten Joyce, Machteld, Nico en Wim 
bedankt voor jullie vriendelijkheid. 
Theo, bedankt voor het sequencen. Janneke, Marion, Astrid, Aziz en Iedereen van MMI en 
OM bedankt voor de collegialiteit. Abdallah veel succes met jouw onderzoek. Leo veel succes 
met het afronden van jouw proefschrift.  
 
Tot slot wil ik mijn ouders bedanken voor de genegenheid en stimulering. Mijn oom wil ik 
bedanken voor zijn belangrijke bijdrage in mijn vorming. Mijn zussen, broers, overige 
familieleden en vrienden wil ik bedanken voor hun volledige steun.  
 
Mocht ik iemand onbedoeld zijn vergeten, dan bied ik hierbij mijn excuses. Nogmaals 
bedankt allemaal! 
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